Document:

Credit Agreement dated as of August 11, 2005

 Exhibit 10.16 
 EXECUTION COPY 
  

 CREDIT AGREEMENT 
 dated as of 
 August 11, 2005 
 among 
 RAINIER ACQUISITION CORP., 
 as Borrower, 
 LCI HOLDCO, LLC 
 The Lenders Party Hereto

 and 
 JPMORGAN CHASE BANK,
N.A., 
 as Administrative Agent and Collateral Agent 
  

 J.P. MORGAN SECURITIES INC. and 
 GECC CAPITAL MARKETS GROUP, INC., 
 as Joint Lead Arrangers and Joint Bookrunning
Managers 
  

 GENERAL
ELECTRIC CAPITAL CORPORATION, 
 as Syndication Agent 
  

 BANC OF AMERICA SECURITIES LLC, 
 as Documentation Agent 
  

  

 LifeCare Credit Agreement 

 TABLE OF CONTENTS 
  

			
	 ARTICLE I Definitions
	  	1
		
	 SECTION 1.01. Defined Terms
	  	1
		
	 SECTION 1.02. Classification of Loans and Borrowings
	  	37
		
	 SECTION 1.03. Terms Generally
	  	37
		
	 SECTION 1.04. Accounting Terms; GAAP
	  	37
		
	 ARTICLE II The Credits
	  	38
		
	 SECTION 2.01. Commitments
	  	38
		
	 SECTION 2.02. Loans and Borrowings
	  	38
		
	 SECTION 2.03. Requests for Borrowings
	  	39
		
	 SECTION 2.04. Swingline Loans
	  	40
		
	 SECTION 2.05. Letters of Credit
	  	41
		
	 SECTION 2.06. Funding of Borrowings
	  	46
		
	 SECTION 2.07. Interest Elections
	  	47
		
	 SECTION 2.08. Termination and Reduction of Commitments
	  	48
		
	 SECTION 2.09. Repayment of Loans; Evidence of Debt
	  	49
		
	 SECTION 2.10. Amortization of Term Loans
	  	50
		
	 SECTION 2.11. Prepayment of Loans
	  	51
		
	 SECTION 2.12. Fees
	  	53
		
	 SECTION 2.13. Interest
	  	54
		
	 SECTION 2.14. Alternate Rate of Interest
	  	55

  

 LifeCare Credit Agreement 

			
		
	 SECTION 2.15. Increased Costs
	  	55
		
	 SECTION 2.16. Break Funding Payments
	  	56
		
	 SECTION 2.17. Taxes
	  	57
		
	 SECTION 2.18. Payments Generally; Pro Rata Treatment; Sharing of Setoffs
	  	58
		
	 SECTION 2.19. Mitigation Obligations; Replacement of Lenders
	  	60
		
	 SECTION 2.20. Incremental Extensions of Credit
	  	61
		
	 ARTICLE III Representations and Warranties
	  	62
		
	 SECTION 3.01. Organization; Powers
	  	62
		
	 SECTION 3.02. Authorization; Enforceability
	  	63
		
	 SECTION 3.03. Governmental Approvals; No Conflicts
	  	63
		
	 SECTION 3.04. Financial Condition; No Material Adverse Change
	  	63
		
	 SECTION 3.05. Properties
	  	64
		
	 SECTION 3.06. Litigation and Environmental Matters
	  	64
		
	 SECTION 3.07. Compliance with Laws; Healthcare Laws
	  	65
		
	 SECTION 3.08. Licenses, etc.
	  	65
		
	 SECTION 3.09. Investment and Holding Company Status
	  	67
		
	 SECTION 3.10. Taxes
	  	67
		
	 SECTION 3.11. ERISA; Margin Regulations
	  	67
		
	 SECTION 3.12. Disclosure
	  	68
		
	 SECTION 3.13. Subsidiaries
	  	68
		
	 SECTION 3.14. Insurance
	  	68

  

 Contents, p. 2 
 LifeCare Credit Agreement 

			
		
	 SECTION 3.15. Labor Matters
	  	68
		
	 SECTION 3.16. Solvency
	  	69
		
	 SECTION 3.17. Senior Debt
	  	69
		
	 SECTION 3.18. Acquisition
	  	69
		
	 SECTION 3.19. Security Documents
	  	70
		
	 SECTION 3.20. Liens
	  	71
		
	 SECTION 3.21. No Default
	  	71
		
	 SECTION 3.22. Casualty, Etc
	  	71
		
	 ARTICLE IV Conditions
	  	71
		
	 SECTION 4.01. Closing Date
	  	71
		
	 SECTION 4.02. Each Credit Event
	  	75
		
	 ARTICLE V Affirmative Covenants
	  	76
		
	 SECTION 5.01. Financial Statements and Other Information
	  	76
		
	 SECTION 5.02. Notices of Material Events
	  	78
		
	 SECTION 5.03. Information Regarding Collateral
	  	79
		
	 SECTION 5.04. Existence; Conduct of Business
	  	80
		
	 SECTION 5.05. Payment of Obligations
	  	80
		
	 SECTION 5.06. Maintenance of Properties
	  	80
		
	 SECTION 5.07. Insurance
	  	80
		
	 SECTION 5.08. Books and Records; Inspection and Audit Rights
	  	80
		
	 SECTION 5.09. Compliance with Laws
	  	81

  

 Contents, p. 3 
 LifeCare Credit Agreement 

			
	 SECTION 5.10. Use of Proceeds and Letters of Credit
	  	81
		
	 SECTION 5.11. Additional Subsidiaries
	  	81
		
	 SECTION 5.12. Further Assurances
	  	82
		
	 SECTION 5.13. Designation of Unrestricted Subsidiaries
	  	83
		
	 SECTION 5.14. Material Contracts
	  	84
		
	 SECTION 5.15. Healthcare Licenses
	  	84
		
	 SECTION 5.16. Interest Rate Hedging
	  	85
		
	 ARTICLE VI Negative Covenants
	  	85
		
	 SECTION 6.01. Indebtedness; Certain Equity Securities
	  	85
		
	 SECTION 6.02. Liens
	  	88
		
	 SECTION 6.03. Fundamental Changes
	  	90
		
	 SECTION 6.04. Investments, Loans, Advances, Guarantees and Acquisitions
	  	91
		
	 SECTION 6.05. Asset Sales
	  	94
		
	 SECTION 6.06. Sale and Leaseback Transactions
	  	95
		
	 SECTION 6.07. Swap Agreements
	  	95
		
	 SECTION 6.08. Restricted Payments; Certain Payments of Indebtedness
	  	96
		
	 SECTION 6.09. Transactions with Affiliates
	  	99
		
	 SECTION 6.10. Restrictive Agreements
	  	100
		
	 SECTION 6.11. Change in Business
	  	101
		
	 SECTION 6.12. Fiscal Year
	  	101
		
	 SECTION 6.13. Amendment of Material Documents
	  	102

  

 Contents, p. 4 
 LifeCare Credit Agreement 

			
	 SECTION 6.14. Interest Coverage Ratio
	  	102
		
	 SECTION 6.15. Leverage Ratio
	  	102
		
	 SECTION 6.16. Capital Expenditures
	  	103
		
	 SECTION 6.17. Partnerships, Etc
	  	103
		
	 ARTICLE VII Events of Default
	  	103
		
	 ARTICLE VIII The Agent
	  	107
		
	 ARTICLE IX Miscellaneous
	  	109
		
	 SECTION 9.01. Notices
	  	109
		
	 SECTION 9.02. Waivers; Amendments
	  	109
		
	 SECTION 9.03. Expenses; Indemnity; Damage Waiver
	  	113
		
	 SECTION 9.04. Successors and Assigns
	  	114
		
	 SECTION 9.05. Survival
	  	118
		
	 SECTION 9.06. Counterparts; Integration; Effectiveness
	  	119
		
	 SECTION 9.07. Severability
	  	119
		
	 SECTION 9.08. Right of Setoff
	  	119
		
	 SECTION 9.09. Governing Law; Jurisdiction; Consent to Service of Process
	  	119
		
	 SECTION 9.10. WAIVER OF JURY TRIAL
	  	120
		
	 SECTION 9.11. Headings
	  	120
		
	 SECTION 9.12. Confidentiality
	  	121
		
	 SECTION 9.13. Interest Rate Limitation
	  	121
		
	 SECTION 9.14. Termination or Release
	  	122
		
	 SECTION 9.15. USA Patriot Act
	  	122

  

 Contents, p. 5 
 LifeCare Credit Agreement 

 SCHEDULES: 
  

					
	 Schedule 2.01
	  	—	  	Commitments
	 Schedule 3.05
	  	—	  	Real Property
	 Schedule 3.06
	  	—	  	Disclosed Matters
	 Schedule 3.08(a)
	  	—	  	Payor Contracts; Provider Agreements
	 Schedule 3.08(b)
	  	—	  	Accreditation Matters
	 Schedule 3.08(c)
	  	—	  	Medicare Healthcare Facility Matters
	 Schedule 3.08(d)
	  	—	  	Medicaid Healthcare Facility Matters
	 Schedule 3.08(e)
	  	—	  	Cost Report Matters
	 Schedule 3.08(f)
	  	—	  	Healthcare Facilities
	 Schedule 3.13
	  	—	  	Subsidiaries
	 Schedule 3.14
	  	—	  	Insurance
	 Schedule 4.01
	  	—	  	Local Counsel
	 Schedule 6.01
	  	—	  	Existing Indebtedness
	 Schedule 6.02
	  	—	  	Existing Liens
	 Schedule 6.04
	  	—	  	Existing Investments
	 Schedule 6.09
	  	—	  	Transactions With Affiliates
	 Schedule 6.10
	  	—	  	Existing Restrictions

 EXHIBITS: 
  

					
	 Exhibit A
	  	—	  	Form of Assignment and Assumption
	 Exhibit B-1
	  	—	  	Form of Opinion of Ropes & Gray LLP
	 Exhibit B-2
	  	—	  	Form of Opinion of Local Counsel
	 Exhibit C
	  	—	  	Form of Collateral Agreement
	 Exhibit D
	  	—	  	Form of Perfection Certificate
	 Exhibit E
	  	—	  	Form of Affiliate Subordination Agreement
	 Exhibit F
	  	—	  	Form of Parent Guaranty
	 Exhibit G
	  	—	  	Form of Subsidiary Guaranty
	 Exhibit H
	  	—	  	Form of Mortgage
	 Exhibit I
	  	—	  	Form of Assumption Agreement

  

 Contents, p. 6 
 LifeCare Credit Agreement 

 CREDIT AGREEMENT dated as of August 11, 2005 (this “Agreement”), among RAINIER
ACQUISITION CORP., a Delaware corporation, LCI HOLDCO, LLC, a Delaware limited liability company, the LENDERS from time to time party hereto and JPMORGAN CHASE BANK, N.A., a national banking association, as administrative agent and collateral agent
for such lenders. 
  
 The parties hereto agree as follows:

  
 ARTICLE I 
  
 Definitions 
  
 SECTION 1.01. Defined Terms. As used in this Agreement, the following
terms have the meanings specified below: 
  
 “ABR”, when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are bearing interest at a rate determined by reference to the Alternate Base Rate. 
  
 “Acquisition” means the acquisition by Holdings of the
Company pursuant to the Merger Agreement, and the other transactions contemplated by the Merger Agreement and the documents related thereto. Such acquisition will be effected pursuant to a Merger of Rainier with the Company, in a transaction in
which the Company will be the surviving entity and a wholly owned subsidiary of Holdings. 
  
 “Adjusted LIBO Rate” means, with respect to any Eurodollar Borrowing for any Interest Period, an interest rate per annum (rounded upwards, if necessary, to the next 1/100 of 1%) equal to (a) the
LIBO Rate for such Interest Period multiplied by (b) the Statutory Reserve Rate. 
  
 “Administrative Agent” means JPMorgan Chase Bank, N.A., in its capacity as administrative agent for the Lenders under the Loan Documents. 
  
 “Administrative Questionnaire” means an Administrative Questionnaire in a form supplied by the
Administrative Agent. 
  
 “Affiliate” means, with
respect to a specified Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified. 
  
 “Affiliate Subordination Agreement” means an Affiliate
Subordination Agreement substantially in the form of Exhibit E pursuant to which intercompany obligations and advances owed by any Loan Party are subordinated to the Obligations. 
  
 “Agent” means JPMorgan Chase Bank, N.A., in its capacities as Administrative Agent and/or Collateral Agent,
and each of its Affiliates and successors 

  

 LifeCare Credit Agreement 

 
acting in any such capacity. The Administrative Agent may act on behalf of or in place of any Person included in the “Agent”. 
  
 “Alternate Base Rate” means, for any day, a rate per annum
equal to the greater of (a) the Prime Rate in effect on such day and (b) the Federal Funds Effective Rate in effect on such day plus  1/2 of 1%. Any change in the Alternate Base Rate due to a change in the Prime Rate or the Federal Funds Effective Rate shall be effective from and including the effective date of such change in the Prime
Rate or the Federal Funds Effective Rate, as the case may be. 
  
 “Applicable Percentage” means, with respect to any Revolving Lender, the percentage of the total Revolving Commitments represented by such Lender’s Revolving Commitment. If the Revolving Commitments have terminated or
expired, the Applicable Percentages shall be determined based upon the relative amounts of the Revolving Exposures of the Revolving Lenders. 
  
 “Applicable Rate” means, for any day, with respect to any ABR Loan or Eurodollar Loan that is a Revolving Loan or a Term Loan, or with
respect to the commitment fees payable hereunder, as the case may be, the applicable rate per annum set forth below under the caption “Term Loan ABR Spread”, “Revolving Loan ABR Spread”, “Term Loan Eurodollar Spread”,
“Revolving Loan Eurodollar Spread” or “Commitment Fee Rate”, as the case may be, based upon the Leverage Ratio as of the most recent determination date; provided that until the Borrower shall have delivered the financial
statements and certificate required by Section 5.01(a) and Section 5.01(c) for the period ended on December 31, 2005, the “Applicable Rate” shall be Category 1: 
  

																
	 Leverage Ratio:

	  	 Term Loan
 ABR Spread

	 	 	 Term Loan
 Eurodollar
 Spread

	 	 	 Revolving Loan
 ABR Spread

	 	 	 Revolving Loan
 Eurodollar
Spread

	 	 	 Commitment Fee
 Rate

	 
	 Category 1: Greater than or equal to 5.00 to 1.00
	  	1.25	%	 	2.25	%	 	1.25	%	 	2.25	%	 	0.50	%
	 Category 2: Less than 5.00 to 1.00 and greater than or equal to 4.25 to 1.00
	  	1.00	%	 	2.00	%	 	1.00	%	 	2.00	%	 	0.50	%
	 Category 3: Less than 4.25 to 1.00 and greater than or equal to 3.50 to 1.00
	  	1.00	%	 	2.00	%	 	0.75	%	 	1.75	%	 	0.375	%
	 Category 4: Less than 3.50 to 1.00
	  	1.00	%	 	2.00	%	 	0.50	%	 	1.50	%	 	0.375	%

  
 For purposes of the
foregoing, (i) the Leverage Ratio shall be determined as of the end of each fiscal quarter of the Borrower’s fiscal year based upon the consolidated financial statements delivered pursuant to Section 5.01(a) or (b) and
(ii) each change in the Applicable Rate resulting from a change in the Leverage Ratio shall be effective during the period commencing on and including the date of delivery to 

  

 LifeCare Credit Agreement 
 2 

 
the Administrative Agent of such consolidated financial statements indicating such change and ending on the date immediately preceding the effective date of
the next such change; provided that, at the option of the Required Lenders, the Leverage Ratio shall be deemed to be in Category 1 (A) at any time that an Event of Default has occurred and is continuing or (B) if the Borrower
fails to deliver the consolidated financial statements required to be delivered by it pursuant to Section 5.01(a) or (b), during the period from the expiration of the time for delivery thereof until such consolidated financial statements are
delivered. 
  
 “Approved Fund” has the meaning
assigned to such term in Section 9.04(b). 
  
 “Arrangers” means J.P. Morgan Securities Inc. and GECC Capital Markets Group, Inc., in their capacities as joint lead arrangers and joint bookrunning managers. 
  
 “Asset Disposition” means (a) any sale, transfer or other disposition (including pursuant to a sale
and leaseback transaction) of any property or asset of Holdings, the Borrower or any Subsidiary, other than (i) dispositions described in Section 6.05, other than clause (d) or (i) thereof, (ii) any disposition resulting in
Net Proceeds, whether through a single transaction or a series of related transactions, not exceeding $500,000, (iii) any financing transaction in the form of a sale and leaseback transaction with respect to a hospital constructed or acquired
by Holdings, the Borrower or any Subsidiary after the Closing Date, provided that such financing transaction occurs within 180 days after such construction or acquisition and the proceeds do not exceed the greater of (A) the cost and
(B) the fair market value thereof, and (iv) other dispositions resulting in aggregate Net Proceeds not exceeding $2,000,000 during any fiscal year of the Borrower, and (b) any casualty or other insured damage to, or any taking under
power of eminent domain or by condemnation or similar proceeding of, any property or asset of Holdings, the Borrower or any Subsidiary, but only in the case of this clause (b) to the extent that (i) the Net Proceeds therefrom, on an
aggregate basis, exceed $2,000,000 in any fiscal year and (ii) the application of the Net Proceeds of such event to the prepayment of the Term Loan hereunder would not violate any applicable laws. 
  
 “Assignment and Assumption” means an assignment and
assumption entered into by a Lender and an assignee (with the consent of any party whose consent is required by Section 9.04), and accepted by the Administrative Agent, in the form of Exhibit A or any other form approved by the
Administrative Agent. 
  
 “Assumption Agreement”
means an assumption agreement, in the form of Exhibit I hereto or otherwise in form and substance reasonably satisfactory to the Administrative Agent, executed and delivered by the Company to evidence the assumption by the Company of all obligations
of Rainier under the Loan Documents effective upon consummation of the Merger. 
  
 “Attributable Debt” means, on any date, in respect of any lease of the Borrower or any Subsidiary entered into as part of a sale and leaseback transaction 

  

 LifeCare Credit Agreement 
 3 

 
subject to Section 6.06, (a) if such lease is a Capital Lease Obligation, the capitalized amount thereof that would appear on a balance sheet of
such Person prepared as of such date in accordance with GAAP and (b) if such lease is not a Capital Lease Obligation, the capitalized amount of the remaining lease payments under such lease that would appear on a balance sheet of such Person
prepared as of such date in accordance with GAAP if such lease were accounted for as a Capital Lease Obligation. 
  
 “Below Threshold Asset Disposition Proceeds” means the aggregate cumulative amount of Net Proceeds received after the Closing Date that
would have constituted Net Proceeds of an Asset Disposition pursuant to clause (a) or (b) of the definition thereof except for the operation of clause (a)(iv) thereof. 
  
 “Below Threshold Asset Disposition Proceeds Uses” means the use by the Borrower of Below Threshold Asset
Disposition Proceeds to (a) make Investments pursuant to Section 6.04(r), (b) make Restricted Payments pursuant to Section 6.08(a)(vi), or (c) repurchase or repay Indebtedness pursuant to Section 6.08(b)(vii).

  
 “Board” means the Board of Governors of the
Federal Reserve System of the United States of America. 
  
 “Borrower” means (a) prior to the consummation of the Merger, Rainier, and (b) from and after the consummation of the Merger, the Company, as the surviving corporation in the Merger with Rainier. 
  
 “Borrowing” means (a) Loans of the same Class and Type,
made, converted or continued on the same date and, in the case of Eurodollar Loans, as to which a single Interest Period is in effect or (b) a Swingline Loan. 
  
 “Borrowing Request” means a request by the Borrower for a Borrowing in accordance with Section 2.03.

  
 “Borrower’s Portion of Excess Cash Flow”
means the aggregate cumulative amount of Excess Cash Flow for all fiscal years ending on or after December 31, 2006 that is not required pursuant to the provisions of Section 2.11(d) to be applied to the prepayment of Term Loans.

  
 “Business Day” means any day that is not a
Saturday, Sunday or other day on which commercial banks in New York City are authorized or required by law to remain closed; provided that, when used in connection with a Eurodollar Loan, the term “Business Day” shall also
exclude any day on which banks are not open for dealings in dollar deposits in the London interbank market. 
  
 “Capital Expenditures” means, for any period, without duplication, the additions to property, plant and equipment and other capital
expenditures of the Borrower and its consolidated Subsidiaries for such period, determined in accordance with GAAP; provided that Capital Expenditures shall not include any such expenditures which constitute (a) a Permitted Acquisition,
(b) expenditures made with Below Threshold Asset Disposition Proceeds or, to the extent permitted by this Agreement, a reinvestment 

  

 LifeCare Credit Agreement 
 4 

 
of the Net Proceeds of any Asset Disposition in accordance with Section 2.11(c), (c) expenditures made in connection with the replacement,
substitution, restoration or repair of assets to the extent financed with (i) insurance proceeds paid on account of the loss of or damage to the assets being replaced, restored or repaired or (ii) awards of compensation arising from the
taking by eminent domain or condemnation of the assets being replaced, (d) interest capitalized during such period, (e) expenditures that are accounted for as capital expenditures of such Person and that actually are paid for by a third
party (excluding Holdings, the Company or any Restricted Subsidiary thereof) and for which neither Holdings, the Company nor any Restricted Subsidiary thereof has provided or is required to provide or incur, directly or indirectly, any consideration
or obligation to such third party or any other person (whether before, during or after such period), (f) the book value of any asset owned by such person prior to or during such period to the extent that such book value is included as a capital
expenditure during such period as a result of such person reusing or beginning to reuse such asset during such period without a corresponding expenditure actually having been made in such period; provided that (A) any expenditure
necessary in order to permit such asset to be reused shall be included as a Capital Expenditure during the period that such expenditure actually is made and (B) such book value shall have been included in Capital Expenditures when such asset
was originally acquired, (g) the purchase price of equipment purchased during such period to the extent the consideration therefor consists of any combination of (A) used or surplus equipment traded in at the time of such purchase and
(B) the proceeds of a concurrent sale of used or surplus equipment, in each case, in the ordinary course of business, or (h) the purchase price of equipment that is purchased substantially contemporaneously with the trade-in of existing
equipment to the extent that the gross amount of such purchase price is reduced by the credit granted by the seller of such equipment for the equipment being traded in at such time. Anything contained herein to the contrary notwithstanding, the term
“Capital Expenditures” shall include the cost of any property (other than property acquired in a Permitted Acquisition) that is subject to a sale and leaseback transaction that does not constitute an Asset Disposition by reason of clause
(a)(iii) of the definition thereof. 
  
 “Capital
Expenditure Carryover Amount” has the meaning assigned to such term in Section 6.16. 
  
 “Capital Lease Obligations” of any Person means the obligations of such Person to pay rent or other amounts under any lease of (or other
arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such Person under GAAP (except for temporary
treatment of construction-related expenditures under EITF 97-10 “The Effects of Lessee Involvement in Asset Construction” that will be treated as operating leases upon a sale and leaseback transaction within 180 days after the completion
of construction thereof), and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP. 
  

 LifeCare Credit Agreement 
 5 

 “Change in Control” means: 
  
 (a) the acquisition of ownership, beneficially or of record,
by any Person other than Holdings of any Equity Interest in the Borrower; 
  
 (b) prior to an IPO, the failure by the Permitted Holders to own (and retain the right to vote), directly or indirectly through wholly owned investment vehicles, Equity Interests in Holdings representing more than 50%
of the aggregate ordinary voting power represented by the issued and outstanding Equity Interests in Holdings; 
  
 (c) after an IPO, the acquisition of ownership, directly or indirectly, beneficially or of record (except as may be held of record by the
Depository Trust Company after such IPO), by (i) any Person (other than a Permitted Holder) or (ii) any Persons (other than one or more Permitted Holders) that together (A) are a group (within the meaning of Section 13(d)(3) or
Section 14(d)(2) of the Securities Exchange Act of 1934 or any successor provision) or (B) are acting, for purposes of acquiring, holding or disposing of securities, as a group (within the meaning of Rule 13d-5(b)(1) of the Securities
Exchange Act of 1934 or any successor provision), in a single transaction or in a related series of transactions, by way of merger, consolidation or other business combination, purchase or otherwise, of Equity Interests in Holdings representing more
than 35% of the aggregate voting power represented by the outstanding Equity Interests in Holdings and representing a greater percentage of such aggregate ordinary voting power than that represented by Equity Interests in Holdings owned directly or
indirectly through one or more Parents by one or more Permitted Holders; 
  
 (d) occupation of a majority of the seats (other than vacant seats) on the board of directors of Holdings by Persons who were neither (i) nominated by the board of directors of Holdings, (ii) appointed by
Persons so nominated or (iii) otherwise designated by the Sponsor; or 
  
 (e) the occurrence of a “Change of Control”, as defined in the Senior Subordinated Debt Documents. 
  
 “Change in Law” means (a) the adoption of any law, rule or regulation after the date of this Agreement, (b) any change in any
law, rule or regulation or in the interpretation or application thereof by any Governmental Authority after the date of this Agreement or (c) compliance by any Lender or the Issuing Bank (or, for purposes of Section 2.15(b), by any lending
office of such Lender or by such Lender’s or the Issuing Bank’s holding company, if any) with any request, guideline or directive (whether or not having the force of law) of any Governmental Authority made or issued after the date of this
Agreement. 
  
 “Class”, when used in reference to
any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are Revolving Loans, Term Loans or Swingline Loans and, when used in reference to any Commitment, refers to whether such Commitment is a Revolving Commitment
or a Term Loan Commitment. 
  

 LifeCare Credit Agreement 
 6 

 “Closing Date” means the date on which the conditions specified in Section 4.01 are
satisfied (or waived in accordance with Section 9.02). 
  
 “CMS” means the Centers for Medicare and Medicaid Services of the United States Department of Health and Human Services, any successor thereof and any predecessor thereof, including the United States Health Care Financing
Administration. 
  
 “Code” means the Internal
Revenue Code of 1986, as amended from time to time. 
  
 “Collateral” means any and all “Collateral”, as defined in any Security Document, and shall include the Mortgaged Properties. 
  
 “Collateral Agent” means JPMorgan Chase Bank, N.A., in its capacity as collateral agent for the Secured
Parties under the Loan Documents. 
  
 “Collateral
Agreement” means the Security Agreement by Holdings, the Borrower and the Subsidiary Loan Parties party thereto in favor of the Agent, substantially in the form of Exhibit C. 
  
 “Collateral and Guarantee Requirement” means the requirement that: 
  
 (a) the Agent shall have received from each Loan Party
either (i) in the case of each Loan Party, a counterpart of the Collateral Agreement duly executed and delivered on behalf of such Loan Party or (ii) in the case of any Person that becomes a Loan Party after the Closing Date, a supplement
to the Collateral Agreement, in the form specified therein, duly executed and delivered on behalf of such Loan Party; 
  
 (b) the Agent shall have received from each Loan Party either (i) in the case of Holdings, a counterpart of the Parent Guaranty duly
executed and delivered on behalf of Holdings or, in the case of each Subsidiary Loan Party, a counterpart of the Subsidiary Guaranty duly executed and delivered on behalf of such Subsidiary Loan Party or (ii) in the case of any Person that
becomes a Subsidiary Loan Party after the Closing Date, a supplement to the Subsidiary Guaranty, in the form specified therein, duly executed and delivered on behalf of such Subsidiary Loan Party; 
  
 (c) all outstanding Equity Interests of the Borrower and
each Subsidiary owned by or on behalf of any Loan Party shall have been pledged pursuant to the Collateral Agreement (except that the Loan Parties shall not be required to pledge more than 66% of the outstanding voting Equity Interests of any
“first-tier” Foreign Subsidiary directly owned by a Loan Party) and the Agent shall have received all certificates or other instruments, if any, representing such Equity Interests, together with stock powers or other instruments of
transfer with respect thereto endorsed in blank; 
  

 LifeCare Credit Agreement 
 7 

 (d) all Indebtedness of the Borrower and each Subsidiary that is owing to any Loan Party
shall be pledged or assigned as security pursuant to the Collateral Agreement (except to the extent any such pledge or assignment would violate applicable law), and the Agent shall have received any promissory notes evidencing such Indebtedness,
together with note powers or other instruments of transfer with respect thereto endorsed in blank, and all such Indebtedness shall be subordinated to the Obligations pursuant to the Affiliate Subordination Agreement; 
  
 (e) except as otherwise specifically contemplated by any
Security Document, all documents and instruments, including Uniform Commercial Code financing statements, required by law or reasonably requested by the Agent to be filed, registered or recorded to create the Liens intended to be created by the
Collateral Agreement (including any supplements thereto) and perfect such Liens to the extent required by, and with the priority required by, the Collateral Agreement, shall have been filed, registered or recorded or delivered to the Agent for
filing, registration or recording; 
  
 (f) the
Agent shall have received with respect to each Mortgaged Property: 
  
 (i) counterparts of a Mortgage duly executed, acknowledged and delivered by the record owner of such Mortgaged Property, and suitable for recording or filing; 
  
 (ii) a policy or policies of title insurance issued by a
nationally recognized title insurance company insuring the Lien of each such Mortgage as a valid first Lien on the Mortgaged Property described therein, free of any other Liens except as expressly permitted by Section 6.02, together with such
endorsements, coinsurance and reinsurance as the Agent or the Required Lenders may reasonably request; and 
  
 (iii) an American Land Title Association/American Congress on Surveying and Mapping form survey, and dated a recent date reasonably
acceptable to the Agent certified to the Agent and the title insurance company in a manner reasonably satisfactory to the Agent by a land surveyor duly registered and licensed in the states in which the real property described in such surveys is
located and acceptable to the Agent, showing all buildings and other improvements, any off-site improvements, the location of any easements, parking spaces, rights of way, building set-back lines and other dimensional regulations and the absence of
encroachments, either by such improvements or on to such property, and other defects, other than encroachments and other defects reasonably acceptable to the Agent; and 
  
 (g) except as otherwise specifically contemplated by any Security Document, each Loan Party shall have
obtained all consents and approvals required to be obtained by it in connection with the execution and delivery of all Security Documents (or supplements thereto) to which it is a party, the 

  

 LifeCare Credit Agreement 
 8 

 
performance of its obligations thereunder and the granting by it of the Liens thereunder. 
  
 Notwithstanding anything to the contrary in this Agreement or in any Security Document, no Loan Party shall be required to perfect security
interests, liens or mortgages in particular assets or property of such Loan Party if, in the reasonable judgment of the Administrative Agent or the Collateral Agent, the burden of perfecting such security interests, liens or mortgages is excessive
in relation to the benefits to the Lenders therefrom. 
  
 “Commitment” means a Revolving Commitment, a Term Loan Commitment or any combination thereof (as the context requires). 
  
 “Company” means LifeCare Holdings, Inc., a Delaware corporation. 
  
 “Consolidated Cash Interest Expense” means, for any period, the excess of (a) the sum of (i) the
interest expense (including imputed interest expense in respect of Capital Lease Obligations), of the Borrower and the Subsidiaries for such period, determined on a consolidated basis in accordance with GAAP, plus (ii) any cash payments
made during such period in respect of obligations referred to in clause (b)(ii) below that were amortized or accrued in a previous period, minus (b) the sum of (i) to the extent included in the Borrower’s consolidated
interest expense for such period, amounts attributable to amortization of financing costs, plus (ii) to the extent included in the Borrower’s consolidated interest expense for such period, non-cash amounts attributable to
amortization of debt discounts or accrued interest payable in kind or other non-cash interest expense, plus (iii) to the extent included in the Borrower’s consolidated interest expense for such period, any one time financing fees,
including those paid in connection with the Transactions, or in connection with any amendment of the Agreement, plus (iv) cash interest income of the Borrower and the Subsidiaries for such period. For purposes of the foregoing, interest
expense of any Person shall be determined after giving effect to any net payments made or received by such Person with respect to interest rate Swap Agreements (other than early termination payments). 
  
 “Consolidated EBITDA” means, for any period, Consolidated
Net Income for such period plus (a) without duplication and to the extent deducted in determining such Consolidated Net Income, the sum of (i) consolidated interest expense for such period (net of interest income for such period),
(ii) consolidated income tax expense for such period, including state franchise and similar taxes, (iii) all amounts attributable to depreciation and amortization for such period, (iv) any non-cash charges for such period
(provided, however, that any cash payment or expenditure made with respect to any such non-cash charge shall be subtracted in computing Consolidated EBITDA during the period in which such cash payment or expenditure is made),
including, without limitation, any non-cash compensation charge arising from any grant of stock, stock options or other equity-based awards and non-cash pension and post-employment benefit expenses, (v) non-recurring fees and expenses of the
Borrower and the Subsidiaries payable in connection with the issuance of Equity Interests, incurrence of Indebtedness permitted hereunder or any Permitted Acquisition or other Investment permitted 

  

 LifeCare Credit Agreement 
 9 

 
hereunder (in each case whether or not successful), (vi) other non-recurring charges and expenses, including with respect to severance costs, facilities
openings, closings and consolidation, relocation or integration costs and other restructuring charges and expenses, provided that such charges or expenses are identified as nonrecurring and set forth in reasonable detail in a schedule to the
certificate of a Financial Officer pursuant to Section 5.01(c)(x), (vii) any non-cash decrease in consolidated revenues during such period resulting from purchase accounting adjustments made in accordance with GAAP in connection with the
Acquisition or any Permitted Acquisitions, (viii) to the extent actually reimbursed, expenses incurred to the extent covered by indemnification provisions in any agreement in connection with the Acquisition or a Permitted Acquisition,
(ix) to the extent covered by insurance, expenses with respect to liability or casualty events or business interruption, (x) management, monitoring, consulting and advisory fees and related expenses and any other fees and expenses
(including Sponsor Termination Fees) (or any accruals relating to such fees and related expenses) paid under Section 6.09(e), (xi) cost-savings initiatives (other than those related to or contemplated by the Acquisition, any Permitted
Acquisition or any Asset Disposition) reflecting cost savings realizable in the next succeeding four fiscal quarters, provided that either (A) the amount thereof would be properly included in a financial statement prepared in accordance
with Regulation S-X under the Securities Act of 1933, as amended, and all other accounting rules and regulations of the SEC promulgated thereunder applicable to a registration statement under such Act on Form S-1, or (B) such amount is approved
by the Administrative Agent in its discretion, and (xii) the amount of startup losses at any long-term acute care hospital operated by the Borrower or its Subsidiaries, which amount will be based on a calculation in good faith by the Borrower
as set forth in a certificate from a Financial Officer delivered to the Administrative Agent in an aggregate amount per four-quarter period not to exceed the greater of $7.5 million and 10% of Consolidated EBITDA for such period (excluding this
clause (xii)), and minus (b) without duplication and to the extent included in determining such Consolidated Net Income, the sum of (i) any non-cash gains or other non-cash items of income (excluding, in each case, the accrual of
revenue and the reversal of reserves) for such period (provided that any cash received in a subsequent period in respect of any such non-cash gain or other non-cash item of income shall be included in Consolidated EBITDA for the period in
which received) and (ii) any increase in consolidated revenues during such period resulting from purchase accounting adjustments made in accordance with GAAP in connection with the Acquisition or any Permitted Acquisition. 
  
 “Consolidated Net Income” means, for any period, the net
income or loss of the Borrower and the Subsidiaries for such period determined on a consolidated basis in accordance with GAAP; provided that: 
  
 (a) (i) net income for such period of any Person that is not a subsidiary of such Person, or that is accounted for by the equity
method of accounting, shall be included only to the extent of the amount of dividends or distributions paid in cash (or to the extent converted into cash) to the referent Person or a subsidiary thereof in respect of such period and (ii) the net
income for such period shall include any ordinary course dividend distribution or other payment in cash received from any Person in excess of the amounts included in clause (i); and 
  

 LifeCare Credit Agreement 
 10 

 (b) there shall be excluded: (i) accruals and reserves that are established within
twelve months after the Closing Date and that are so required to be established in accordance with GAAP; provided that any such accruals or reserves paid in cash shall be deducted from Consolidated Net Income for the period in which paid
unless excluded pursuant to another clause of this definition; 
  
 (ii) the income or loss of any Person accrued prior to the date it becomes a Subsidiary or is merged into or consolidated with the Borrower or any Subsidiary or the date that such Person’s assets are acquired by
the Borrower or any Subsidiary; 
  
 (iii) the
cumulative effect of any change in accounting principles during such period; 
  
 (iv) any gain or loss realized upon the sale or other disposition of any assets of the Borrower or its Subsidiaries that are not sold or otherwise disposed of in the ordinary course of business and any gain or loss
realized upon the sale or other disposition of any Equity Interests of any Person and any extraordinary gains or losses; 
  
 (v) any non-cash SFAS 133 income (or loss) related to hedging activities; 
  
 (vi) all deferred financing costs written off, premiums paid and other net gains or losses in connection
with any early extinguishment of Indebtedness; 
  
 (vii) any non-cash impairment charges resulting from the application of SFAS Nos. 142 and 144 and the amortization of intangibles arising pursuant to SFAS No. 141; 
  
 (viii) any non-cash expense or gain related to recording of the fair market value of Swap Agreements, in
each case entered into in the ordinary course of business and not for speculative purposes; and 
  
 (ix) unrealized gains and losses relating to hedging transactions and mark-to-market of Indebtedness denominated in foreign currencies
resulting from the application of FAS 52. 
  
 “Consolidated Total Assets” means, as at any date of determination, the aggregate amount of assets reflected on the consolidated balance sheet of the Borrower and the Subsidiaries most recently delivered by the Borrower
pursuant to Section 5.01 on or prior to such date of determination. 
  
 “Contract Provider” means any Person or any employee, agent or subcontractor of such Person who provides professional health care services under or pursuant to any contract with any Loan Party.

  
 “Control” means the possession, directly or
indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through 

  

 LifeCare Credit Agreement 
 11 

 
the ability to exercise voting power, by contract or otherwise. “Controlling” and “Controlled” have meanings correlative
thereto. 
  
 “Cure Amount” has the meaning
assigned to such term in Article VII. 
  
 “Cure
Right” has the meaning assigned to such term in Article VII. 
  
 “Debt Issuance” means (a) the incurrence by Holdings, the Borrower or any Subsidiary of any Indebtedness, other than Indebtedness permitted by Section 6.01(a)(i)-(xviii) and Permitted
Holdings Debt, (b) the incurrence of any Permitted Subordinated Indebtedness, the proceeds of which are not applied pursuant to Section 6.01(a)(xviii)(A), and (c) the incurrence of any Permitted Holdings Debt unless no Default has
occurred and is continuing or would result therefrom and either (i) the proceeds of which (A) are used by Holdings to acquire assets that are contributed to the Borrower as a Permitted Acquisition or (B) are contributed to the
Borrower and applied to consummate one or more Permitted Acquisitions or (ii) after giving effect to the incurrence of such Permitted Holdings Debt, the Holdings Leverage Ratio would be less than 6.25:1.00. 
  
 “Default” means any event or condition that constitutes an
Event of Default or which upon notice, lapse of time or both would, unless cured or waived, become an Event of Default. 
  
 “Defaulting Lender” means any Lender which has defaulted in the performance of any of its material obligations to the Borrower under this
Agreement for so long as such Lender has not cured or remedied all such defaults. 
  
 “Designated Excess Cash Flow Expenditures” means the cash expenditures made by the Borrower and the Subsidiaries from the Borrower’s Portion of Excess Cash Flow (a) to make Restricted
Payments pursuant to Section 6.08(a)(v)(B), (b) to repurchase or repay Indebtedness pursuant to Section 6.08(b)(v)(B), or (c) to make Investments pursuant to Section 6.04(d) or (k). 
  
 “Disclosed Matters” means the actions, suits and proceedings
and the environmental matters disclosed in Schedule 3.06. 
  
 “Domestic Subsidiary” means any Subsidiary that is organized under the laws of the United States of America, any State thereof or the District of Columbia and that is not a “Controlled Foreign Corporation” as such
term is defined in the Code. 
  
 “dollars” or
“$” refers to lawful money of the United States of America. 
  
 “Eligible Equity Proceeds” means Equity Proceeds received by Holdings and contributed by Holdings in cash to the common equity of the Borrower, other than any such Equity Proceeds
(i) constituting Cure Amounts from the issuance of Permitted Cure Securities or (ii) received by Holdings from officers, employees, directors or consultants of Holdings, the Borrower or its Subsidiaries under stock purchase, stock option
or other incentive plans or arrangements. 
  

 LifeCare Credit Agreement 
 12 

 “Eligible Equity Proceeds Uses” means the use by the Borrower of Eligible Equity
Proceeds to (a) make Investments pursuant to Section 6.04(o), (b) make Restricted Payments pursuant to Section 6.08(a)(iv), (c) repurchase or repay Indebtedness pursuant to Section 6.08(b)(vi) or (d) make Capital
Expenditures. 
  
 “Environmental Laws” means all
applicable federal, state, and local laws (including common law), regulations, rules, ordinances, codes, decrees, judgments, directives, orders (including consent orders), and binding agreements with any Governmental Authority in each case, relating
to protection of the environment, natural resources, human health and safety from exposure to Hazardous Materials or the presence, Release of, or exposure to, Hazardous Materials, or the generation, manufacture, processing, distribution, use,
treatment, storage, transport, recycling or handling of, or the arrangement for such activities with respect to, Hazardous Materials. 
  
 “Environmental Liability” means any liability, claim, action, suit, judgment or order under or relating to any Environmental Law for any
damages, injunctive relief, losses, fines, penalties, fees, expenses (including reasonable fees and expenses of attorneys and consultants) or costs, whether contingent or otherwise, including those arising from or relating to: (a) compliance or
non-compliance with any Environmental Law, (b) the generation, use, handling, transportation, storage, treatment or disposal of any Hazardous Materials, (c) exposure to any Hazardous Materials, (d) the Release of any Hazardous
Materials or (e) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing. 
  
 “Equity Financing” means (i) the indirect purchases through the Parent by Permitted Holders of Equity
Interests of Holdings and/or the indirect contributions by Permitted Holders through the Parent to the equity capital of Holdings for aggregate cash consideration of $170,700,000 and (ii) the use by Holdings of the full amount of such cash
indirectly received from the Permitted Holders through the Parent (other than cash previously utilized to pay such expenses) to make a cash contribution to the common equity of the Borrower, in each case on or prior to the Closing Date. 

 
 “Equity Interests” means shares of capital stock,
partnership interests, membership interests in a limited liability company, beneficial interests in a trust or other equity ownership interests in a Person of whatever nature, and any warrants, options or other rights entitling the holder thereof to
purchase or acquire any of the foregoing. 
  
 “Equity
Proceeds” means the Net Proceeds received by Holdings from contributions to its common equity or from the issuance and sale of its common Equity Interests or Non-Cash Pay Preferred Stock, in each case other than pursuant to the Equity
Financing. 
  
 “ERISA” means the Employee
Retirement Income Security Act of 1974, as amended from time to time. 
  

 LifeCare Credit Agreement 
 13 

 “ERISA Affiliate” means any trade or business (whether or not incorporated) that,
together with the Borrower, is treated as a single employer under Section 414(b) or (c) of the Code or, solely for purposes of Section 302 of ERISA and Section 412 of the Code, is treated as a single employer under
Section 414 of the Code. 
  
 “ERISA Event”
means (a) any “reportable event”, as defined in Section 4043 of ERISA or the regulations issued thereunder with respect to a Plan (other than an event for which the 30-day notice period is waived); (b) the existence with
respect to any Plan of an “accumulated funding deficiency” (as defined in Section 412 of the Code or Section 302 of ERISA), whether or not waived; (c) the filing pursuant to Section 412(d) of the Code or
Section 303(d) of ERISA of an application for a waiver of the minimum funding standard with respect to any Plan; (d) the incurrence by the Borrower or any of its ERISA Affiliates of any liability under Title IV of ERISA with respect
to the termination of any Plan; (e) the receipt by the Borrower or any ERISA Affiliate from the PBGC or a plan administrator of any notice relating to an intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan;
(f) the incurrence by the Borrower or any of its ERISA Affiliates of any liability with respect to the withdrawal or partial withdrawal from any Plan or Multiemployer Plan; or (g) the receipt by the Borrower or any ERISA Affiliate of any
notice, or the receipt by any Multiemployer Plan from the Borrower or any ERISA Affiliate of any notice, concerning the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be, insolvent or in
reorganization, within the meaning of Title IV of ERISA. 
  
 “Eurodollar”, when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are bearing interest at a rate determined by reference to the Adjusted LIBO Rate.

  
 “Event of Default” has the meaning assigned
to such term in Article VII. 
  
 “Excess Cash
Flow” means, for any fiscal year, the sum (without duplication) of: 
  
 (a) Consolidated Net Income for such fiscal year, adjusted to exclude any gains or losses attributable to Prepayment Events; plus 
  
 (b) depreciation, amortization and other non-cash charges or losses (other than non-cash charges to the
extent that they represent a reserve for future cash payments or to the extent any cash payment is made in respect thereof) deducted in determining such Consolidated Net Income for such fiscal year; plus 
  
 (c) the sum of (i) the amount, if any, by which Net
Working Capital decreased during such fiscal year (except as a result of reclassification of items from short-term to long-term) plus (ii) the net amount, if any, by which the deferred income taxes of Holdings, the Borrower and its
consolidated Subsidiaries increased during such fiscal year; minus 
  

 LifeCare Credit Agreement 
 14 

 (d) the sum of (i) any non-cash gains included in determining such Consolidated Net
Income for such fiscal year plus (ii) the amount, if any, by which Net Working Capital increased during such fiscal year (except as a result of reclassification of items from long-term to short-term) plus (iii) the net
amount, if any, by which the deferred income taxes of Holdings, the Borrower and its consolidated Subsidiaries decreased during such fiscal year; minus 
  

(e) the sum of (i) Capital Expenditures for such fiscal year (except to the extent attributable to the incurrence of Capital Lease
Obligations or otherwise financed by incurring Long-Term Indebtedness, or deducted in a prior fiscal year pursuant to clause (k) of this definition) plus (ii) cash consideration paid during such fiscal year to make acquisitions or
other capital investments (other than Permitted Investments and except to the extent financed by incurring Long-Term Indebtedness); minus 
  
 (f) Taxes for which reserves have been established in accordance with GAAP, to the extent not reflected in the computation of Consolidated
Net Income, provided that any amount so deducted shall be added to Excess Cash Flow in respect of any subsequent fiscal year in which such Taxes reduced Consolidated Net Income; minus 
  
 (g) cash expenditures made in respect of Swap Agreements
during such fiscal year, to the extent not reflected in the computation of Consolidated Net Income; plus 
  
 (h) cash payments received in respect of Swap Agreements during such fiscal year to the extent not included in the computation of
Consolidated Net Income; minus 
  
 (i) the aggregate principal amount of Long-Term Indebtedness repaid or prepaid by the Borrower and its Subsidiaries during such fiscal year, excluding (i) Indebtedness in respect of Revolving Loans and Letters of Credit (but only
to the extent Revolving Commitments were not simultaneously reduced), (ii) Term Loans prepaid pursuant to Section 2.11(c) or (d) and (iii) repayments or prepayments of Long-Term Indebtedness made with Eligible Equity Proceeds or
financed by incurring other Long-Term Indebtedness; minus 
  
 (j) permitted dividends and distributions or repurchases of its Equity Interests paid in cash by the Borrower during such fiscal year and permitted dividends paid in cash by any Subsidiary during such fiscal year
to any Person other than Holdings, the Borrower or any of the Subsidiaries, in each case pursuant to and in accordance with Section 6.08, other than Section 6.08(a)(iv) or (a)(v)(B); minus 
  
 (k) Capital Expenditures that the Borrower or any Subsidiary
shall, during such fiscal year, become obligated to make but that are not made during such fiscal year, provided that the Borrower shall deliver a certificate to the 

  

 LifeCare Credit Agreement 
 15 

 
Administrative Agent not later than 105 days after the end of such fiscal year, signed by an officer of the Borrower and certifying that such Capital
Expenditures and the delivery of the related equipment will be made in the following fiscal year; minus 
  
 (l) to the extent not deducted in the computation of Net Proceeds in respect of any asset disposition, casualty or condemnation giving
rise thereto, the amount of any mandatory prepayment of Indebtedness (other than Indebtedness created hereunder or under any other Loan Document), together with any interest, premium or penalties required to be paid (and actually paid) in connection
therewith; minus 
  
 (m) amounts paid
in cash during such fiscal year on account of items that were accounted for as non-cash reductions in determining Consolidated Net Income in a prior fiscal year and were added back in determining Excess Cash Flow in respect of such prior fiscal
year. 
  
 “Excluded Taxes” means, with respect to
the Administrative Agent, any Lender, the Issuing Bank or any other recipient of any payment to be made by or on account of any obligation of the Borrower hereunder, (a) net income or franchise taxes imposed on (or measured by) its net income
by the United States of America, or by the jurisdiction under the laws of which such recipient is organized or in which its principal office is located or, in the case of any Lender, in which its applicable lending office is located, (b) any
branch profits taxes imposed by the United States of America or any similar tax imposed by any other jurisdiction described in clause (a) above, (c) in the case of a Foreign Lender (other than an assignee pursuant to a request by the
Borrower under Section 2.19(b)), any withholding tax that is in effect and would apply to amounts payable to such Foreign Lender at the time such Foreign Lender becomes a party to this Agreement (or designates a new lending office), except to
the extent that such Foreign Lender (or its assignor, if any) was entitled, at the time of designation of a new lending office (or assignment), to receive additional amounts from the Borrower with respect to any withholding tax pursuant to
Section 2.17(a), and (d) any withholding tax that is attributable to such Foreign Lender’s failure to comply with Section 2.17(e), unless such failure is due to a Change in Law after the Foreign Lender became a party to this
Agreement or where compliance with Section 2.17(e) is not required. 
  
 “Federal Funds Effective Rate” means, for any day, the weighted average (rounded upwards, if necessary, to the next 1/100 of 1%) of the rates on overnight Federal funds transactions with members of
the Federal Reserve System arranged by Federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve Bank of New York, or, if such rate is not so published for any day that is a Business Day, the average
(rounded upwards, if necessary, to the next 1/100 of 1%) of the quotations for such day for such transactions received by the Administrative Agent from three Federal funds brokers of recognized standing selected by it. 
  
 “Financial Covenants” means the covenants set forth in
Sections 6.14 and 6.15. 
  

 LifeCare Credit Agreement 
 16 

 “Financial Officer” means the chief financial officer, principal accounting officer,
treasurer or controller of the Borrower. 
  
 “Financing
Transactions” means (a) the execution, delivery and performance by each Loan Party of the Loan Documents to which it is to be a party, the borrowing of Loans, the use of the proceeds thereof and the issuance of Letters of Credit
hereunder, (b) the execution, delivery and performance by each Loan Party of the Senior Subordinated Debt Documents to which it is to be a party, the issuance of the Senior Subordinated Debt and the use of the proceeds thereof and (c) the
Equity Financing. 
  
 “Foreign Lender” means any
Lender that is organized under the laws of a jurisdiction other than the United States of America. For purposes of this definition, the United States of America includes the United States, each State thereof and the District of Columbia. 

 
 “Foreign Subsidiary” means any Subsidiary that is not a
Domestic Subsidiary. 
  
 “GAAP” means generally
accepted accounting principles in the United States of America. 
  
 “Governmental Authority” means the government of the United States of America, any other nation or any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body,
court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government. 
  
 “Guarantee” of or by any Person (the “guarantor”) means any obligation, contingent or
otherwise, of the guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other obligation of any other Person (the “primary obligor”) in any manner, whether directly or indirectly, and including any
obligation of the guarantor, direct or indirect, (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation or to purchase (or to advance or supply funds for the purchase of) any
security for the payment thereof, (b) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness or other obligation of the payment thereof, (c) to maintain working capital, equity
capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation or (d) as an account party in respect of any letter of credit or letter of
guaranty issued to support such Indebtedness or obligation; provided, that the term Guarantee shall not include endorsements for collection or deposit in the ordinary course of business or customary and reasonable indemnity obligations in
effect on the Closing Date or entered into in connection with any acquisition or disposition of assets or any Investment permitted under this Agreement. 
  
 “Guaranties” means the Parent Guaranty and the Subsidiary Guaranty. 
  
 “Guarantors” means Holdings and the Subsidiary Loan Parties. 
  

 LifeCare Credit Agreement 
 17 

 “Hazardous Materials” means (i) any petroleum products or byproducts, radon gas,
asbestos, toxic mold, urea formaldehyde foam insulation, polychlorinated biphenyls, chlorofluorocarbons and all other ozone-depleting substances; or (ii) any chemical, material, substance or waste that is prohibited, limited, defined or
regulated as a “hazardous” or “toxic” material, substance or waste by or pursuant to any applicable Environmental Law. 
  
 “Healthcare Facility” or “Healthcare Facilities” means the hospitals, medical office buildings and other healthcare
facilities directly or indirectly owned or leased by Holdings, the Borrower or any of the Subsidiaries. 
  
 “Hedge Bank” means any Person that is a Lender or an Affiliate of a Lender in its capacity as a party to a Secured Hedge Agreement.

  
 “HIPAA” means the privacy, transaction and
security provisions of the Health Insurance Portability and Accountability Act of 1996, as it may be amended, and all regulations promulgated thereunder. 
  
 “Holdings” means LCI Holdco, LLC, a Delaware limited liability company. 
  
 “Holdings Leverage Ratio” means, as of any date, the ratio of (a) Total Indebtedness plus the
aggregate principal amount of Indebtedness of Holdings, in each case, as of such date to (b) Consolidated EBITDA for the period of four consecutive fiscal quarters most recently ended on or prior to such date for which financial statements of
Holdings are available. For purposes of calculating the Holdings Leverage Ratio with respect to any period during which any Specified Transaction occurs, the Holdings Leverage Ratio shall be calculated with respect to such period and such Specified
Transaction (and all other Specified Transactions that have been consummated during such period) on a Pro Forma Basis. 
  
 “Inactive Subsidiary” means a Subsidiary that (a) conducts no business operations, (b) has total assets with a fair market
value of not more than $500,000 individually and, together with all other Inactive Subsidiaries, not more than $5,000,000 in the aggregate and (c) has no Indebtedness outstanding. 
  
 “Indebtedness” of any Person means, without duplication, (a) all obligations of such Person for
borrowed money, (b) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such Person under conditional sale agreements relating to property acquired by such Person,
(d) all obligations of such Person in respect of the deferred purchase price of property or services (excluding current accounts payable incurred in the ordinary course of business) to the extent the same would be required to be shown as a
liability on a balance sheet prepared in accordance with GAAP, (e) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on property owned
or acquired by such Person, whether or not the Indebtedness secured thereby has been assumed, (f) all Guarantees by such Person of 

  

 LifeCare Credit Agreement 
 18 

 
Indebtedness of others, (g) all Capital Lease Obligations of such Person, (h) the maximum amount (after giving effect to all reductions and
drawings that have been reimbursed) of all obligations, contingent or otherwise, of such Person as an account party in respect of letters of credit and letters of guaranty and (i) the principal component of all obligations, contingent or
otherwise, of such Person in respect of bankers’ acceptances. The Indebtedness of any Person shall include the Indebtedness of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is
liable therefor as a result of such Person’s ownership interest in or other relationship with such entity, except to the extent the terms of such Indebtedness provide that such Person is not liable therefor. 
  
 “Indemnified Taxes” means Taxes other than Excluded Taxes
and Other Taxes. 
  
 “Information Memorandum”
means the Confidential Information Memorandum dated July 2005, as modified or supplemented prior to the Closing Date, relating to Holdings, the Borrower and the Transactions. 
  
 “Initial Lenders” means JPMorgan Chase Bank, N.A., General Electric Capital Corporation and Bank of
America, N.A. 
  
 “Insurance Subsidiary” means a
subsidiary of the Borrower established for the sole purpose of providing insurance benefits to the Borrower and its subsidiaries. 
  
 “Intellectual Property” has the meaning assigned to such term in the Collateral Agreement. 
  
 “Intellectual Property Security Agreement” has the meaning
assigned to such term in the Collateral Agreement. 
  
 “Interest Coverage Ratio” means, with respect to the Borrower and its Subsidiaries on a consolidated basis, as of the end of any fiscal quarter of the Borrower for the four consecutive fiscal quarters ending on such date,
the ratio of (a) Consolidated EBITDA for such period of four fiscal quarters to (b) Consolidated Cash Interest Expense for such period of four fiscal quarters. For purposes of calculating the Interest Coverage Ratio with respect to any
period during which any Specified Transaction occurs, the Interest Coverage Ratio shall be calculated with respect to such period and such Specified Transaction (and all other Specified Transactions that have been consummated during such period) on
a Pro Forma Basis. 
  
 “Interest Election
Request” means a request by the Borrower to convert or continue a Revolving Borrowing or Term Borrowing in accordance with Section 2.07. 
  
 “Interest Payment Date” means (a) with respect to any ABR Loan (other than a Swingline Loan), the last day of each March, June,
September and December, (b) with respect to any Eurodollar Loan, the last day of the Interest Period applicable to the Borrowing of which such Loan is a part and, in the case of a Eurodollar Borrowing with an Interest Period of more than three
months’ duration, each day prior to the last day 

  

 LifeCare Credit Agreement 
 19 

 
of such Interest Period that occurs at intervals of three months’ duration after the first day of such Interest Period and (c) with respect to any
Swingline Loan, the day that such Loan is required to be repaid. 
  
 “Interest Period” means, with respect to any Eurodollar Borrowing, the period commencing on the date of such Borrowing and ending on the numerically corresponding day in the calendar month that is one, two, three or
six months thereafter (or nine or 12 months thereafter if, at the time of the relevant Borrowing, all Lenders participating therein agree to make an interest period of such duration available, or one or two weeks thereafter until the earlier of
September 9, 2005 and the date on which the Administrative Agent has notified the Borrower that syndication of the Commitments hereunder has been completed as determined by the Joint Lead Arrangers), as the Borrower may elect; provided,
that (a) if any Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless such next succeeding Business Day would fall in the next calendar month, in which
case such Interest Period shall end on the next preceding Business Day and (b) any Interest Period that commences on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the last calendar
month of such Interest Period) shall end on the last Business Day of the last calendar month of such Interest Period. For purposes hereof, the date of a Borrowing initially shall be the date on which such Borrowing is made and thereafter shall be
the effective date of the most recent conversion or continuation of such Borrowing. 
  
 “Investment” means purchasing, holding or acquiring (including pursuant to any merger with any Person that was not a wholly owned Subsidiary prior to such merger) any Equity Interest, evidences of
indebtedness or other securities (including any option, warrant or other right to acquire any of the foregoing) of, or making or permitting to exist any loans or advances (other than commercially reasonable extensions of trade credit) to,
guaranteeing any obligations of, or making or permitting to exist any investment in, any other Person, or purchasing or otherwise acquiring (in one transaction or a series of transactions) any assets of any Person constituting a business unit. The
amount, as of any date of determination, of any Investment shall be the original cost of such Investment (including any Indebtedness of a Person existing at the time such Person becomes a Subsidiary in connection with any Investment and any
Indebtedness assumed in connection with any acquisition of assets) and minus the amount, as of such date, of any portion of such Investment repaid to the investor in cash or property as a repayment of principal or a return of capital
(including pursuant to any sale or disposition of such Investment), as the case may be, but without any other adjustments for increases or decreases in value, or write-ups, write-downs or write-offs with respect to such Investment. In determining
the amount of any Investment or repayment involving a transfer of any property other than cash, such property shall be valued at its fair market value at the time of such transfer. 
  
 “IPO” means a bona fide underwritten initial public offering (other than a public offering pursuant to a
registration statement on Form S-8) of voting common stock of Holdings or a Parent which generates cash proceeds to Holdings or such Parent of at least $50,000,000. 
  

 LifeCare Credit Agreement 
 20 

 “Issuing Bank” means JPMorgan Chase Bank, N.A., in its capacity as the issuer of Letters
of Credit hereunder, and each other Lender appointed as an Issuing Bank hereunder pursuant to Section 2.05(k) and, in each case, its successors in such capacity as provided in Section 2.05(i). An Issuing Bank may, in its discretion,
arrange for one or more Letters of Credit to be issued by Affiliates of such Issuing Bank, in which case the term “Issuing Bank” shall include any such Affiliate with respect to Letters of Credit issued by such Affiliate. 
  
 “JCAHO” means the Joint Commission on Accreditation of
Healthcare Organizations. 
  
 “LC Disbursement”
means a payment made by the Issuing Bank pursuant to a Letter of Credit. 
  
 “LC Exposure” means, at any time, the sum of (a) the aggregate undrawn amount of all outstanding Letters of Credit at such time plus (b) the aggregate amount of all LC Disbursements
that have not yet been reimbursed by or on behalf of the Borrower at such time. The LC Exposure of any Revolving Lender at any time shall be its Applicable Percentage of the total LC Exposure at such time. 
  
 “Lenders” means (a) the Persons listed on
Schedule 2.01 and (b) any other Person that shall have become a party hereto pursuant to an Assignment and Assumption, other than any such Person that ceases to be a party hereto pursuant to an Assignment and Assumption. Unless the context
otherwise requires, the term “Lenders” includes the Swingline Lender. 
  
 “Letter of Credit” means any letter of credit issued pursuant to this Agreement. 
  
 “Leverage Ratio” means, with respect to the last day of any period, the ratio of (a) Total Indebtedness as of such date to
(b) Consolidated EBITDA for the period of four consecutive fiscal quarters of the Borrower most recently ended on or prior to such date. For purposes of calculating the Leverage Ratio with respect to any period during which any Specified
Transaction occurs, the Leverage Ratio shall be calculated with respect to such period and such Specified Transaction (and all other Specified Transactions that have been consummated during such period) on a Pro Forma Basis. 
  
 “LIBO Rate” means, with respect to any Eurodollar Borrowing
for any Interest Period, the rate appearing on Page 3750 of the Telerate Service (or on any successor or substitute page of such service, or any successor to or substitute for such service, providing rate quotations comparable to those currently
provided on such page of such service, as determined by the Administrative Agent from time to time for purposes of providing quotations of interest rates applicable to dollar deposits in the London interbank market) at approximately 11:00 a.m.,
London time, two Business Days prior to the commencement of such Interest Period, as the rate for dollar deposits with a maturity comparable to such Interest Period. In the event that such rate is not available at such time for any reason, then the
“LIBO Rate” with respect to such Eurodollar Borrowing for 

  

 LifeCare Credit Agreement 
 21 

 
such Interest Period shall be the rate at which dollar deposits of $5,000,000 and for a maturity comparable to such Interest Period are offered by the
principal London office of the Administrative Agent in immediately available funds in the London interbank market at approximately 11:00 a.m., London time, two Business Days prior to the commencement of such Interest Period. 
  
 “Lien” means, with respect to any asset, (a) any
mortgage, deed of trust, lien, pledge, hypothecation, encumbrance, charge or security interest in, on or of such asset, (b) the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement
(or any financing lease having substantially the same economic effect as any of the foregoing) relating to such asset and (c) in the case of securities, any purchase option, call or similar right of a third party with respect to such
securities. 
  
 “Loan Documents” means this
Agreement, the Guaranties, the Assumption Agreement and the Security Documents. 
  
 “Loan Parties” means Holdings, the Borrower and the Subsidiary Loan Parties. 
  
 “Loans” means the loans made by the Lenders to the Borrower pursuant to this Agreement. 
  
 “Long-Term Indebtedness” means any Indebtedness that, in
accordance with GAAP, constitutes (or, when incurred, constituted) a long-term liability. For purposes of determining the Long-Term Indebtedness of the Borrower and the Subsidiaries, Indebtedness of the Borrower or any Subsidiary owed to Holdings,
the Borrower or a Subsidiary shall be excluded. 
  
 “Management Group” means the group of individuals consisting of the directors, executive officers and other management personnel of the Borrower or Holdings on the Closing Date. 
  
 “Margin Stock” has the meaning assigned to such term in
Regulation U of the Board. 
  
 “Material Adverse
Effect” means a material adverse effect on (i) the business, operations, assets, liabilities or financial condition of Holdings, the Borrower and the Subsidiaries, taken as a whole, (ii) the ability of any Loan Party to perform
any of its obligations under the Loan Documents to which it is a party or (iii) the rights and remedies of the Administrative Agent or the Lenders under the Loan Documents. 
  
 “Material Indebtedness” means Indebtedness (other than the Loans and Letters of Credit), or obligations in
respect of one or more Swap Agreements, of any one or more of Holdings, the Borrower and its Subsidiaries in an aggregate principal amount exceeding $12,500,000. For purposes of determining Material Indebtedness, the “principal amount” of
the obligations of Holdings, the Borrower or any Subsidiary in respect of any Swap Agreement at any time shall be the maximum aggregate amount 

  

 LifeCare Credit Agreement 
 22 

 
(giving effect to any netting agreements) that Holdings, the Borrower or such Subsidiary would be required to pay if such Swap Agreement were terminated at
such time. 
  
 “Material Subsidiary” means any
Subsidiary, including its subsidiaries, which meets any of the following conditions: (a) Holdings’, the Borrower’s and the other Subsidiaries’ investments in and advances to such Subsidiary exceed 5% of the consolidated total
assets of Holdings and the Subsidiaries as of the end of the most recently completed fiscal year, (b) the consolidated assets of such Subsidiary exceed 5% of the consolidated total assets of Holdings and the Subsidiaries as of the end of the
most recently completed fiscal year or (c) the consolidated pre-tax income from continuing operations of such Subsidiary for the most recently ended period of four consecutive fiscal quarters exceeds 5% of the consolidated pre-tax income from
continuing operations of Holdings and the Subsidiaries for such period. 
  
 “Medicaid” means that means-tested entitlement program under Title XIX of the Social Security Act, which provides federal grants to states for medical assistance based on specific eligibility criteria, as set forth at
Section 1396, et seq. of Title 42 of the United States Code, as amended, and any successor statute thereto. 
  
 “Medicaid Certification” means certification by CMS or a state agency or entity under contract with CMS that health care operations are
in compliance with all the conditions of participation set forth in the Medicaid Regulations. 
  
 “Medicaid Provider Agreement” means an agreement entered into between a state agency or other such entity administering the Medicaid program and a health care operation under which the health care
operation agrees to provide services for Medicaid patients in accordance with the terms of the agreement and Medicaid Regulations. 
  
 “Medicaid Regulations” means, collectively, (i) all federal statutes (whether set forth in Title XIX of the Social Security Act or
elsewhere) affecting the medical assistance program established by Title XIX of the Social Security Act and any statutes succeeding thereto; (ii) all applicable provisions of all federal rules, regulations, manuals and orders of all
Governmental Authorities promulgated pursuant to or in connection with the statutes described in clause (i) above and all federal administrative, reimbursement and other guidelines of all Governmental Authorities having the force of law
promulgated pursuant to or in connection with the statutes described in clause (i) above; (iii) all state statutes and plans for medical assistance enacted in connection with the statutes and provisions described in clauses (i) and
(ii) above; and (iv) all applicable provisions of all rules, regulations, manuals and orders of all Governmental Authorities promulgated pursuant to or in connection with the statutes described in clause (iii) above and all state
administrative, reimbursement and other guidelines of all Governmental Authorities having the force of law promulgated pursuant to or in connection with the statutes described in clause (ii) above, in each case as may be amended, supplemented
or otherwise modified from time to time. 
  

 LifeCare Credit Agreement 
 23 

 “Medical Reimbursement Programs” means a collective reference to the Medicare, Medicaid
and TRICARE programs and any other health care program operated by or financed in whole or in part by any foreign or domestic federal, state or local government and any other non-government funded third-party payor programs. 
  
 “Medicare” means that government-sponsored entitlement
program under Title XVIII of the Social Security Act, which provides for a health insurance system for eligible elderly and disabled individuals, as set forth at Section 1395, et seq. of Title 42 of the United States Code, as amended, and
any successor statute thereto. 
  
 “Medicare
Certification” means certification by CMS or a state agency or entity under contract with CMS that the health care operation is in compliance with all the conditions of participation set forth in the Medicare Regulations. 
  
 “Medicare Provider Agreement” means an agreement entered
into between a state agency, CMS or other such entity administering the Medicare program and a health care operation under which the health care operation agrees to provide services for Medicare patients in accordance with the terms of the agreement
and Medicare Regulations. 
  
 “Medicare
Regulations” means, collectively, all federal statutes (whether set forth in Title XVIII of the Social Security Act or elsewhere) affecting the health insurance program for the aged and disabled established by Title XVIII of the Social
Security Act and any statutes succeeding thereto; together with all applicable provisions of all rules, regulations, manuals and orders and administrative, reimbursement and other guidelines having the force of law of all Governmental Authorities
(including, without limitation, Health and Human Services (“HHS”), CMS, the OIG, or any person succeeding to the functions of any of the foregoing) promulgated pursuant to or in connection with any of the foregoing having the force
of law, as each may be amended, supplemented or otherwise modified from time to time. 
  
 “Merger” means the merger of Rainier with and into the Company pursuant to the Merger Agreement, with the Company as the surviving corporation. 
  
 “Merger Agreement” means the Agreement of Merger dated as of
July 19, 2005, among the Company, Holdings, Rainier and Golder, Thoma, Cressey, Rauner, Inc., in its capacity as Representative thereunder, relating to the acquisition of the Company by Holdings through the merger of Rainier with and into the
Company. 
  
 “Moody’s” means Moody’s
Investors Service, Inc. 
  
 “Mortgage” means any
mortgage, trust deed, deed of trust, deed to secure debt, assignment of leases and rents or other security document granting a Lien on any real property and improvements thereto to secure the Obligations delivered on or after the Closing Date
pursuant to Section 5.12. Each Mortgage shall be substantially in the form of Exhibit H hereto (with such changes as may be reasonably satisfactory to the Agent and its counsel to account for local law matters), and otherwise in form and
substance reasonably satisfactory to the Collateral Agent. 
  

 LifeCare Credit Agreement 
 24 

 “Mortgaged Property” means each parcel of real property and the improvements thereto
owned by a Loan Party and identified as a Mortgaged Property on Schedule 3.05, and each other parcel of real property and improvements thereto acquired by a Loan Party after the Closing Date with respect to which a Mortgage is granted pursuant
to Section 5.12. 
  
 “Multiemployer Plan”
means a multiemployer plan as defined in Section 4001(a)(3) of ERISA. 
  
 “Net Proceeds” means, with respect to any event (a) the cash proceeds actually received in respect of such event including (i) any cash received in respect of any debt instrument or equity
security received as non-cash proceeds, but only as and when received (excluding, for the avoidance of doubt, any interest payments), (ii) in the case of a casualty, insurance proceeds, and (iii) in the case of a condemnation or similar
event, condemnation awards and similar payments, net of (b) the sum of (i) all fees and out-of-pocket expenses (including underwriting discounts and commissions and collection expenses) paid or payable by Holdings, the Borrower and the
Subsidiaries to third parties (including Affiliates, if permitted by Section 6.09) in connection with such event, (ii) in the case of a sale, transfer or other disposition of an asset (including pursuant to a sale and leaseback transaction
or a casualty or a condemnation or similar proceeding), the amount of all payments required to be made by Holdings, the Borrower and the Subsidiaries as a result of such event to repay Indebtedness (other than Loans) secured by such asset or
otherwise subject to mandatory prepayment as a result of such event, and (iii) the amount of all taxes paid (or reasonably estimated to be payable) by Holdings, the Borrower and the Subsidiaries (provided that such amounts withheld or estimated
for the payment of taxes shall, to the extent not utilized for the payment of taxes, be deemed to be Net Proceeds received when such nonutilization is determined), and the amount of any reserves established by Holdings, the Borrower and the
Subsidiaries to fund contingent liabilities reasonably estimated to be payable, in each case that are directly attributable to such event (provided that any reversal of any such reserves will be deemed to be Net Proceeds received at the time and in
the amount of such reversal), in each case as determined reasonably and in good faith by a Financial Officer. 
  
 “Net Working Capital” means, at any date, (a) the consolidated current assets of Holdings, the Borrower and its consolidated
Subsidiaries as of such date (excluding cash, Permitted Investments and current deferred income taxes) minus (b) the consolidated current liabilities of Holdings, the Borrower and its consolidated Subsidiaries as of such date (excluding
current liabilities in respect of Indebtedness and current deferred income taxes). Net Working Capital at any date may be a positive or negative number. Net Working Capital increases when it becomes more positive or less negative and decreases when
it becomes less positive or more negative. 
  
 “Non-Cash
Pay Preferred Stock” means preferred stock or other preferred securities or membership interests of a Parent, Holdings or the Borrower which (i) are not mandatorily redeemable, in whole or part, or required to be repurchased or
reacquired, in whole or part, by Holdings, the Borrower or any Subsidiary, and which do not require 

  

 LifeCare Credit Agreement 
 25 

 
any payment of cash dividends or distributions (it being understood that accrued dividends shall be permitted), in each case, prior to the date that is six
months after the Term Loan Maturity Date (other than upon an event of default, asset sale or change of control, provided, that any such payment is subject to the prior repayment in full of the Loans and the other Obligations that are accrued
and payable and termination of the Commitments hereunder), (ii) are not secured by any assets of Holdings, the Borrower or any Subsidiary, (iii) are not guaranteed by Holdings, the Borrower or any Subsidiary and (iv) are not
exchangeable or convertible into Indebtedness of Holdings, the Borrower or any Subsidiary, except at the option of the Borrower and subject to compliance with Section 6.01(a), or any preferred stock or other Equity Interest (other than common
equity of Holdings or other Non-Cash Pay Preferred Stock). 
  
 “Obligations” has the meaning assigned to such term in the Collateral Agreement. 
  
 “OIG” means the Office of the Inspector General of the United States Department of Health and Human Services. 
  
 “OIG Review” means (i) the review by the OIG, initiated
following a voluntary disclosure of the matter to the OIG in July 2003 in connection with the home office cost statements filed with the Medicare Program for fiscal years 1997 through 2002, into home office cost reporting issues involving related
organization disclosures and expenses, administrative costs, employee payroll, owner compensation, conference and travel expenses, meals and entertainment expenses, lobbying expenses, political campaign contributions, related physician relations
issues and related hospital cost report issues, (ii) subsequent disclosures made by the Company to the OIG (including issues involving employment of excluded individuals) at or prior to the Closing; (iii) cost reporting issues disclosed to
or identified by the OIG with respect to cost statements filed with the Medicaid Program for fiscal years 2001 and 2002; (iv) any other cost reporting issues identified by the OIG as part of its review of the voluntary disclosure described in
clauses (i), (ii), and (iii) of this definition; and (v) any subsequent review, response or action by any Governmental Authority directly resulting from the matters described in clauses (i), (ii), (iii) or (iv) of this
definition, provided that such subsequent action was initiated prior to the final resolution of the OIG Review. 
  
 “Other Taxes” means any and all present or future recording, stamp, documentary, excise, transfer, sales, property, intangible, mortgage
recording or similar taxes, charges or levies arising from any payment made under any Loan Document or from the execution, delivery or enforcement of, or otherwise with respect to, any Loan Document. 
  
 “Parent” means any direct or indirect parent of Holdings
organized at the direction of the Permitted Holders, which directly or indirectly owns 100% of the Equity Interests of Holdings, and the sole asset of which is 100% the Equity Interests of Holdings or of another direct or indirect parent of
Holdings. 
  

 LifeCare Credit Agreement 
 26 

 “Parent Guaranty” means the Parent Guaranty made by Holdings in favor of the
Administrative Agent on behalf of the Secured Parties, substantially in the form of Exhibit F. 
  
 “Participant” has the meaning assigned to such term in Section 9.04. 
  
 “PBGC” means the Pension Benefit Guaranty Corporation referred to and defined in ERISA and any successor entity performing similar
functions. 
  
 “Perfection Certificate” means a
certificate in the form of Exhibit D hereto or any other form approved by the Collateral Agent. 
  
 “Permitted Acquisitions” means any acquisition (by merger, consolidation or otherwise) by the Borrower or a Subsidiary Loan Party
(including an acquisition by Holdings in which the acquired assets are contributed to the Borrower) of all or substantially all the assets or business of, or at least 80% of each class of Equity Interests in, a Person or division, business unit or
line of business of a Person, if (a) immediately after giving effect thereto, no Event of Default has occurred and is continuing or would result therefrom, (b) immediately after giving effect thereto, the unused Revolving Commitments and
unrestricted cash and Permitted Investments of the Borrower and its Subsidiaries is at least $10,000,000, (c) such acquired Person is organized under the laws of the United States of America or any State thereof or the District of Columbia and
substantially all the business of such acquired Person or business consists of one or more Permitted Businesses and all or substantially all of the consolidated gross operating revenues of such acquired Person or business for the most recently ended
period of twelve months is derived from domestic operations in the United States of America, (d) each Subsidiary resulting from such acquisition (and which survives such acquisition) shall be a Subsidiary Loan Party and at least 80% of the
Equity Interests of each such Subsidiary shall be owned directly by the Borrower and/or Subsidiary Loan Parties and shall have been (or within 20 Business Days (or such longer period as may be acceptable to the Agent) after such acquisition shall
be) pledged pursuant to the Collateral Agreement, (e) the Borrower and the Subsidiaries are in Pro Forma Compliance with the Financial Covenants, after giving effect to such acquisition, computed as of the last day of the most recently ended
fiscal quarter of the Borrower for which financial statements are available, as if such acquisition had occurred on the first day of the relevant period for testing compliance, (f) the aggregate consideration (including the amount of
Indebtedness assumed) paid by the Borrower and its Subsidiaries for such acquisition and all prior acquisitions since the Closing Date does not exceed an amount equal to $100,000,000; provided, however, that such aggregate limit shall
not apply at any time after a Financial Officer first delivers a certificate pursuant to Section 5.01(c) setting forth a Leverage Ratio of less than 4.50:1.00, and (g) the Borrower has delivered to the Agent an officer’s certificate
to the effect set forth in clauses (a), (b), (c), (d), (e) and (f) above, together with all relevant financial information for the Person or assets acquired and reasonably detailed calculations demonstrating satisfaction of the
requirement set forth in clause (e) above. 
  

 LifeCare Credit Agreement 
 27 

 “Permitted Business” means the ownership and operation of long term acute care
hospitals, rehabilitation facilities, skilled nursing facilities, behavioral facilities, other specialized hospitals and related activities. 
  
 “Permitted Cure Security” shall mean common stock or Non-Cash Pay Preferred Stock of Holdings. 
  
 “Permitted Encumbrances” means: 
  
 (a) Liens imposed by law or any Governmental Authority for
taxes, assessments or other governmental charges or levies that are not yet due or are being contested in compliance with Section 5.05; 
  
 (b) carriers’, warehousemen’s, mechanics’, materialmen’s, landlord’s, repairmen’s, construction and other
like Liens, arising in the ordinary course of business and securing obligations that are not overdue by more than 60 days or are being contested in compliance with Section 5.05; 
  
 (c) pledges and deposits made in the ordinary course of
business in compliance with workers’ compensation, unemployment insurance and other social security laws or regulations; 
  
 (d) deposits to secure the performance of bids, trade contracts, leases, statutory obligations, surety and appeal bonds, performance bonds
and other obligations of a like nature, in each case in the ordinary course of business; 
  
 (e) judgment liens in respect of judgments or attachments that do not constitute an Event of Default under clause (j) of Article VII;

  
 (f) easements, zoning restrictions,
rights-of-way and similar encumbrances on real property imposed by law or arising in the ordinary course of business that do not materially interfere with the ordinary conduct of business of the Borrower or any Subsidiary; and 
  
 (g) liens and other encumbrances shown as exceptions in the
title insurance policies insuring the Mortgages; 
  
 provided that the term
“Permitted Encumbrances” shall not include any Lien securing Indebtedness. 
  
 “Permitted Holders” means (i) TC Group, L.L.C., Carlyle Partners IV, L.P. and CP IV Coinvestment, L.P. and their Affiliates (but excluding any portfolio companies of the foregoing) and
(ii) any members of management of the Borrower listed in the Preliminary Offering Memorandum for the Senior Subordinated Notes under the heading “Management.” 
  
 “Permitted Holdings Debt” means Indebtedness of Holdings which (i) provides for payment of all
interest in like-kind Indebtedness and does not require or 

  

 LifeCare Credit Agreement 
 28 

 
permit interest to be paid in cash prior to the date that is four years after the issuance of such Indebtedness, (ii) does not mature, and is not
subject to mandatory repurchase, redemption or amortization (other than pursuant to customary asset sale or change in control provisions that are no more restrictive than the comparable provisions of the Senior Subordinated Debt Documents as in
effect on the Closing Date), in each case, prior to the date that is six months after the Term Loan Maturity Date, (iii) does not contain default provisions or covenants that are more restrictive than the comparable provisions of the Senior
Subordinated Debt Documents as in effect on the Closing Date, (iv) does not contain provisions cross-defaulting such Indebtedness to non-payment defaults under other Indebtedness, other than failure to pay at maturity, (v) is not secured
by any assets of Holdings, the Borrower or any Subsidiary, (vi) is not Guaranteed by the Borrower or any Subsidiary, (vii) is not exchangeable or convertible into Indebtedness of Holdings (except other Permitted Holdings Debt), the
Borrower or any Subsidiary or any preferred stock or other Equity Interest (other than common equity or Non-Cash Pay Preferred Stock of a Parent or Holdings, provided that any such exchange or conversion, if effected, would not result in a Change in
Control) and (viii) if subordinated, is subordinated to the Obligations pursuant to a written instrument delivered, and reasonably satisfactory, to the Administrative Agent or on terms no less favorable in any material respect to the Lenders
than the subordination terms applicable to the Senior Subordinated Debt. 
  
 “Permitted Investments” means: 
  
 (a) direct obligations of, or obligations the principal of and interest on which are unconditionally guaranteed by, the United States of
America (or by any agency thereof to the extent such obligations are backed by the full faith and credit of the United States of America), in each case maturing or allowing for liquidation at the original par value at the option of the holder within
two years from the date of acquisition thereof; 
  
 (b) investments in commercial paper (other than commercial paper issued by Holdings, the Borrower, the Permitted Holders or any of their Affiliates) maturing within one year from the date of acquisition thereof and having, at such date of
acquisition, a rating of at least A-1 (or the equivalent thereof) from S&P or P-1 (or the equivalent thereto) by Moody’s; 
  
 (c) investments in certificates of deposit, banker’s acceptances, time deposits or overnight bank deposits maturing within one year
from the date of acquisition thereof issued or guaranteed by or placed with, and money market deposit accounts issued or offered by, any domestic office of any commercial bank organized under the laws of the United States of America or any State
thereof which has a combined capital and surplus and undivided profits of not less than $250,000,000; 
  
 (d) fully collateralized repurchase agreements for securities described in clause (a) above and entered into with a financial
institution satisfying the criteria described in clause (c) above; 
  

 LifeCare Credit Agreement 
 29 

 (e) securities with maturities of two years or less from the date of acquisition issued
or fully guaranteed by any State, commonwealth or territory of the United States of America, or by any political subdivision or taxing authority thereof, having one of the two highest rating categories obtainable from either Moody’s or S&P;

  
 (f) investments in money market funds that
comply with the criteria set forth in Rule 2a-7 under the Investment Company Act of 1940, as amended, substantially all of whose assets are invested in investments of the type described in clauses (a) through (e) above; and 
  
 (g) shares of restricted mutual funds whose investment
guidelines restrict substantially all of such funds’ investments to those satisfying the provisions of clauses (a) through (e) above. 
  
 “Permitted Subordinated Indebtedness” means Indebtedness of the Borrower which (i) does not mature, and is not subject to mandatory
repurchase, redemption or amortization (other than pursuant to customary asset sale or change in control provisions that are no more restrictive than the comparable provisions of the Senior Subordinated Debt Documents as in effect on the Closing
Date), in each case, prior to the date that is six months after the Term Loan Maturity Date, (ii) is not secured by any assets of Holdings, the Borrower or any Subsidiary, (iii) is not exchangeable or convertible into Indebtedness of
Holdings, the Borrower or any Subsidiary (other than Permitted Subordinated Indebtedness) or any preferred stock or other Equity Interest (other than common equity or Non-Cash Pay Preferred Stock, provided that any such exchange or
conversion, if effected, would not result in a Change in Control) and (iv) is, together with any Guarantee thereof by any Subsidiary (a “Permitted Subordinated Guarantee”), subordinated to the Obligations pursuant to a written
instrument delivered, and reasonably satisfactory, to the Administrative Agent or on terms no less favorable in any material respect to the Lenders than the subordination terms applicable to the Senior Subordinated Debt. 
  
 “Person” means any natural person, corporation, limited
liability company, trust, joint venture, association, company, partnership, Governmental Authority or other entity. 
  
 “Plan” means any employee pension benefit plan (other than a Multiemployer Plan) subject to the provisions of Title IV of ERISA or
Section 412 of the Code or Section 302 of ERISA, and in respect of which the Borrower or any ERISA Affiliate is (or, if such plan were terminated, would under Section 4069 of ERISA be deemed to be) an “employer” as defined
in Section 3(5) of ERISA. 
  
 “Prepayment
Event” means any (a) Asset Disposition, (b) Debt Issuance or (c) Specified Equity Issuance. 
  
 “Prime Rate” means the rate of interest per annum publicly announced from time to time by JPMorgan Chase Bank, N.A., as its prime rate in
effect for dollars at 

  

 LifeCare Credit Agreement 
 30 

 
its principal office in New York City; each change in the Prime Rate shall be effective from and including the date such change is publicly announced as
being effective. 
  
 “Pro Forma Basis”,
“Pro Forma Compliance” or “Pro Forma Effect” means, with respect to the Interest Coverage Ratio, Leverage Ratio, Holdings Leverage Ratio, any test or any Financial Covenant, that for any Specified Transaction or
incurrence of Indebtedness that has been consummated (or in each case that is the Specified Transaction or incurrence of Indebtedness for which Pro Forma Compliance is required) in any period (and all other Specified Transactions that have been
consummated during the applicable period), such Specified Transaction or incurrence of Indebtedness and the following transactions in connection therewith, shall be deemed to have occurred as of the first day of the applicable period of measurement
in such financial definition, test or Financial Covenant: (a) income statement items (whether positive or negative) attributable to the property or Person subject to such Specified Transaction, (i) in the case of an Asset Disposition
involving all or substantially all Equity Interests in any Subsidiary of the Company or any division, product line, or facility used for operations of the Borrower or any of its Subsidiaries, or the designation of a Subsidiary as an Unrestricted
Subsidiary, shall be excluded, and (ii) in the case of a Permitted Acquisition or the designation of an Unrestricted Subsidiary as a Subsidiary, shall be included, (b) any retirement of Indebtedness, and (c) any Indebtedness incurred
or assumed by the Borrower or any of its Subsidiaries in connection therewith and if such Indebtedness has a floating or formula rate, shall have an implied rate of interest for the applicable period for purposes of this definition determined by
utilizing the rate which is or would be in effect with respect to such Indebtedness as at the relevant date of determination; provided that the foregoing pro forma adjustments may be applied to any such test or financial covenant solely to
the extent that such adjustments are consistent with the definition of Consolidated EBITDA and give effect to events (including operating expense reductions) that are (x) directly attributable to such transaction, (y) expected to have a
continuing impact on the Borrower and its Subsidiaries and (z) factually supportable (provided that pro forma effect shall only be given to operating expense reductions or similar anticipated benefits from any Specified Transaction to
the extent that such adjustments and the bases therefor are set forth in reasonable detail in a certificate of a Financial Officer delivered to the Administrative Agent and dated the relevant date of determination and which certifies that the
Borrower reasonably anticipates that such expense reductions or other benefits will be realized, or all necessary steps for the realization thereof taken, within six months following such date). 
  
 “Rainier” means Rainier Acquisition Corp., a Delaware
corporation. 
  
 “Real Property” means the real
properties owned or leased by Holdings, the Borrower or any Subsidiary set forth on Schedule 3.05, as the same may be supplemented from time to time by the Borrower in accordance with the provisions hereof. 
  
 “Refinancing Indebtedness” means Indebtedness issued or
incurred (including by means of the extension or renewal of existing Indebtedness) to extend, renew, replace or refinance existing Indebtedness (“Refinanced Debt”); provided that 

  

 LifeCare Credit Agreement 
 31 

 
(i) such extending, renewing, replacing or refinancing Indebtedness is in an original aggregate principal amount not greater than the aggregate
principal amount of, and unpaid interest on, the Refinanced Debt plus the amount of any premiums paid thereon and fees and expenses associated therewith, (ii) such Indebtedness has a maturity and a weighted average life equal to or
greater than that of the Refinanced Debt, (iii) if the Refinanced Debt or any Guarantees thereof are subordinated to the Obligations, such Indebtedness and Guarantees thereof are subordinated to the Obligations on terms no less favorable in any
significant respect to the holders of the Obligations than the subordination terms of such Refinanced Debt or Guarantees thereof (and no Loan Party that has not guaranteed such Refinanced Debt Guarantees such Indebtedness), (iv) such
Indebtedness contains covenants and events of default and is benefited by Guarantees (if any) which, taken as a whole, are determined in good faith by the board of directors of the Borrower not to be materially less favorable to the Lenders than the
covenants and events of default of or Guarantees (if any) in respect of such Refinanced Debt, (v) if such Refinanced Debt or any Guarantees thereof are secured, such Indebtedness and any Guarantees thereof are either unsecured or secured only
by such assets as secured the Refinanced Debt and Guarantees thereof, (vi) if such Refinanced Debt and any Guarantees thereof are unsecured, such Indebtedness and Guarantees thereof are also unsecured, (vii) such Indebtedness is issued
only by the issuer of such Refinanced Debt and (viii) the proceeds of such Indebtedness are applied promptly (and in any event within 45 days) after receipt thereof to the repayment of such Refinanced Debt. 
  
 “Register” has the meaning assigned to such term in
Section 9.04. 
  
 “Related Parties” means,
with respect to any specified Person, such Person’s Affiliates and the directors, officers, employees, agents, trustees, Controlling Persons and advisors of such Person and of each of such Person’s Affiliates. 
  
 “Release” means any actual or threatened release, spill,
emission, leaking, dumping, injection, pouring, deposit, disposal, discharge, dispersal, leaching or migration into or through the environment or within or upon any building, structure, facility or fixture. 
  
 “Required Lenders” means, at any time, Lenders having
Revolving Exposures, Term Loans and unused Commitments representing more than 50% of the sum of the total Revolving Exposures, outstanding Term Loans and unused Commitments at such time. 
  
 “Required Percentage” has the meaning assigned to such term in Section 2.11(c). 
  
 “Restricted Payment” means any dividend or other
distribution (whether in cash, securities or other property) with respect to any Equity Interests in Holdings, the Borrower or any Subsidiary, or any payment (whether in cash, securities or other property), including any sinking fund or similar
deposit, on account of the purchase, redemption, retirement, acquisition, cancellation, termination or amendment of any Equity Interests in Holdings, the Borrower or any Subsidiary or of any option, warrant or 

  

 LifeCare Credit Agreement 
 32 

 
other right to acquire any such Equity Interests in Holdings, the Borrower or any Subsidiary. 
  
 “Revolving Availability Period” means the period from the Closing Date to but excluding the earlier of the
Revolving Maturity Date and the date of termination of the Revolving Commitments. 
  
 “Revolving Commitment” means, with respect to each Lender, the commitment, if any, of such Lender to make Revolving Loans and to acquire participations in Letters of Credit and Swingline Loans
hereunder, expressed as an amount representing the maximum aggregate amount of such Lender’s Revolving Exposure hereunder, as such commitment may be (a) reduced from time to time pursuant to Section 2.08 and (b) reduced or
increased from time to time pursuant to assignments by or to such Lender pursuant to Section 9.04. The initial amount of each Lender’s Revolving Commitment is set forth on Schedule 2.01, or in the Assignment and Assumption pursuant to
which such Lender shall have assumed its Revolving Commitment, as applicable. The initial aggregate amount of the Lenders’ Revolving Commitments is $75,000,000. 
  
 “Revolving Exposure” means, with respect to any Lender at any time, the sum of the outstanding principal
amount of such Lender’s Revolving Loans and its LC Exposure and Swingline Exposure at such time. 
  
 “Revolving Lender” means a Lender with a Revolving Commitment or, if the Revolving Commitments have terminated or expired, a Lender with
Revolving Exposure. 
  
 “Revolving Loan” means a
Loan made pursuant to clause (b) of Section 2.01. 
  
 “Revolving Maturity Date” means August 11, 2011, or, if such day is not a Business Day, the next preceding Business Day. 
  
 “S&P” means Standard & Poor’s Ratings Group, Inc. 
  
 “Secured Hedge Agreement” means any interest rate Swap Agreement permitted under Articles V or VI that is
entered into by and between the Borrower and any Lender or Affiliate of a Lender. 
  
 “Secured Parties” has the meaning assigned to such term in the Collateral Agreement. 
  
 “Security Documents” means the Collateral Agreement, the Intellectual Property Security Agreement, the Mortgages and each other security
agreement or other instrument or document executed and delivered pursuant to Section 5.11 or 5.12 or pursuant to the Collateral Agreement to secure any of the Obligations. 
  

 LifeCare Credit Agreement 
 33 

 “Senior Subordinated Debt” means the Indebtedness represented by the Senior Subordinated
Notes (including the Note Guarantees, Exchange Notes (each as defined in the Senior Subordinated Debt Documents), Guarantees of Exchange Notes and any replacement Exchange Notes). 
  
 “Senior Subordinated Debt Documents” means the indenture under which the Senior Subordinated Debt was
issued, the Senior Subordinated Notes, and the Guarantees of the Senior Subordinated Notes. 
  
 “Senior Subordinated Notes” means the Borrower’s Senior Subordinated Notes due 2013 to be issued on or prior to the Closing Date in the aggregate principal amount of $150,000,000. 
  
 “Social Security Act” means the Social Security Act as set
forth in Title 42 of the United States Code, as amended, and any successor statute thereto, as interpreted by the rules and regulations issued thereunder, in each case as in effect from time to time. References to sections of the Social Security Act
shall be construed also to refer to any successor sections. 
  
 “Specified Equity Issuances” means the issuance by a Parent, Holdings, the Borrower or any of its Restricted Subsidiaries of any of its Equity Interests in a public offering that is underwritten, managed, arranged, placed
or initially purchased by an investment bank (it being understood that no Permitted Holder that is not a registered broker-dealer is an investment bank). 
  
 “Specified Transaction” means any (a) Asset Disposition involving all or substantially all of the assets of or all of the Equity
Interests of any Subsidiary of the Borrower or any division, product line or facility used for operations of the Borrower or any of its Subsidiaries, (b) Permitted Acquisition or (c) designation of any Subsidiary as an Unrestricted
Subsidiary, or of any Unrestricted Subsidiary as a Subsidiary. 
  
 “Sponsor” means TC Group, L.L.C., together with its Affiliates. 
  
 “Sponsor Management Agreement” means the Management Agreement, dated August 11, 2005, among LifeCare Holdings, Inc., LCI Holdco LLC, LCI Intermediate Holdco, Inc., LCI Holding Company, Inc., TC
Group, L.L.C. and the Borrower. 
  
 “Sponsor Termination
Fees” means the one-time payment under the Sponsor Management Agreement of a termination fee to one or more of the Sponsors in the event of either a Change of Control or the completion of an IPO. 
  
 “Statutory Reserve Rate” means a fraction (expressed as a
decimal), the numerator of which is the number one and the denominator of which is the number one minus the aggregate of the maximum reserve percentages (including any marginal, special, emergency or supplemental reserves) expressed as a
decimal established by the Board to which the Administrative Agent is subject with respect to eurocurrency funding (currently referred to as “Eurocurrency Liabilities” in Regulation D of the Board). Such 

  

 LifeCare Credit Agreement 
 34 

 
reserve percentages shall include those imposed pursuant to such Regulation D. Eurodollar Loans shall be deemed to constitute eurocurrency funding and
to be subject to such reserve requirements without benefit of or credit for proration, exemptions or offsets that may be available from time to time to any Lender under such Regulation D or any comparable regulation. The Statutory Reserve Rate
shall be adjusted automatically on and as of the effective date of any change in any reserve percentage. 
  
 “subsidiary” means, with respect to any Person (the “parent”) at any date, any corporation, limited liability company,
partnership, association or other entity the accounts of which would be consolidated with those of the parent in the parent’s consolidated financial statements if such financial statements were prepared in accordance with GAAP as of such date,
as well as any other corporation, limited liability company, partnership, association or other entity of which securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary voting power or, in the
case of a partnership, more than 50% of the general partnership interests are, as of such date, owned, Controlled or held by the parent or one or more subsidiaries of the parent or by the parent and one or more subsidiaries of the parent.

  
 “Subsidiary” means (a) any subsidiary of
the Borrower on the Closing Date and (b) each subsidiary of the Borrower organized or acquired after the Closing Date. For purposes of the representations and warranties made herein on (and the conditions to borrowing on) the Closing Date, the
Acquisition shall be assumed to have already been consummated. Notwithstanding the foregoing (except for the definition of Unrestricted Subsidiary contained herein), an Unrestricted Subsidiary shall be deemed not to be a Subsidiary of the Borrower
or any of its Subsidiaries for purposes of this Agreement. 
  
 “Subsidiary Guaranty” means the Subsidiary Guaranty made by the Subsidiary Loan Parties in favor of the Administrative Agent on behalf of the Secured Parties, substantially in the form of Exhibit G, together with each other
guarantee and guarantee supplement delivered pursuant to Section 5.11 or 5.12. 
  
 “Subsidiary Loan Party” means any Subsidiary that is not (a) a Foreign Subsidiary, (b) an Insurance Subsidiary or (c) an Inactive Subsidiary for which the Borrower has not satisfied the
Collateral and Guarantee Requirement. 
  
 “Subsidiary
Redesignation” has the meaning set forth in Section 5.13. 
  
 “Swap Agreement” means any agreement with respect to any swap, forward, future or derivative transaction or option or similar agreement involving, or settled by reference to, one or more rates, currencies, commodities,
equity or debt instruments or securities, or economic, financial or pricing indices or measures of economic, financial or pricing risk or value or any similar transaction or any combination of these transactions; provided that no phantom
stock or similar plan providing for payments only on account of services provided by current or former directors, officers, employees or consultants of the Borrower or the Subsidiaries shall be a Swap Agreement. 
  

 LifeCare Credit Agreement 
 35 

 “Swingline Exposure” means, at any time, the aggregate principal amount of all Swingline
Loans outstanding at such time. The Swingline Exposure of any Lender at any time shall be its Applicable Percentage of the total Swingline Exposure at such time. 
  
 “Swingline Lender” means JPMorgan Chase Bank, N.A., in its capacity as lender of Swingline Loans hereunder.

  
 “Swingline Loan” means a Loan made pursuant
to Section 2.04. 
  
 “Taxes” means any and
all present or future taxes, levies, imposts, duties, deductions, charges or withholdings imposed by any Governmental Authority. 
  
 “Term Lender” means a Lender with a Term Loan Commitment or an outstanding Term Loan. 
  
 “Term Loan” means a Loan made pursuant to clause (a) of
Section 2.01. 
  
 “Term Loan Commitment”
means, with respect to each Lender, the commitment, if any, of such Lender to make a Term Loan hereunder, expressed as an amount representing the maximum principal amount of the Term Loan to be made by such Lender hereunder, as such commitment may
be (a) reduced from time to time pursuant to Section 2.08 and (b) reduced or increased from time to time pursuant to assignments by or to such Lender pursuant to Section 9.04. The initial amount of each Lender’s Term Loan
Commitment is set forth on Schedule 2.01, or in the Assignment and Assumption pursuant to which such Lender shall have assumed its Term Loan Commitment, as applicable. The initial aggregate amount of the Lenders’ Term Loan Commitments is
$255,000,000. 
  
 “Term Loan Maturity Date” means
August 11, 2012, or, if such day is not a Business Day, the next preceding Business Day. 
  
 “Total Indebtedness” means, as of any date, (a) the aggregate principal amount of Indebtedness of the Borrower and the Subsidiaries outstanding as of such date, in the amount that would be
reflected on a balance sheet prepared as of such date on a consolidated basis in accordance with GAAP minus (b) the aggregate amount of unrestricted Permitted Investments and cash (in each case held by the Borrower and its Subsidiaries
free of Liens other than Liens under the Security Documents), together in excess of $5,000,000 that would be reflected on a balance sheet prepared as of such date on a consolidated basis in accordance with GAAP. 
  
 “Transactions” means the Acquisition and the Financing
Transactions. 
  
 “TRICARE” means the United
States Department of Defense health care program for service families (including TRICARE Prime, TRICARE Extra and TRICARE Standard), and any successor or predecessor thereof. 
  

 LifeCare Credit Agreement 
 36 

 “Type”, when used in reference to any Loan or Borrowing, refers to whether the rate of
interest on such Loan, or on the Loans comprising such Borrowing, is determined by reference to the Adjusted LIBO Rate or the Alternate Base Rate. 
  
 “Unrestricted Subsidiary” shall mean any Subsidiary of the Borrower designated as an Unrestricted Subsidiary pursuant to
Section 5.13. 
  
 “Withdrawal Liability”
means liability to a Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA. 
  
 “wholly owned” means with respect to a subsidiary of a
Person, a subsidiary of such Person all of the outstanding Equity Interests of which (other than (a) director’s qualifying shares and (b) shares issued to foreign nationals to the extent required by applicable law) are owned by such
Person and/or by one or more wholly owned subsidiaries of such Person. 
  
 SECTION 1.02. Classification of Loans and Borrowings. For purposes of this Agreement, Loans may be classified and referred to by Class (e.g., a “Revolving Loan”) or by Type (e.g., a “Eurodollar
Loan”) or by Class and Type (e.g., a “Eurodollar Revolving Loan”). Borrowings also may be classified and referred to by Class (e.g., a “Revolving Borrowing”) or by Type (e.g., a “Eurodollar
Borrowing”) or by Class and Type (e.g., a “Eurodollar Revolving Borrowing”). 
  
 SECTION 1.03. Terms Generally. The definitions of terms herein shall apply equally to the singular and plural forms of the terms defined. Whenever
the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include”, “includes” and “including” shall be deemed to be followed by the phrase “without
limitation”. The word “will” shall be construed to have the same meaning and effect as the word “shall”. Unless the context requires otherwise (a) any definition of or reference to any agreement, instrument or other
document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented or otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth
herein), (b) any reference herein to any Person shall be construed to include such Person’s successors and assigns, (c) the words “herein”, “hereof” and “hereunder”, and words of similar import, shall be
construed to refer to this Agreement in its entirety and not to any particular provision hereof, (d) all references herein to Articles, Sections, Exhibits and Schedules shall be construed to refer to Articles and Sections of, and Exhibits and
Schedules to, this Agreement and (e) the words “asset” and “property” shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash,
securities, accounts and contract rights. 
  
 SECTION 1.04.
Accounting Terms; GAAP. Except as otherwise expressly provided herein, all terms of an accounting or financial nature shall be construed in accordance with GAAP, as in effect from time to time; provided that, if the Borrower notifies
the Administrative Agent that the Borrower requests an amendment to 

  

 LifeCare Credit Agreement 
 37 

 
any provision hereof to eliminate the effect of any change occurring after the date hereof in GAAP or in the application thereof on the operation of such
provision (or if the Administrative Agent notifies the Borrower that the Required Lenders request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in GAAP or in the
application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in
accordance herewith. 
  
 ARTICLE II 
  
 The Credits 
  
 SECTION 2.01. Commitments. Subject to the terms and conditions set
forth herein, each Lender agrees (a) to make a Term Loan to the Borrower on the Closing Date in a principal amount equal to its Term Loan Commitment and (b) to make Revolving Loans to the Borrower from time to time during the Revolving
Availability Period in an aggregate principal amount that will not (after giving effect to any concurrent use of the proceeds thereof to repay Swingline Loans or LC Disbursements) result in such Lender’s Revolving Exposure exceeding such
Lender’s Revolving Commitment; provided, however, that Revolving Loans will only be available on the Closing Date in an aggregate amount of up to $10,000,000, provided, further, that the proceeds of such Revolving
Loans available on the Closing Date may only be used for the purpose of (i) funding payment of the amount by which the cash merger consideration payable at closing under the Merger Agreement exceeds the cash purchase price amount,
(ii) paying excess fees and expenses incurred by the Borrower in connection with the Acquisition and (iii) providing working capital to the Borrower and its Subsidiaries. Within the foregoing limits and subject to the terms and conditions
set forth herein, the Borrower may borrow, prepay and reborrow Revolving Loans. Amounts repaid or prepaid in respect of Term Loans may not be reborrowed. 
  
 SECTION 2.02. Loans and Borrowings. (a) Each Loan (other than a Swingline Loan) shall be made as part of a Borrowing consisting of Loans of
the same Class and Type made by the Lenders ratably in accordance with their Commitments of the applicable Class. The failure of any Lender to make any Loan required to be made by it shall not relieve any other Lender of its obligations hereunder;
provided that the Commitments of the Lenders are several and no Lender shall be responsible for any other Lender’s failure to make Loans as required. 
  
 (b) Subject to Section 2.14, each Revolving Borrowing and the Term Borrowing shall be comprised entirely of ABR Loans
or Eurodollar Loans as the Borrower may request in accordance herewith. Each Swingline Loan shall be an ABR Loan. 
  
 (c) At the commencement of each Interest Period for any Eurodollar Borrowing, such Borrowing shall be in an aggregate amount that is an integral multiple

  

 LifeCare Credit Agreement 
 38 

 
of $500,000 and not less than $1,000,000. At the time that each ABR Revolving Borrowing is made, such Borrowing shall be in an aggregate amount that is an
integral multiple of $250,000 and not less than $500,000; provided that an ABR Revolving Borrowing may be in an aggregate amount that is equal to the entire unused balance of the total Revolving Commitments or that is required to finance the
reimbursement of an LC Disbursement as contemplated by Section 2.05(e). Each Swingline Loan shall be in an amount that is an integral multiple of $250,000 and not less than $500,000. Borrowings of more than one Type and Class may be outstanding
at the same time; provided that there shall not at any time be more than a total of 15 Eurodollar Borrowings outstanding. 
  
 (d) Notwithstanding any other provision of this Agreement, the Borrower shall not be entitled to request, or to elect to convert or continue, any
Borrowing if the Interest Period requested with respect thereto would end after the Revolving Maturity Date or the Term Loan Maturity Date, as applicable. 
  
 SECTION 2.03. Requests for Borrowings. To request funding of a Revolving Borrowing or a Term Borrowing, the Borrower shall notify the
Administrative Agent of such request by telephone (a) in the case of a Eurodollar Borrowing, not later than 2:00 p.m., New York City time, three Business Days before the date of the proposed Borrowing or (b) in the case of an ABR
Borrowing, not later than 2:00 p.m., New York City time, one Business Day before the date of the proposed Borrowing; provided that any such notice of an ABR Revolving Borrowing to finance the reimbursement of an LC Disbursement as
contemplated by Section 2.05(e) may be given not later than 10:00 a.m., New York City time, on the date of the proposed Borrowing. Each such telephonic Borrowing Request shall be irrevocable and shall be confirmed promptly by hand delivery or
telecopy to the Administrative Agent of a written Borrowing Request in a form approved by the Administrative Agent and signed by the Borrower. Each such telephonic and written Borrowing Request shall specify the following information in compliance
with Section 2.02: 
  
 (i) whether the
requested Borrowing is to be a Revolving Borrowing, or a Term Borrowing; 
  
 (ii) the aggregate amount of such Borrowing; 
  
 (iii) the date of such Borrowing, which shall be a Business Day; 
  
 (iv) subject to the proviso to the fourth sentence of Section 2.02(c), whether such Borrowing is to be an ABR Borrowing or a
Eurodollar Borrowing; 
  
 (v) in the case of a
Eurodollar Borrowing, the initial Interest Period to be applicable thereto, which shall be a period contemplated by the definition of the term “Interest Period”; and 
  
 (vi) the location and number of the Borrower’s account to which funds are to be disbursed, which shall
comply with the requirements of Section 2.06. 
  

 LifeCare Credit Agreement 
 39 

 If no election as to the Type of Borrowing is specified, then the requested Borrowing shall be an ABR Borrowing. If no
Interest Period is specified with respect to any requested Eurodollar Borrowing, then the Borrower shall be deemed to have selected an Interest Period of one month’s duration. Promptly following receipt of a Borrowing Request in accordance with
this Section, the Administrative Agent shall advise each Lender of the details thereof and of the amount of such Lender’s Loan to be made as part of the requested Borrowing. 
  
 SECTION 2.04. Swingline Loans. (a) Subject to the terms and conditions set forth herein, the Swingline Lender
agrees to make Swingline Loans to the Borrower from time to time during the Revolving Availability Period, in an aggregate principal amount at any time outstanding that will not result in (i) the aggregate principal amount of outstanding
Swingline Loans exceeding $10,000,000 or (ii) the sum of the total Revolving Exposures exceeding the total Revolving Commitments; provided that the Swingline Lender shall not be required to make a Swingline Loan to refinance an
outstanding Swingline Loan. Within the foregoing limits and subject to the terms and conditions set forth herein, the Borrower may borrow, prepay and reborrow Swingline Loans. 
  
 (b) To request a Swingline Loan, the Borrower shall notify the Administrative Agent of such request by telephone (confirmed
by telecopy), not later than 2:00 p.m., New York City time, on the day of a proposed Swingline Loan. Each such notice shall be irrevocable and shall specify the requested date (which shall be a Business Day) and amount of the requested Swingline
Loan. The Administrative Agent will promptly advise the Swingline Lender of any such notice received from the Borrower. The Swingline Lender shall make each Swingline Loan available to the Borrower by means of a credit to the general deposit account
of the Borrower with the Swingline Lender (or, in the case of a Swingline Loan made to finance the reimbursement of an LC Disbursement as provided in Section 2.05(e), by remittance to the Issuing Bank) by 3:00 p.m., New York City time, on
the requested date of such Swingline Loan. 
  
 (c) The Swingline
Lender may by written notice given to the Administrative Agent not later than 12:00 noon, New York City time, on any Business Day require the Revolving Lenders to acquire participations on such Business Day in all or a portion of the Swingline
Loans outstanding. Such notice shall specify the aggregate amount of Swingline Loans in which Revolving Lenders will participate. Promptly upon receipt of such notice, the Administrative Agent will give notice thereof to each Revolving Lender,
specifying in such notice such Lender’s Applicable Percentage of such Swingline Loan or Loans. Each Revolving Lender hereby absolutely and unconditionally agrees, upon receipt of notice as provided above, to pay to the Administrative Agent, for
the account of the Swingline Lender, such Lender’s Applicable Percentage of such Swingline Loan or Loans. Each Revolving Lender acknowledges and agrees that its obligation to acquire participations in Swingline Loans pursuant to this paragraph
is absolute and unconditional and shall not be affected by any circumstance whatsoever, including the occurrence and continuance of a Default or reduction or termination of the Commitments, and that each such payment shall be made without any

  

 LifeCare Credit Agreement 
 40 

 
offset, abatement, withholding or reduction whatsoever; provided that no Lender shall be required to acquire a participation in any Swingline Loan to
the extent that doing so would cause the Revolving Exposure of such Lender to exceed such Lender’s Revolving Commitment. Each Revolving Lender shall comply with its obligation under this paragraph by wire transfer of immediately available
funds, in the same manner as provided in Section 2.06 with respect to Loans made by such Lender (and Section 2.06 shall apply, mutatis mutandis, to the payment obligations of the Revolving Lenders), and the Administrative
Agent shall promptly pay to the Swingline Lender the amounts so received by it from the Revolving Lenders. The Administrative Agent shall notify the Borrower of any participations in any Swingline Loan acquired pursuant to this paragraph, and
thereafter payments in respect of such Swingline Loan shall be made to the Administrative Agent and not to the Swingline Lender. Any amounts received by the Swingline Lender from the Borrower (or other party on behalf of the Borrower) in respect of
a Swingline Loan after receipt by the Swingline Lender of the proceeds of a sale of participations therein shall be promptly remitted to the Administrative Agent; any such amounts received by the Administrative Agent shall be promptly remitted by
the Administrative Agent to the Revolving Lenders that shall have made their payments pursuant to this paragraph and to the Swingline Lender, as their interests may appear; provided that any such payment so remitted shall be repaid to the
Swingline Lender or to the Administrative Agent, as applicable, if and to the extent such payment is required to be refunded to the Borrower for any reason. The purchase of participations in a Swingline Loan pursuant to this paragraph shall not
relieve the Borrower of any default in the payment thereof. 
  
 SECTION 2.05. Letters of Credit. (a) General. Subject to the terms and conditions set forth herein, the Borrower may request the issuance of Letters of Credit for its own account or the account of any Subsidiary, in a
form reasonably acceptable to the Administrative Agent and the applicable Issuing Bank, on the Closing Date and at any time and from time to time during the Revolving Availability Period. In the event of any inconsistency between the terms and
conditions of this Agreement and the terms and conditions of any form of letter of credit application or other agreement submitted by the Borrower to, or entered into by the Borrower with, an Issuing Bank relating to any Letter of Credit, the terms
and conditions of this Agreement shall control. 
  
 (b) Notice
of Issuance, Amendment, Renewal, Extension; Certain Conditions. To request the issuance of a Letter of Credit (or the amendment, renewal or extension of an outstanding Letter of Credit), the Borrower shall hand deliver or telecopy (or transmit
by electronic communication, if arrangements for doing so have been approved by the applicable Issuing Bank) to the applicable Issuing Bank and the Administrative Agent (reasonably in advance of the requested date of issuance, amendment, renewal or
extension) a notice requesting the issuance of a Letter of Credit, or identifying the Letter of Credit to be amended, renewed or extended, and specifying the date of issuance, amendment, renewal or extension (which shall be a Business Day), the date
on which such Letter of Credit is to expire (which shall comply with paragraph (c) of this Section), the amount of such Letter of Credit, the name and address of the beneficiary thereof and such other information as shall be necessary to
prepare, amend, renew or extend such Letter of Credit. If requested by the applicable Issuing 

  

 LifeCare Credit Agreement 
 41 

 
Bank, the Borrower also shall submit a letter of credit application on the Issuing Bank’s standard form in connection with any request for a Letter of
Credit. A Letter of Credit shall be issued, amended, renewed or extended only if (and upon issuance, amendment, renewal or extension of each Letter of Credit the Borrower shall be deemed to represent and warrant that), after giving effect to such
issuance, amendment, renewal or extension (i) the LC Exposure shall not exceed $15,000,000 and (ii) the total Revolving Exposures shall not exceed the total Revolving Commitments. 
  
 (c) Expiration Date. Each Letter of Credit shall expire at or prior to
the close of business on the earlier of (i) the date one year after the date of the issuance of such Letter of Credit (or, in the case of any renewal or extension thereof (including any automatic renewal pursuant to an evergreen feature), one
year after the most recent such renewal or extension) and (ii) the date that is five Business Days prior to the Revolving Maturity Date. 
  
 (d) Participations. By the issuance of a Letter of Credit (or an amendment to a Letter of Credit increasing the amount thereof) and without any
further action on the part of an Issuing Bank or the Lenders, each Issuing Bank hereby grants to each Revolving Lender, and each Revolving Lender hereby acquires from such Issuing Bank, a participation in such Letter of Credit equal to such
Lender’s Applicable Percentage of the aggregate amount available to be drawn under such Letter of Credit. In consideration and in furtherance of the foregoing, each Revolving Lender hereby absolutely and unconditionally agrees to pay to the
Administrative Agent, for the account of the applicable Issuing Bank, such Lender’s Applicable Percentage of each LC Disbursement made by such Issuing Bank and not reimbursed by the Borrower on the date due as provided in paragraph (e) of
this Section 2.05, or of any reimbursement payment required to be refunded to the Borrower for any reason. Each Revolving Lender acknowledges and agrees that its obligation to acquire participations pursuant to this paragraph in respect of
Letters of Credit is absolute and unconditional and shall not be affected by any circumstance whatsoever, including any amendment, renewal or extension of any Letter of Credit or the occurrence and continuance of a Default or reduction or
termination of the Commitments, and that each such payment shall be made without any offset, abatement, withholding or reduction whatsoever; provided that no Lender shall be required to acquire a participation in any Letter of Credit to the
extent that doing so would cause the Revolving Exposure of such Lender to exceed such Lender’s Revolving Commitment. 
  
 (e) Reimbursement. If an Issuing Bank shall make any LC Disbursement in respect of a Letter of Credit, the Borrower shall reimburse such LC
Disbursement by paying to the Administrative Agent an amount equal to such LC Disbursement not later than 2:00 p.m., New York City time, on the date that such LC Disbursement is made, if the Borrower shall have received notice of such LC
Disbursement prior to 10:00 a.m., New York City time, on such date, or, if such notice has not been received by the Borrower prior to such time on such date, then not later than 2:00 p.m., New York City time, on (i) the Business Day that the
Borrower receives such notice, if such notice is received prior to 10:00 a.m., New York City time, on the day of receipt, or (ii) the Business Day immediately following the day that the Borrower receives such notice, if 

  

 LifeCare Credit Agreement 
 42 

 
such notice is not received prior to such time on the day of receipt; provided that (whether or not the conditions in Section 4.02 are satisfied
or a Default exists) each of the Administrative Agent and the Borrower shall have the absolute and unconditional right to require that such payment be financed with an ABR Revolving Borrowing or Swingline Loan in an equivalent amount and, to the
extent so financed, the Borrower’s obligation to make such payment shall be discharged and replaced by the resulting ABR Revolving Borrowing or Swingline Loan. If the Borrower fails to make such payment when due, the Administrative Agent shall
notify each Revolving Lender of the applicable LC Disbursement, the payment then due from the Borrower in respect thereof and such Lender’s Applicable Percentage thereof. Promptly following receipt of such notice, each Revolving Lender shall
pay to the Administrative Agent its Applicable Percentage of the payment then due from the Borrower, in the same manner as provided in Section 2.06 with respect to Loans made by such Lender (and Section 2.06 shall apply, mutatis
mutandis, to the payment obligations of the Revolving Lenders), and the Administrative Agent shall promptly pay to the applicable Issuing Bank the amounts so received by it from the Revolving Lenders. Promptly following receipt by the
Administrative Agent of any payment from the Borrower pursuant to this paragraph, the Administrative Agent shall distribute such payment to the applicable Issuing Bank or, to the extent that Revolving Lenders have made payments pursuant to this
paragraph to reimburse such Issuing Bank, then to such Lenders and the Issuing Bank as their interests may appear. Any payment made by a Revolving Lender pursuant to this paragraph to reimburse an Issuing Bank for any LC Disbursement (other than the
funding of ABR Revolving Loans or a Swingline Loan as contemplated above) shall not constitute a Loan and shall not relieve the Borrower of its obligation to reimburse such LC Disbursement. 
  
 (f) Obligations Absolute. The Borrower’s obligation to reimburse
LC Disbursements as provided in paragraph (e) of this Section 2.05 shall be absolute, unconditional and irrevocable, and shall be performed strictly in accordance with the terms of this Agreement under any and all circumstances whatsoever
and irrespective of (i) any lack of validity or enforceability of any Letter of Credit or this Agreement, or any term or provision therein, (ii) any draft or other document presented under a Letter of Credit proving to be forged,
fraudulent or invalid in any respect or any statement therein being untrue or inaccurate in any respect, (iii) payment by the Issuing Bank under a Letter of Credit against presentation of a draft or other document that does not comply strictly
with the terms of such Letter of Credit, or (iv) any other event or circumstance whatsoever, whether or not similar to any of the foregoing, that might, but for the provisions of this Section, constitute a legal or equitable discharge of, or
provide a right of setoff against, the Borrower’s obligations hereunder. None of the Administrative Agent, the Lenders, the Issuing Banks or any of their Related Parties shall have any liability or responsibility by reason of or in connection
with the issuance or transfer of any Letter of Credit or any payment or failure to make any payment thereunder (irrespective of any of the circumstances referred to in the preceding sentence), or any error, omission, interruption, loss or delay in
transmission or delivery of any draft, notice or other communication under or relating to any Letter of Credit (including any document required to make a drawing thereunder), any error in interpretation of technical terms or any consequence arising
from causes beyond the control of the Issuing Bank; provided that the provisions of this Section 2.05(f) shall not be construed to excuse an Issuing 

  

 LifeCare Credit Agreement 
 43 

 
Bank from liability to the Borrower to the extent of any direct damages (as opposed to consequential damages, claims in respect of which are hereby waived by
the Borrower to the extent permitted by applicable law) suffered by the Borrower that are caused by such Issuing Bank’s failure to exercise care when determining whether drafts and other documents presented under a Letter of Credit comply with
the terms thereof. The parties hereto expressly agree that, in the absence of gross negligence or willful misconduct on the part of an Issuing Bank (as finally determined by a court of competent jurisdiction), such Issuing Bank shall be deemed to
have exercised care in each such determination. In furtherance of the foregoing and without limiting the generality thereof, the parties agree that, with respect to documents presented which appear on their face to be in substantial compliance with
the terms of a Letter of Credit, an Issuing Bank may, in its sole discretion, either accept and make payment upon such documents without responsibility for further investigation, regardless of any notice or information to the contrary, or refuse to
accept and make payment upon such documents if such documents are not in strict compliance with the terms of such Letter of Credit. 
  
 (g) Disbursement Procedures. An Issuing Bank shall, promptly following its receipt thereof, examine all documents purporting to represent a demand
for payment under a Letter of Credit issued by it. The Issuing Bank shall promptly notify the Administrative Agent and the Borrower by telephone (confirmed by telecopy) of such demand for payment and whether the Issuing Bank has made or will make an
LC Disbursement thereunder; provided that any failure to give or delay in giving such notice shall not relieve the Borrower of its obligation to reimburse the Issuing Bank and the Revolving Lenders with respect to any such LC Disbursement.

  
 (h) Interim Interest. If an Issuing Bank shall make any
LC Disbursement, then, unless the Borrower shall reimburse such LC Disbursement in full on the date such LC Disbursement is made, the unpaid amount thereof shall bear interest, for each day from and including the date such LC Disbursement is made to
but excluding the date that the Borrower reimburses such LC Disbursement, at the rate per annum then applicable to ABR Revolving Loans; provided that, if the Borrower fails to reimburse such LC Disbursement when due pursuant to
paragraph (e) of this Section 2.05, then Section 2.13(c) shall apply. Interest accrued pursuant to this paragraph shall be for the account of the applicable Issuing Bank, except that interest accrued on and after the date of payment
by any Revolving Lender pursuant to paragraph (e) of this Section to reimburse an Issuing Bank shall be for the account of such Lender to the extent of such payment. 
  
 (i) Replacement of the Issuing Bank. An Issuing Bank may be replaced at any time by written agreement among the
Borrower, the Administrative Agent and the successor Issuing Bank. The Administrative Agent shall notify the Lenders of any such replacement of an Issuing Bank. At the time any such replacement shall become effective, the Borrower shall pay all
unpaid fees accrued for the account of the replaced Issuing Bank pursuant to Section 2.12(b). From and after the effective date of any such replacement, (i) the successor Issuing Bank shall have all the rights and obligations of an Issuing
Bank under this Agreement with respect to Letters of Credit to be issued by it thereafter and (ii) references herein to the term “Issuing Bank” shall be deemed to refer to 

  

 LifeCare Credit Agreement 
 44 

 
such successor or to any predecessor Issuing Bank, or to such successor and all predecessor Issuing Banks, as the context shall require. After the
replacement of an Issuing Bank hereunder, the replaced Issuing Bank shall remain a party hereto and shall continue to have all the rights and obligations of an Issuing Bank under this Agreement with respect to Letters of Credit issued by it prior to
such replacement, but shall not be required to issue additional Letters of Credit. 
  
 (j) Cash Collateralization. If any Event of Default under clauses (a), (b), (h) or (i) of Article VII shall occur and be continuing or if the Loans have been accelerated pursuant to
Article VII as a result of any other Event of Default, on or before the third Business Day (subject to the proviso below) after the Borrower receives notice from the Administrative Agent or the Required Lenders (or, if the maturity of the Loans
has been accelerated, Revolving Lenders with LC Exposure representing greater than 50% of the total LC Exposure) demanding the deposit of cash collateral pursuant to this paragraph, the Borrower shall deposit in an account with the Administrative
Agent, in the name of the Administrative Agent and for the benefit of the Lenders, an amount in cash equal to the LC Exposure as of such date plus any accrued and unpaid interest thereon; provided that the obligation to deposit such
cash collateral shall become effective immediately, and such deposit shall become immediately due and payable, without demand or other notice of any kind, upon the occurrence of any Event of Default with respect to the Borrower described in
clause (h) or (i) of Article VII. The Borrower also shall deposit cash collateral pursuant to this paragraph as and to the extent required by Section 2.11(b). Each such deposit under this Section 2.05(j) or
Section 2.11(b) shall be held by the Administrative Agent as collateral for the payment and performance of the obligations of the Borrower under this Agreement, and the Borrower hereby grants to the Agent, for the benefit of the Secured
Parties, a security interest in all funds and investments from time to time in such account, and in the proceeds thereof, to secure the Obligations. The Administrative Agent shall have exclusive dominion and control, including the exclusive right of
withdrawal, over such account. Other than any interest earned on the investment of such deposits, which investments shall be made at the option and sole discretion of (i) for so long as an Event of Default shall be continuing, the
Administrative Agent and (ii) at any other time, the Borrower, in each case, in Permitted Investments and at the Borrower’s risk and expense, such deposits shall not bear interest. Interest or profits, if any, on such investments shall
accumulate in such account. Moneys in such account shall be applied by the Administrative Agent to reimburse the Issuing Bank for LC Disbursements for which it has not been reimbursed and, to the extent not so applied, shall be held for the
satisfaction of the reimbursement obligations of the Borrower for the LC Exposure at such time or, if the maturity of the Loans has been accelerated (but subject to the consent of Revolving Lenders with LC Exposure representing greater than 50% of
the total LC Exposure), be applied to satisfy other obligations of the Borrower under this Agreement. If the Borrower is required to provide an amount of cash collateral under this Section 2.05(j) as a result of the occurrence of an Event of
Default specified above, such amount (to the extent not applied as aforesaid) shall be returned to the Borrower within three Business Days after the applicable Events of Default have been cured or waived. If the Borrower is required to provide an
amount of cash collateral hereunder pursuant to Section 2.11(b), such amount (to the extent not applied as aforesaid) shall be returned to the Borrower as and to the extent that, after 

  

 LifeCare Credit Agreement 
 45 

 
giving effect to such return, the Borrower would remain in compliance with Section 2.11(b) and no Default shall have occurred and be continuing.

  
 (k) Additional Issuing Banks. From time to time, the
Borrower may by notice to the Administrative Agent designate up to three Lenders (in addition to JPMorgan Chase Bank, N.A.) to act as Issuing Banks; provided (i) each agrees (in its sole discretion) to act in such capacity pursuant to a
written instrument satisfactory to the Borrower and the Administrative Agent, (ii) each is reasonably satisfactory to the Administrative Agent as an Issuing Bank and (iii) at the time of designation and for all periods such Lender acts as
an Issuing Bank such Lender has a Revolving Commitment hereunder. 
  
 (l) Reporting. Unless otherwise requested by the Administrative Agent, each Issuing Bank shall (i) provide to the Administrative Agent copies of any notice received from the Borrower pursuant to Section 2.05(b) no later
than the next Business Day after receipt thereof and (ii) report in writing to the Administrative Agent (A) on or prior to each Business Day on which such Issuing Bank expects to issue, amend, renew or extend any Letter of Credit, the date
of such issuance, amendment, renewal or extension, and the aggregate face amount of the Letters of Credit to be issued, amended, renewed or extended by it and outstanding after giving effect to such issuance, amendment, renewal or extension occurred
(and whether the amount thereof changed), and the Issuing Bank shall be permitted to issue, amend, renew or extend such Letter of Credit if the Administrative Agent shall not have advised the Issuing Bank that such issuance, amendment renewal or
extension would not be in conformity with the requirements of this Agreement, (B) on each Business Day on which such Issuing Bank makes any LC Disbursement, the date of such LC Disbursement and the amount of such LC Disbursement and (C) on
any other Business Day, such other information as the Administrative Agent shall reasonably request, including but not limited to prompt verification of such information as may be requested by the Administrative Agent. 
  
 SECTION 2.06. Funding of Borrowings. (a) Each Lender shall make
each Loan to be made by it hereunder on the proposed date thereof by wire transfer of immediately available funds by 12:00 noon, New York City time, to the account of the Administrative Agent most recently designated by it for such purpose by notice
to the Lenders; provided that Swingline Loans shall be made as provided in Section 2.04. The Administrative Agent will make such Loans available to the Borrower by promptly crediting the amounts so received, in like funds, to an account
of the Borrower maintained with the Administrative Agent in New York City and designated by the Borrower in the applicable Borrowing Request; provided that ABR Revolving Loans and Swingline Loans made to finance the reimbursement of an LC
Disbursement as provided in Section 2.05(e) shall be remitted by the Administrative Agent to the Issuing Bank. 
  
 (b) Unless the Administrative Agent shall have received notice from a Lender prior to the proposed date of any Borrowing that such Lender will not make
available to the Administrative Agent such Lender’s share of such Borrowing, the Administrative Agent may assume that such Lender has made such share available on such date in accordance with paragraph (a) of this Section and may, in
reliance upon such 

  

 LifeCare Credit Agreement 
 46 

 
assumption, make available to the Borrower a corresponding amount. In such event, if a Lender has not in fact made its share of the applicable Borrowing
available to the Administrative Agent, then the applicable Lender and the Borrower severally agree to pay to the Administrative Agent forthwith on demand such corresponding amount with interest thereon, for each day from and including the date such
amount is made available to the Borrower to but excluding the date of payment to the Administrative Agent, at (i) in the case of such Lender, the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in
accordance with banking industry rules on interbank compensation or (ii) in the case of the Borrower, the interest rate applicable to ABR Loans. If such Lender pays such amount to the Administrative Agent, then such amount shall constitute such
Lender’s Loan included in such Borrowing. 
  
 SECTION 2.07.
Interest Elections. (a) Each Revolving Borrowing and Term Borrowing initially shall be of the Type specified in the applicable Borrowing Request and, in the case of a Eurodollar Borrowing, shall have an initial Interest Period as
specified in such Borrowing Request. Thereafter, the Borrower may elect to convert such Borrowing to a different Type or to continue such Borrowing and, in the case of a Eurodollar Borrowing, may elect Interest Periods therefor, all as provided in
this Section. The Borrower may elect different options with respect to different portions of the affected Borrowing, in which case each such portion shall be allocated ratably among the Lenders holding the Loans comprising such Borrowing, and the
Loans comprising each such portion shall be considered a separate Borrowing. This Section shall not apply to Swingline Borrowings, which may not be converted or continued. Anything contained herein to the contrary notwithstanding, the Borrower may
not select Interest Periods of other than one or two weeks for any Eurodollar Borrowings until the earlier of (i) September 9, 2005 and (ii) the date of completion of primary syndication of the Commitments as specified in a written
notice to the Borrower by the Joint Lead Arrangers. 
  
 (b) To
make an election pursuant to this Section, the Borrower shall notify the Administrative Agent of such election by telephone by the time that a Borrowing Request would be required under Section 2.03 if the Borrower were requesting a Revolving
Borrowing of the Type resulting from such election to be made on the effective date of such election. Each such telephonic Interest Election Request shall be irrevocable and shall be confirmed promptly by hand delivery or telecopy to the
Administrative Agent of a written Interest Election Request in a form approved by the Administrative Agent and signed by the Borrower. 
  
 (c) Each telephonic and written Interest Election Request shall specify the following information in compliance with Section 2.02: 
  
 (i) the Borrowing to which such Interest Election Request
applies and, if different options are being elected with respect to different portions thereof, the portions thereof to be allocated to each resulting Borrowing (in which case the information to be specified pursuant to clauses (iii) and
(iv) below shall be specified for each resulting Borrowing); 
  

 LifeCare Credit Agreement 
 47 

 (ii) the effective date of the election made pursuant to such Interest Election Request,
which shall be a Business Day; 
  
 (iii) whether
the resulting Borrowing is to be an ABR Borrowing or a Eurodollar Borrowing; and 
  
 (iv) if the resulting Borrowing is a Eurodollar Borrowing, the Interest Period to be applicable thereto after giving effect to such
election, which shall be a period contemplated by the definition of the term “Interest Period”. 
  
 If any such Interest Election Request requests a Eurodollar Borrowing but does not specify an Interest Period, then the Borrower shall be deemed to have selected an Interest Period of one month’s duration.

  
 (d) Promptly following receipt of an Interest Election
Request, the Administrative Agent shall advise each Lender of the details thereof and of such Lender’s portion of each resulting Borrowing. 
  
 (e) If the Borrower fails to deliver a timely Interest Election Request with respect to a Eurodollar Borrowing prior to the end of the Interest Period
applicable thereto, then, unless such Borrowing is repaid as provided herein, at the end of such Interest Period such Borrowing shall be converted to an ABR Borrowing. Notwithstanding any contrary provision hereof, if an Event of Default has
occurred and is continuing then, so long as an Event of Default is continuing (i) no outstanding Borrowing may be converted to or continued as a Eurodollar Borrowing and (ii) unless repaid, each Eurodollar Borrowing shall be converted to
an ABR Borrowing at the end of the Interest Period applicable thereto. 
  
 SECTION 2.08. Termination and Reduction of Commitments. (a) Unless previously terminated, (i) the Term Loan Commitments shall terminate at 5:00 p.m., New York City time, on the Closing Date and (ii) the Revolving
Commitments shall terminate on the Revolving Maturity Date. 
  
 (b) The Borrower may at any time, without premium or penalty, terminate, or from time to time reduce, the Revolving Commitments; provided that (i) each reduction of the Revolving Commitments shall be in an amount that is an
integral multiple of $500,000 and not less than $1,000,000 and (ii) the Borrower shall not terminate or reduce the Revolving Commitments if, after giving effect to any concurrent prepayment of the Revolving Loans in accordance with
Section 2.11, the sum of the Revolving Exposures would exceed the total Revolving Commitments. 
  
 (c) The Borrower shall notify the Administrative Agent of any election to terminate or reduce the Commitments under paragraph (b) of this
Section 2.08 at least three Business Days prior to the effective date of such termination or reduction, specifying such election and the effective date thereof. Promptly following receipt of any notice, the Administrative Agent shall advise the
Lenders of the contents thereof. Each notice delivered by the Borrower pursuant to this Section shall be irrevocable; provided that a notice of termination of the Revolving Commitments delivered by the Borrower 

  

 LifeCare Credit Agreement 
 48 

 
may state that such notice is conditioned upon the effectiveness of other credit facilities, in which case such notice may be revoked by the Borrower (by
notice to the Administrative Agent on or prior to the specified effective date) if such condition is not satisfied. 
  
 (d) Any termination or reduction of the Commitments of any Class shall be permanent. Each reduction of the Commitments of any Class shall be made ratably
among the Lenders in accordance with their respective Commitments of such Class. 
  
 SECTION 2.09. Repayment of Loans; Evidence of Debt. (a) The Borrower hereby unconditionally promises to pay (i) to the Administrative Agent for the account of each Lender the then unpaid
principal amount of each Revolving Loan of such Lender on the Revolving Maturity Date, (ii) to the Administrative Agent for the account of each Lender the then unpaid principal amount of each Term Loan of such Lender as provided in
Section 2.10 and (iii) to the Swingline Lender the then unpaid principal amount of each Swingline Loan on the earlier of the Revolving Maturity Date and the date that is ten Business Days after such Swingline Loan is made; provided
that on each date that a Revolving Borrowing is made, the Borrower shall repay all Swingline Loans that were outstanding on the date such Borrowing was requested. 
  
 (b) Each Lender shall maintain in accordance with its usual practice an account or accounts evidencing the indebtedness of
the Borrower to such Lender resulting from each Loan made by such Lender, including the amounts of principal and interest payable and paid to such Lender from time to time hereunder. 
  
 (c) The Administrative Agent shall maintain accounts in which it shall record (i) the amount of each Loan made
hereunder, the Class and Type thereof and the Interest Period applicable thereto, (ii) the amount of any principal or interest due and payable or to become due and payable from the Borrower to each Lender hereunder and (iii) the amount of
any sum received by the Administrative Agent hereunder for the account of the Lenders and each Lender’s share thereof. 
  
 (d) The entries made in the accounts maintained pursuant to paragraph (b) or (c) of this Section 2.09 shall be prima facie
evidence of the existence and amounts of the obligations recorded therein; provided that the failure of any Lender or the Administrative Agent to maintain such accounts or any error therein shall not in any manner affect the obligation of the
Borrower to repay the Loans in accordance with the terms of this Agreement. 
  
 (e) Any Lender may request that Loans of any Class made by it be evidenced by a promissory note. In such event, the Borrower shall prepare, execute and deliver to such Lender a promissory note payable to the order of
such Lender (or, if requested by such Lender, to such Lender and its registered assigns) and in a form reasonably satisfactory to the Administrative Agent. Such promissory note shall state that it is subject to the provisions of this Agreement.
Thereafter, the Loans evidenced by such promissory note and interest thereon shall at all times (including after assignment pursuant to Section 9.04) be represented by one or more promissory notes in such form 

  

 LifeCare Credit Agreement 
 49 

 
payable to the order of the payee named therein (or, if such promissory note is a registered note, to such payee and its registered assigns). 
  
 SECTION 2.10. Amortization of Term Loans. (a) Subject to
adjustment pursuant to paragraph (c) of this Section 2.10, the Borrower shall repay the Term Borrowing on each date set forth below in the aggregate principal amount set forth opposite such date: 
  

				
	 Date

	  	Amount

	 December 31, 2005
	  	$	637,500
	 March 31, 2006
	  	$	637,500
	 June 30, 2006
	  	$	637,500
	 September 30, 2006
	  	$	637,500
	 December 31, 2006
	  	$	637,500
	 March 31, 2007
	  	$	637,500
	 June 30, 2007
	  	$	637,500
	 September 30, 2007
	  	$	637,500
	 December 31, 2007
	  	$	637,500
	 March 31, 2008
	  	$	637,500
	 June 30, 2008
	  	$	637,500
	 September 30, 2008
	  	$	637,500
	 December 31, 2008
	  	$	637,500
	 March 31, 2009
	  	$	637,500
	 June 30, 2009
	  	$	637,500
	 September 30, 2009
	  	$	637,500
	 December 31, 2009
	  	$	637,500
	 March 31, 2010
	  	$	637,500
	 June 30, 2010
	  	$	637,500
	 September 30, 2010
	  	$	637,500
	 December 31, 2010
	  	$	637,500
	 March 31, 2011
	  	$	637,500
	 June 30, 2011
	  	$	637,500
	 September 30, 2011
	  	$	637,500
	 December 31, 2011
	  	$	637,500
	 March 31, 2012
	  	$	637,500
	 June 30, 2012
	  	$	637,500
	 Term Loan Maturity Date
	  	$	237,787,500

  
 (b) To the extent not
previously paid, Term Loans shall be due and payable on the Term Loan Maturity Date. 
  
 (c) Any mandatory prepayment of the Term Borrowing shall be applied to reduce the subsequent scheduled repayments of the Term Borrowing to be made pursuant to this Section first, in direct order of the next four
scheduled payments to become due 

  

 LifeCare Credit Agreement 
 50 

 
under Section 2.10(a), and thereafter, ratably. Any optional prepayment of the Term Loans shall be applied to the remaining installments thereof as
directed by the Borrower. 
  
 (d) Prior to any repayment of the
Term Borrowing hereunder, the Borrower shall notify the Administrative Agent by telephone (confirmed by telecopy) of such selection not later than 11:00 a.m., New York City time, three Business Days before the scheduled date of such repayment. Each
repayment of a Borrowing shall be applied ratably to the Loans included in the repaid Borrowing. Repayments of the Term Borrowing shall be accompanied by accrued interest on the amount repaid. 
  
 SECTION 2.11. Prepayment of Loans. (a) The Borrower shall have
the right at any time and from time to time to prepay any Borrowing in whole or in part, without premium or penalty (but subject to Section 2.16), in an aggregate principal amount that is an integral multiple of $500,000 and not less than
$1,000,000 (or $500,000 or more, in the case of Swingline Loans) or, if less, the amount outstanding, subject to the requirements of this Section. 
  
 (b) In the event and on such occasion that the sum of the Revolving Exposures exceeds the total Revolving Commitments, the Borrower shall prepay Revolving
Borrowings or Swingline Borrowings (or, if no such Borrowings are outstanding, deposit cash collateral in an account with the Administrative Agent pursuant to Section 2.05(j)) in an aggregate amount equal to such excess. 
  
 (c) In the event and on each occasion that any Net Proceeds are received by
or on behalf of a Parent, Holdings, the Borrower or any Subsidiary in respect of any Prepayment Event, the Borrower shall, not later than five Business Days after the date on which such Net Proceeds are received, prepay Term Borrowings in an
aggregate amount equal to the Required Percentage of such Net Proceeds; provided that, in the case of any Asset Disposition described in clauses (a) and (b) of the definition of the term Asset Disposition, if the Borrower shall
deliver to the Administrative Agent a certificate of a Financial Officer to the effect that the Borrower or a Subsidiary intends to apply the Net Proceeds from such event (or a portion thereof specified in such certificate), within fifteen months
after receipt of such Net Proceeds, to acquire, maintain, develop, construct, improve, upgrade or repair assets (other than Equity Interests) to be used in the business of the Borrower or such Subsidiaries or to fund a Permitted Acquisition in
accordance with the terms of Section 6.04, and certifying that no Event of Default has occurred and is continuing, then no prepayment shall be required pursuant to this paragraph in respect of the Net Proceeds in respect of such event (or the
portion of such Net Proceeds specified in such certificate, if applicable), except to the extent of any such Net Proceeds therefrom that have not been so applied by the end of such fifteen-month period or contractually committed by the end of such
fifteen-month period to be so applied within 180 days after the date of such contractual commitment, at which time a prepayment shall be required in an amount equal to such Net Proceeds that have not been so applied or committed (and if any
portion of Net Proceeds contractually committed to be applied within such 180-day period are not so applied within such period, a prepayment shall be required in an amount equal to such portion on the last day of such period). For purposes hereof,
“Required Percentage” shall mean: (i) in the case of an 

  

 LifeCare Credit Agreement 
 51 

 
Asset Disposition, 100%; (ii) in the case of a Debt Issuance, 100%; and (iii) in the case of a Specified Equity Issuance, 25%, or if the Leverage
Ratio on the last day of the most recently completed fiscal quarter is less than or equal to 3.50 to 1.00, 0%. 
  
 (d) Following the end of each fiscal year of the Borrower, commencing with the fiscal year ending December 31, 2006, the Borrower will prepay Term
Borrowings in an aggregate amount equal to (i) 50% of Excess Cash Flow for such fiscal year minus (ii) the aggregate amount of voluntary prepayments of Term Loans made pursuant to this Section 2.11 during such fiscal year and
the aggregate amount of voluntary prepayments of Revolving Loans made during such fiscal year (to the extent the corresponding Revolving Commitments were simultaneously reduced pursuant to Section 2.08); provided that (A) such
percentage will be reduced to 25% of Excess Cash Flow in respect of any fiscal year if the Leverage Ratio is less than or equal to 4.50 to 1.00 on both the last day of such fiscal year and the date on which financial statements for such fiscal year
are delivered pursuant to Section 5.01 and (B) no such prepayment shall be required in respect of any such fiscal year if the Leverage Ratio is less than or equal to 3.50 to 1.00 on both the last day of such fiscal year and the date on
which financial statements for such fiscal year are delivered pursuant to Section 5.01. Each prepayment pursuant to this paragraph shall be made on or before the date on which financial statements are delivered pursuant to Section 5.01
with respect to the fiscal year for which Excess Cash Flow is being calculated (and in any event within 105 days after the end of such fiscal year). 
  
 (e) Prior to any optional or, subject to Sections 2.11(c) and (d), mandatory prepayment of Borrowings hereunder, the Borrower shall select the
Borrowing or Borrowings to be prepaid and shall specify such selection in the notice of such prepayment pursuant to paragraph (f) of this Section 2.11. 
  
 (f) The Borrower shall notify the Administrative Agent (and, in the case of prepayment of a Swingline Loan, the Swingline
Lender) by telephone (confirmed by telecopy) of any prepayment hereunder (i) in the case of prepayment of a Eurodollar Borrowing, not later than 2:00 p.m., New York City time, three Business Days before the date of prepayment, (ii) in the
case of prepayment of an ABR Borrowing, not later than 2:00 p.m., New York City time, one Business Day before the date of prepayment or (iii) in the case of prepayment of a Swingline Loan, not later than 3:00 p.m., New York City time, on the
date of prepayment. Each such notice shall be irrevocable and shall specify the prepayment date, the principal amount of each Borrowing or portion thereof to be prepaid, in the case of a mandatory prepayment, a reasonably detailed calculation of the
amount of such prepayment, and, in the case of a voluntary prepayment of Term Borrowings, the application thereof to the remaining scheduled repayments of such Borrowings; provided that, if a notice of optional prepayment is given in
connection with a conditional notice of termination of the Revolving Commitments as contemplated by Section 2.08, then such notice of prepayment may be revoked if such notice of termination is revoked in accordance with Section 2.08.
Promptly following receipt of any such notice (other than a notice relating solely to Swingline Loans), the Administrative Agent shall advise the Lenders of the contents thereof. Each partial prepayment of any Borrowing shall be in an amount that
would be permitted in the case 

  

 LifeCare Credit Agreement 
 52 

 
of an advance of a Borrowing of the same Type as provided in Section 2.02, except as necessary to apply fully the required amount of a mandatory
prepayment or to prepay such Borrowing in full. Each prepayment of a Borrowing shall be applied ratably to the Loans included in the prepaid Borrowing. Prepayments shall be accompanied by accrued interest and other amounts to the extent required by
Sections 2.13 and 2.16. 
  
 SECTION 2.12. Fees.
(a) The Borrower agrees to pay to the Administrative Agent for the account of each Revolving Lender a commitment fee, which shall accrue at the Applicable Rate on the daily unused amount of each Revolving Commitment of such Lender during the
period from and including the Closing Date to but excluding the date on which the Revolving Commitments terminate. Accrued commitment fees shall be payable in arrears on the last day of March, June, September and December of each year and on the
dates on which the Revolving Commitments terminate, commencing on the first such date to occur after the date hereof. All commitment fees shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days
elapsed (including the first day but excluding the last day). For purposes of computing commitment fees with respect to Revolving Commitments, a Revolving Commitment of a Lender shall be deemed to be used to the extent of the outstanding Revolving
Loans and LC Exposure of such Lender (and the Swingline Exposure of such Lender shall be disregarded for such purpose). 
  
 (b) The Borrower agrees to pay (i) to the Administrative Agent for the account of each Revolving Lender (other than a Defaulting Lender) a
participation fee with respect to its participations in Letters of Credit, which shall accrue at the same Applicable Rate from time to time in effect for purposes of determining the interest rate applicable to Eurodollar Revolving Loans, in each
case minus the amount of the fronting fee payable to the Issuing Bank pursuant to clause (ii) below, on the daily amount of such Lender’s LC Exposure (excluding any portion thereof attributable to unreimbursed LC Disbursements)
during the period from and including the Closing Date to but excluding the later of the date on which such Lender’s Revolving Commitment terminates and the date on which such Lender ceases to have any LC Exposure, and (ii) to the Issuing
Bank a fronting fee, which shall accrue at the rate of 0.125% per annum on the average daily amount of the LC Exposure (excluding any portion thereof attributable to unreimbursed LC Disbursements) during the period from and including the
Closing Date to but excluding the later of the date of termination of the Revolving Commitments and the date on which there ceases to be any LC Exposure, as well as the Issuing Bank’s customary documentary and processing fees with respect to
the issuance, amendment, renewal or extension of any Letter of Credit or processing of drawings thereunder. Participation fees and fronting fees accrued through and including the last day of March, June, September and December of each year shall be
payable in arrears on the third Business Day following such last day, commencing on the first such date to occur after the Closing Date; provided that all such fees shall be payable on the date on which the Revolving Commitments terminate and
any such fees accruing after the date on which the Revolving Commitments terminate shall be payable on demand. Any other fees payable to the Issuing Bank pursuant to this paragraph shall be payable within 10 days after demand. All participation
fees and fronting fees shall be computed on the basis of a year 

  

 LifeCare Credit Agreement 
 53 

 
of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day). 
  
 (c) The Borrower agrees to pay to the Administrative Agent, for its own
account, fees payable in the amounts and at the times separately agreed upon between the Borrower and the Administrative Agent. 
  
 (d) All fees payable hereunder shall be paid on the dates due, in immediately available funds, to the Administrative Agent (or to the applicable Issuing
Bank, in the case of fees payable to it) for distribution, in the case of commitment fees and participation fees, to the Lenders entitled thereto. Fees paid shall not be refundable under any circumstances. 
  
 SECTION 2.13. Interest. (a) The Loans comprising each ABR
Borrowing (including each Swingline Loan) shall bear interest at the Alternate Base Rate plus the Applicable Rate. 
  
 (b) The Loans comprising each Eurodollar Borrowing shall bear interest at the Adjusted LIBO Rate for the Interest Period in effect for such Borrowing
plus the Applicable Rate. 
  
 (c) Notwithstanding the
foregoing, if any principal of or interest on any Loan or any fee or other amount payable by the Borrower hereunder is not paid when due, whether at stated maturity, upon acceleration or otherwise, such overdue amount shall, upon the request of the
Required Lenders, bear interest, after as well as before judgment, at a rate per annum equal to (i) in the case of overdue principal of any Loan, 2% plus the rate otherwise applicable to such Loan as provided in the preceding paragraphs
of this Section or (ii) in the case of any other amount, 2% plus the rate applicable to ABR Revolving Loans as provided in paragraph (a) of this Section 2.13. 
  
 (d) Accrued interest on each Loan shall be payable in arrears on each Interest Payment Date for such Loan and, in the case
of Revolving Loans, upon termination of the Revolving Commitments; provided that (i) interest accrued pursuant to paragraph (c) of this Section shall be payable on demand, (ii) in the event of any repayment or prepayment of any
Loan (other than a prepayment of an ABR Revolving Loan prior to the end of the Revolving Availability Period), accrued interest on the principal amount repaid or prepaid shall be payable on the date of such repayment or prepayment and (iii) in
the event of any conversion of any Eurodollar Loan prior to the end of the current Interest Period therefor, accrued interest on such Loan shall be payable on the effective date of such conversion. 
  
 (e) All interest hereunder shall be computed on the basis of a year of
360 days, except that interest computed by reference to the Alternate Base Rate at times when the Alternate Base Rate is based on the Prime Rate shall be computed on the basis of a year of 365 days (or 366 days in a leap year), and in
each case shall be payable for the actual number of days elapsed (including the first day but excluding the last day). 

  

 LifeCare Credit Agreement 
 54 

 
The applicable Alternate Base Rate or Adjusted LIBO Rate shall be determined by the Administrative Agent, and such determination shall be conclusive absent
manifest error. 
  
 SECTION 2.14. Alternate Rate of
Interest. If prior to the commencement of any Interest Period for a Eurodollar Borrowing: 
  
 (a) the Administrative Agent determines (which determination shall be conclusive absent manifest error) that adequate and reasonable means
do not exist for ascertaining the Adjusted LIBO Rate for such Interest Period; or 
  
 (b) the Administrative Agent is advised by the Required Lenders that the Adjusted LIBO Rate for such Interest Period will not adequately
and fairly reflect the cost to such Lenders of making or maintaining their Loans included in such Borrowing for such Interest Period; 
  
 then the Administrative Agent shall give notice thereof to the Borrower and the Lenders by telephone or telecopy as promptly as practicable thereafter and, until the
Administrative Agent notifies the Borrower and the Lenders that the circumstances giving rise to such notice no longer exist, (i) any Interest Election Request that requests the conversion of any Borrowing to, or continuation of any Borrowing
as, a Eurodollar Borrowing shall be ineffective and (ii) if any Borrowing Request requests a Eurodollar Borrowing, such Borrowing shall be made as an ABR Borrowing; provided, however, that, in the case of a notice received
pursuant to clause (b) above, if the Administrative Agent is able prior to the commencement of such Interest Period to ascertain, after using reasonable efforts to poll the Lenders giving such notice, that a rate other than the Alternate Base
Rate would adequately and fairly reflect the cost to such Lenders of making or maintaining their Loans included in such Borrowing for such Interest Period, the Administrative Agent shall notify the Borrower of such alternate rate and the Borrower
may agree by written notice to the Administrative Agent prior to the commencement of such Interest Period to increase the Applicable Rate for the Loans included in such Borrowing for such Interest Period to result in an interest rate equal to such
alternate rate, in which case such increased Applicable Rate shall apply to all the Eurodollar Loans included in the relevant Borrowing. 
  
 SECTION 2.15. Increased Costs. (a) If any Change in Law (except with respect to Taxes, which shall be governed by Section 2.17) shall:

  
 (i) impose, modify or deem applicable any
reserve, special deposit or similar requirement against assets of, deposits with or for the account of, or credit extended by, any Lender (except any such reserve requirement reflected in the Adjusted LIBO Rate) or the Issuing Bank; or 

 
 (ii) impose on any Lender or the Issuing Bank or the
London interbank market any other condition affecting this Agreement or Eurodollar Loans made by such Lender or any Letter of Credit or participation therein; 
  

and the result of any of the foregoing shall be to increase the cost to such Lender of making or maintaining any Eurodollar Loan (or of maintaining its obligation to
make any 

  

 LifeCare Credit Agreement 
 55 

 
such Loan) or to increase the cost to such Lender or the Issuing Bank of participating in, issuing or maintaining any Letter of Credit or to reduce the
amount of any sum received or receivable by such Lender or the Issuing Bank hereunder (whether of principal, interest or otherwise), then the Borrower will pay to such Lender or the Issuing Bank, as the case may be, such additional amount or amounts
as will compensate such Lender or the Issuing Bank, as the case may be, for such additional costs incurred or reduction suffered. 
  
 (b) If any Lender or the Issuing Bank determines that any Change in Law regarding capital requirements has or would have the effect of reducing the rate
of return on such Lender’s or the Issuing Bank’s capital or on the capital of such Lender’s or the Issuing Bank’s holding company, if any, as a consequence of this Agreement or the Loans made by, or participations in Letters of
Credit held by, such Lender, or the Letters of Credit issued by the Issuing Bank, to a level below that which such Lender or the Issuing Bank or such Lender’s or the Issuing Bank’s holding company could have achieved but for such Change in
Law (taking into consideration such Lender’s or the Issuing Bank’s policies and the policies of such Lender’s or the Issuing Bank’s holding company with respect to capital adequacy), then from time to time after submission by
such Lender to the Borrower of a written request therefor, the Borrower will pay to such Lender or the Issuing Bank, as the case may be, such additional amount or amounts as will compensate such Lender or the Issuing Bank or such Lender’s or
the Issuing Bank’s holding company for any such reduction suffered. 
  
 (c) A certificate of a Lender or the Issuing Bank setting forth in reasonable detail the matters giving rise to a claim under this Section 2.15 and the calculation of such claim by such Lender or the Issuing Bank
or its holding company, as the case may be, shall be delivered to the Borrower and shall be conclusive absent manifest error. The Borrower shall pay such Lender or the Issuing Bank, as the case may be, the amount shown as due on any such certificate
within 10 days after receipt thereof. 
  
 (d) Failure or
delay on the part of any Lender or the Issuing Bank to demand compensation pursuant to this Section shall not constitute a waiver of such Lender’s or the Issuing Bank’s right to demand such compensation; provided that the Borrower
shall not be required to compensate a Lender or the Issuing Bank pursuant to this Section for any increased costs or reductions incurred more than 180 days prior to the date that such Lender or the Issuing Bank, as the case may be, notifies the
Borrower of the Change in Law giving rise to such increased costs or reductions and of such Lender’s or the Issuing Bank’s intention to claim compensation therefor; provided further that, if the Change in Law giving rise to
such increased costs or reductions is retroactive, then the 180-day period referred to above shall be extended to include the period of retroactive effect thereof. 
  
 SECTION 2.16. Break Funding Payments. In the event of (a) the payment of any principal of any Eurodollar Loan
prior to the last day of an Interest Period applicable thereto (including as a result of an Event of Default), (b) the conversion of any Eurodollar Loan prior to the last day of the Interest Period applicable thereto, (c) the failure to
borrow, convert, continue or prepay any Eurodollar Loan on the date 

  

 LifeCare Credit Agreement 
 56 

 
specified in any notice delivered pursuant hereto (regardless of whether such notice may be revoked under Section 2.11(f) and is revoked in accordance
therewith) or (d) the assignment of any Eurodollar Loan other than on the last day of the Interest Period applicable thereto as a result of a request by the Borrower pursuant to Section 2.19 or Section 9.02(c), then, in any such
event, the Borrower shall compensate each Lender for the loss, cost and expense attributable to such event. Such loss, cost or expense to any Lender shall consist of an amount determined by such Lender to be the excess, if any, of (i) the
amount of interest that would have accrued on the principal amount of such Loan had such event not occurred, at the Adjusted LIBO Rate that would have been applicable to such Loan, for the period from the date of such event to the last day of the
then current Interest Period therefor (or, in the case of a failure to borrow, convert or continue, for the period that would have been the Interest Period for such Loan), over (ii) the amount of interest that would accrue on such principal
amount for such period at the interest rate that such Lender would bid were it to bid, at the commencement of such period, for dollar deposits of a comparable amount and period from other banks in the Eurodollar market. A certificate of any Lender
setting forth any amount or amounts that such Lender is entitled to receive pursuant to this Section shall be delivered to the Borrower and shall be conclusive absent manifest error. The Borrower shall pay such Lender the amount shown as due on any
such certificate within 10 days after receipt thereof. 
  
 SECTION 2.17. Taxes. (a) Any and all payments by or on account of any obligation of the Borrower hereunder or under any other Loan Document shall be made free and clear of, and without deduction for, any Indemnified Taxes or
Other Taxes; provided that if the Borrower shall be required to deduct any Indemnified Taxes or Other Taxes from such payments, then (i) the sum payable shall be increased as necessary so that after making all required deductions
(including deductions applicable to additional sums payable under this Section) the Administrative Agent, Lender or Issuing Bank (as the case may be) receives an amount equal to the sum it would have received had no such deductions been made,
(ii) the Borrower shall make such deductions and (iii) the Borrower shall pay the full amount deducted to the relevant Governmental Authority in accordance with applicable law. 
  
 (b) In addition, the Borrower shall pay any Other Taxes to the relevant Governmental Authority in accordance with applicable
law. 
  
 (c) The Borrower shall indemnify the Administrative
Agent, each Lender and the Issuing Bank, within 10 days after written demand therefor, for the full amount of any Indemnified Taxes or Other Taxes paid by the Administrative Agent, such Lender or the Issuing Bank, as the case may be, on or with
respect to any payment by or on account of any obligation of the Borrower hereunder or under any other Loan Document (including Indemnified Taxes or Other Taxes imposed or asserted on or attributable to amounts payable under this Section) and any
penalties, interest and reasonable expenses arising therefrom or with respect thereto. A certificate as to the amount of such payment or liability prepared in good faith and delivered to the Borrower by a Lender or the Issuing Bank, or by the
Administrative Agent on its own behalf or on behalf of a Lender or the Issuing Bank, shall be presumed correct, provided that upon reasonable request of 

  

 LifeCare Credit Agreement 
 57 

 
the Borrower, a Lender shall provide all relevant information reasonably accessible to it justifying such amount. 
  
 (d) As soon as practicable after any payment of Indemnified Taxes or Other
Taxes by the Borrower to a Governmental Authority, the Borrower shall deliver to the Administrative Agent a copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other
evidence of such payment reasonably satisfactory to the Administrative Agent. 
  
 (e) A Foreign Lender shall deliver to the Borrower and the Administrative Agent a copy of either U.S. Internal Revenue Service Form W-8BEN or Form W-8ECI, or, in the case of a Foreign Lender claiming exemption from
U.S. federal withholding tax under Section 871(h) or 881(c) of the Code with respect to payments of “portfolio interest,” a statement to the effect that such Lender is eligible for a complete exemption from withholding of U.S. taxes
under Section 871(h) or 881(c) of the Code and a Form W-8BEN, or any subsequent versions thereof or successors thereto properly completed and duly executed by such Foreign Lender claiming complete exemption from, or a reduced rate of, U.S.
federal withholding tax on all payments by the Borrower under this Agreement and the other Loan Documents. Such forms shall be delivered by each Foreign Lender on or before the date it becomes a party to this Agreement (and from time to time upon
the request of the Borrower, but only if such Foreign Lender is legally entitled to do so). 
  
 (f) If the Administrative Agent, a Lender or the Issuing Bank determines, in its reasonable judgment, that it has received a refund of any Taxes or Other Taxes as to which it has been indemnified by the Borrower or
with respect to which the Borrower has paid additional amounts pursuant to this Section 2.17, it shall pay over such refund to the Borrower within a reasonable period of time (but only to the extent of indemnity payments made, or additional
amounts paid, by the Borrower under this Section 2.17 with respect to the Taxes or Other Taxes giving rise to such refund), net of all out-of-pocket expenses of the Administrative Agent, such Lender or the Issuing Bank and without interest
(other than any interest paid by the relevant Governmental Authority with respect to such refund); provided, that the Borrower, upon the request of the Administrative Agent, such Lender or the Issuing Bank, agrees to repay the amount paid
over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent, such Lender or the Issuing Bank in the event the Administrative Agent, such Lender or the Issuing
Bank is required to repay such refund to such Governmental Authority. This Section shall not be construed to require the Administrative Agent, any Lender or the Issuing Bank to make available its tax returns (or any other information relating to its
Taxes that it deems confidential) to the Borrower or any other Person. 
  
 SECTION 2.18. Payments Generally; Pro Rata Treatment; Sharing of Setoffs. (a) The Borrower shall make each payment required to be made by it hereunder or under any other Loan Document (whether of principal, interest, fees or
reimbursement of LC Disbursements, or of amounts payable under Section 2.15, 2.16 or 2.17, or otherwise) prior to the time expressly required hereunder or under such other Loan 

  

 LifeCare Credit Agreement 
 58 

 
Document for such payment (or, if no such time is expressly required, prior to 2:00 p.m., New York City time), on the date when due, in immediately available
funds, without setoff or counterclaim. Any amounts received after such time on any date may, in the discretion of the Administrative Agent, be deemed to have been received on the next succeeding Business Day for purposes of calculating interest
thereon. All such payments shall be made to the Administrative Agent at its offices at 270 Park Avenue, New York, New York, except payments to be made directly to the Issuing Bank or Swingline Lender as expressly provided herein and except that
payments pursuant to Sections 2.15, 2.16, 2.17 and 9.03 shall be made directly to the Persons entitled thereto and payments pursuant to other Loan Documents shall be made to the Persons specified therein. The Administrative Agent shall
distribute any such payments received by it for the account of any other Person to the appropriate recipient promptly following receipt thereof. If any payment under any Loan Document shall be due on a day that is not a Business Day, the date for
payment shall be extended to the next succeeding Business Day, and, in the case of any payment accruing interest, interest thereon shall be payable for the period of such extension. All payments under each Loan Document shall be made in dollars.

  
 (b) If at any time insufficient funds are received by and
available to the Administrative Agent to pay fully all amounts of principal, unreimbursed LC Disbursements, interest and fees then due hereunder, such funds shall be applied (i) first, towards payment of interest and fees then due hereunder,
ratably among the parties entitled thereto in accordance with the amounts of interest and fees then due to such parties, and (ii) second, towards payment of principal and unreimbursed LC Disbursements then due hereunder, ratably among the
parties entitled thereto in accordance with the amounts of principal and unreimbursed LC Disbursements then due to such parties. 
  
 (c) If any Lender shall, by exercising any right of setoff or counterclaim or otherwise, obtain payment in respect of any principal of or interest on any
of its Revolving Loans, Term Loans or participations in LC Disbursements or Swingline Loans resulting in such Lender receiving payment of a greater proportion of the aggregate amount of its Revolving Loans, Term Loans and participations in LC
Disbursements and Swingline Loans and accrued interest thereon than the proportion received by any other Lender, then the Lender receiving such greater proportion shall purchase (for cash at face value) participations in the Revolving Loans, Term
Loans and participations in LC Disbursements and Swingline Loans of other Lenders to the extent necessary so that the benefit of all such payments shall be shared by the Lenders ratably in accordance with the relative aggregate amounts of principal
of and accrued interest on their Revolving Loans, Term Loans and participations in LC Disbursements and Swingline Loans; provided that (i) if any such participations are purchased and all or any portion of the payment giving rise thereto
is recovered, such participations shall be rescinded and the purchase price restored to the extent of such recovery, without interest, and (ii) the provisions of this paragraph shall not be construed to apply to any payment made by the Borrower
pursuant to and in accordance with the express terms of this Agreement or any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans or participations in LC Disbursements to any assignee or
participant, other than to the Borrower or any Subsidiary or Affiliate thereof (as to which the provisions of this 

  

 LifeCare Credit Agreement 
 59 

 
paragraph shall apply). The Borrower consents to the foregoing and agrees, to the extent it may effectively do so under applicable law, that any Lender
acquiring a participation pursuant to the foregoing arrangements may exercise against the Borrower rights of setoff and counterclaim with respect to such participation as fully as if such Lender were a direct creditor of the Borrower in the amount
of such participation. 
  
 (d) Unless the Administrative Agent
shall have received notice from the Borrower prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders or the Issuing Bank hereunder that the Borrower will not make such payment, the Administrative
Agent may assume that the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the Lenders or the Issuing Bank, as the case may be, the amount due. In such event, if the Borrower
has not in fact made such payment, then each of the Lenders or the Issuing Bank, as the case may be, severally agrees to repay to the Administrative Agent forthwith on demand the amount so distributed to such Lender or Issuing Bank with interest
thereon, for each day from and including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent
in accordance with banking industry rules on interbank compensation. 
  
 (e) If any Lender shall fail to make any payment required to be made by it pursuant to Section 2.04(c), 2.05(d) or (e), 2.06(b), 2.18(d) or 9.03(c), then the Administrative Agent may, in its discretion (notwithstanding any contrary
provision hereof), apply any amounts thereafter received by the Administrative Agent for the account of such Lender to satisfy such Lender’s obligations under such Sections until all such unsatisfied obligations are fully paid. 
  
 SECTION 2.19. Mitigation Obligations; Replacement of Lenders.
(a) If any Lender requests compensation under Section 2.15, or if the Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.17, then such
Lender shall use reasonable efforts to designate a different lending office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its offices, branches or affiliates, if, in the judgment of such
Lender, such designation or assignment (i) would eliminate or reduce amounts payable pursuant to Section 2.15 or 2.17, as the case may be, in the future and (ii) would not subject such Lender to any unreimbursed cost or expense and
would not otherwise be disadvantageous to such Lender in any material respect. The Borrower hereby agrees to pay all reasonable costs and expenses incurred by any Lender in connection with any such designation or assignment. 
  
 (b) If any Lender requests compensation under Section 2.15, or if the
Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.17, or if any Lender is a Defaulting Lender, then the Borrower may, at its sole expense and
effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in Section 9.04), all its interests, rights and
obligations under this Agreement to an assignee 

  

 LifeCare Credit Agreement 
 60 

 
that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment); provided that (i) the Borrower
shall have received the prior written consent of the Administrative Agent (and, if a Revolving Commitment is being assigned, the Issuing Bank and Swingline Lender), which consent shall not unreasonably be withheld and (ii) such Lender shall
have received payment of an amount equal to the outstanding principal of its Loans and funded participations in LC Disbursements and Swingline Loans, accrued interest thereon, accrued fees and all other amounts payable to it hereunder, from the
assignee (to the extent of such outstanding principal and accrued interest and fees) or the Borrower (in the case of all other amounts) and such Lender shall be released from all obligations hereunder. A Lender shall not be required to make any such
assignment and delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Borrower to require such assignment and delegation cease to apply. Nothing in this Section 2.19 shall be deemed to
prejudice any rights that the Borrower may have against a Lender that is a Defaulting Lender in respect of actions taken or not taken by such Lender prior to its replacement hereunder. 
  
 SECTION 2.20. Incremental Extensions of Credit. At any time during the Revolving Availability Period, subject to the
terms and conditions set forth herein, the Borrower may at any time and from time to time, by notice to the Administrative Agent (whereupon the Administrative Agent shall promptly deliver a copy to each of the Lenders), request to add additional
term loans or additional revolving commitments (together, the “Incremental Extensions of Credit”) in minimum principal amounts of $25,000,000; provided that such amount may be less than $25,000,000 if such amount represents
all the remaining availability under the aggregate principal amount set forth below; provided, further, that (x) immediately prior to and after giving effect to any Incremental Facility Amendment (as defined below), no Default has
occurred or is continuing or shall result therefrom and (y) the Borrower shall be in Pro Forma Compliance with the Financial Covenants recomputed as of the last day of the most recently ended fiscal quarter of the Borrower for which financial
statements are available. The Incremental Extensions of Credit: 
  
 (a) shall be in an aggregate principal amount not exceeding $100,000,000, 
  
 (b) shall rank pari passu in right of payment and right of security in respect of the Collateral with the Revolving Loans
and Term Loans and 
  
 (c) other than
amortization, pricing or maturity date, shall have the same terms as the Term Loans or Revolving Commitments, as applicable, existing immediately prior to the effectiveness of such Incremental Facility Amendment (the “Existing Extensions of
Credit”); provided, that terms and conditions applicable to Incremental Extensions of Credit in the form of additional term loans maturing after the Term Loan Maturity Date may provide for additional or different financial or other
covenants or prepayment requirements applicable only during periods after the Term Loan Maturity Date; provided further that (i) the Incremental Extensions of Credit in the form of term loans shall not have a final maturity date
earlier than the Term Loan Maturity Date, (ii) the Incremental Extensions of Credit in the form of revolving loans shall not have a final maturity date earlier than the Revolving Maturity Date, (iii) the Incremental Extensions 

  

 LifeCare Credit Agreement 
 61 

 
of Credit in the form of term loans shall not have a weighted average life that is shorter than that of the then-remaining weighted average life of the
Existing Extensions of Credit that are Term Loans (other than by virtue of nominal amortization of or prepayments of the Existing Extensions of Credit that are Term Loans) and (iv) the Incremental Extensions of Credit in the form of revolving
loans shall not require any mandatory commitment reductions, mandatory prepayments or scheduled payments other than those applicable to the Revolving Loans and Revolving Commitments. Any additional bank, financial institution or other Person that
elects to extend Incremental Extensions of Credit shall be reasonably satisfactory to the Borrower and the Administrative Agent and, in the case of Incremental Extensions of Credit in the form of revolving loans, the Issuing Bank and the Swingline
Lender (any such bank, financial institution or other Person being called an “Additional Lender”) and shall become a Lender under this Agreement pursuant to an amendment (an “Incremental Facility Amendment”) to this
Agreement giving effect to the modifications permitted by this Section 2.20 and, as appropriate, the other Loan Documents and executed by the Borrower, each Additional Lender and the Administrative Agent. Commitments in respect of Incremental
Extensions of Credit shall be Commitments under this Agreement. An Incremental Facility Amendment may, without the consent of any other Lenders, effect such amendments to this Agreement and the other Loan Documents as may be necessary or
appropriate, in the opinion of the Administrative Agent, to effect the provisions of this Section 2.20 (including voting provisions applicable to the Additional Lenders comparable to the provisions of clause (B) of the second proviso of
Section 9.02(b)). The effectiveness of any Incremental Facility Amendment shall be subject to the satisfaction on the date thereof (each, an “Incremental Facility Closing Date”) of each of the conditions set forth in
Section 4.02 (it being understood that all references to “the date of such Borrowing” in such Section 4.02 shall be deemed to refer to the Incremental Facility Closing Date). The proceeds of the Incremental Extensions of Credit
shall be used for working capital and general corporate purposes. 
  
 ARTICLE III 
  
 Representations and Warranties

  
 Each of Holdings and the Borrower represents and warrants
to the Lenders (it being understood that the representations and warranties made on the Closing Date are deemed made concurrently with the consummation of the Transactions) that: 
  
 SECTION 3.01. Organization; Powers. Each of Holdings, the Borrower and the Subsidiaries is duly organized, validly
existing and in good standing under the laws of the jurisdiction of its organization, has all requisite power and authority to carry on its business as now conducted and, except where the failure to do so, individually or in the aggregate, would not
reasonably be expected to result in a Material Adverse Effect, is qualified to do business in, and is in good standing in, every jurisdiction where such qualification is required. 
  

 LifeCare Credit Agreement 
 62 

 SECTION 3.02. Authorization; Enforceability. The Transactions entered into and to be entered into
by each Loan Party are within such Loan Party’s corporate, limited partnership or limited liability company powers, as applicable, and have been duly authorized by all necessary corporate, limited partnership or limited liability company and,
if required, stockholder action. This Agreement has been duly executed and delivered by each of Holdings and the Borrower and constitutes, and each other Loan Document to which any Loan Party is to be a party, when executed and delivered by such
Loan Party, will constitute, a legal, valid and binding obligation of Holdings, the Borrower or such Loan Party (as the case may be), enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law, and implied covenants of good faith and fair dealing.

  
 SECTION 3.03. Governmental Approvals; No Conflicts.
(a) The Transactions do not require any consent or approval of, registration or filing with, or any other action by, any Governmental Authority, except such as have been obtained or made and are in full force and effect and except
(i) filings necessary to perfect Liens created under the Loan Documents and (ii) the recordation of Mortgages, (b) the Transactions will not violate any applicable law or regulation or the charter, by-laws or other organizational
documents of Holdings, the Borrower or any of its Subsidiaries or any order of any Governmental Authority, (c) the Acquisition will not violate or result in a default under any indenture, agreement or other instrument binding upon Holdings, the
Borrower or any of its Subsidiaries or any of their assets, or give rise to a right thereunder to require any payment to be made by Holdings, the Borrower or any of its Subsidiaries, (d) the Financing Transactions will not violate or result in
a default under any indenture, agreement or other instrument binding upon Holdings, the Borrower or any of its Subsidiaries or any of their assets, or give rise to a right thereunder to require any payment to be made by Holdings, the Borrower or any
of its Subsidiaries, (e) the Transactions will not result in the creation or imposition of any Lien on any asset of Holdings, the Borrower or any of its Subsidiaries, except Liens permitted under Section 6.02; except, in the case of
clauses (a), (b) and (c), where the failure to obtain such consent or approval or make such registration, filing or action or any such violation or default would not reasonably be expected to result, individually or in the aggregate, in a
Material Adverse Effect and (f) the Transaction will not result in any limitation on any right, qualification, approval, permit, authorization, reimbursement approval, reimbursement or franchise, or authorization granted by a Governmental
Authority or third-party payor or other Person applicable to the business or operations of the Borrower or adversely affect the ability of the Borrower or any of the Subsidiaries to participate in any third-party payor arrangement or restrict the
ability of the Borrower or any of its Subsidiaries to operate the Healthcare Facilities, except where such limitation will not have a Material Adverse Effect. 
  

SECTION 3.04. Financial Condition; No Material Adverse Change. (a) The Borrower has heretofore furnished to the Lenders its consolidated
balance sheet and statements of income, stockholders equity and cash flows of the Company and its subsidiaries (i) as of and for the fiscal years ended December 31, 2004, December 31, 

  

 LifeCare Credit Agreement 
 63 

 
2003 and December 31, 2002, reported on by KPMG LLP, independent registered public accountants, without qualification and (ii) as of and for the
fiscal quarter and the portion of the fiscal year ended March 31, 2005, certified by a Financial Officer. Such financial statements present fairly, in all material respects, the financial position and results of operations and cash flows of the
Company and its subsidiaries as of such dates and for such periods in accordance with GAAP, subject to year end audit adjustments and the absence of footnotes in the case of the statements referred to in clause (ii) above. 
  
 (b) Except as disclosed in the financial statements referred to above or the
notes thereto or in the Information Memorandum and except for the Disclosed Matters, after giving effect to the Transactions, none of Holdings, the Borrower or its Subsidiaries has, as of the Closing Date, any contingent liabilities or unusual
long-term commitments that, individually or in the aggregate, would reasonably be expected to result in a Material Adverse Effect. 
  
 (c) Since December 31, 2004, there has been no material adverse change in the business, operations or financial condition of the Company, Holdings,
the Borrower and the Subsidiaries, taken as a whole. 
  
 SECTION
3.05. Properties. (a) Subject to any Liens permitted to exist pursuant to Section 6.02, each of Holdings, the Borrower and its Subsidiaries has good title to, or valid leasehold interests in, (x) all its Real Property
(including its Mortgaged Properties) and (y) all of its personal property material to its business, except, in the case of (x) or (y), for defects in title that do not interfere in any material respect with its ability to conduct its
business as currently conducted on any such property or to utilize any such property for its intended purposes. 
  
 (b) Each of Holdings, the Borrower and its Subsidiaries owns, or is licensed to use, all trademarks, tradenames, copyrights, patents and other
intellectual property material to its business, and the use thereof by Holdings, the Borrower and its Subsidiaries does not infringe upon the rights of any other Person, except, in each case, for any matters that, individually or in the aggregate,
would not reasonably be expected to result in a Material Adverse Effect. 
  
 (c) Schedule 3.05 sets forth the address of each Real Property that is owned or leased by the Borrower or any of its Subsidiaries as of the Closing Date (and as of the date of the delivery by the Borrower of any
supplement thereto pursuant to Section 5.12(b)) after giving effect to the Transactions and indicates each parcel of Real Property owned in fee that is a Mortgaged Property as of the Closing Date (and as of the date of the delivery by the
Borrower of any supplement thereto pursuant to Section 5.12(b)). 
  
 SECTION 3.06. Litigation and Environmental Matters. (a) There are no actions, suits, proceedings or investigations by or before any arbitrator or Governmental Authority pending against or, to the knowledge of Holdings or the
Borrower, threatened against or affecting Holdings, the Borrower or any of their Subsidiaries (i) which would reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect (other than the Disclosed Matters) or
(ii) that involve any of the Loan Documents 

  

 LifeCare Credit Agreement 
 64 

 
or the Transactions. Since the Closing Date, there has been no adverse change in the status, or the reasonably anticipated financial effect on any Loan Party
or any of its Subsidiaries, of the Disclosed Matters, that could reasonably be expected to have a Material Adverse Effect. 
  
 (b) Except for either the Disclosed Matters or any other matters that, individually or in the aggregate, would not reasonably be expected to result in a
Material Adverse Effect, none of the Mortgaged Property, Holdings, the Borrower or any of their Subsidiaries (i) has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval
required under any Environmental Law, (ii) has become subject to any Environmental Liability, (iii) has received written notice of any claim with respect to any Environmental Liability or (iv) knows of any facts or circumstances which
are reasonably likely to form the basis for any Environmental Liability. 
  
 SECTION 3.07. Compliance with Laws; Healthcare Laws. Except as set forth on Schedule 3.07, each of Holdings, the Borrower and their Subsidiaries is in compliance with all laws, regulations and orders of any
Governmental Authority (including Medicare Regulations and Medicaid Regulations and other Federal and State healthcare laws and regulations) applicable to it or its property, except where the failure to be in compliance, individually or in the
aggregate, would not reasonably be expected to result in a Material Adverse Effect. 
  
 SECTION 3.08. Licenses, etc.. (a) Set forth on Schedule 3.08(a) is a list, as of the Closing Date, of (i) all third-party payor contracts of Holdings, the Borrower and the Subsidiaries, (ii) each
of the Medicare Provider Agreements of Holdings, the Borrower and the Subsidiaries and (iii) each of the state Medicaid Provider Agreements of Holdings, the Borrower and the Subsidiaries. 
  
 (b) Except as set forth on Schedule 3.08(b), as of the Closing Date, each
Healthcare Facility is duly accredited with no contingencies by JCAHO, and true, correct, and complete copies of such Healthcare Facility’s most recent survey reports, including statements of deficiencies and plans of correction, if any, and
the most recent Certificates of Accreditation relating to each such Healthcare Facility, have been furnished or made available to the Lenders. 
  
 (c) Each Healthcare Facility (i) participates in the Medicare program and is in compliance in all material respects with the conditions of
participation for Medicare, and (ii) has a current and valid provider contract and provider number with the Medicare program. Set forth on Schedule 3.08(c) are the Medicare provider numbers of each of the Healthcare Facilities as of the
Closing Date. Each Healthcare Facility (A) is eligible to receive payment under Title XVIII of the Social Security Act, (B) is a “provider” under provider agreements with the Medicare program through the applicable
intermediaries, (C) except for any new Healthcare Facility that is not yet eligible to receive payments as a long-term care hospital under 42 C.F.R. §412.23(e) because it has not been in existence for more than one complete cost report
period, is eligible to receive payments as a long-term care hospital under 42 C.F.R. §412.23(e), and (D) except as set forth on Schedule 

  

 LifeCare Credit Agreement 
 65 

 
3.08(c) (specifying the average length of stay), has an average length of stay in its current cost reporting period as of May 31, 2005 that exceeds 25
days. As of the Closing Date, each Healthcare Facility that Holdings, the Borrower or any Subsidiary treats as provider-based with respect to another Healthcare Facility meets the applicable requirements in 42 C.F.R. §413.65. Except as set
forth on Schedule 3.08(c) or under seal and not known to Holdings, the Borrower or any Subsidiary, as of the Closing Date, there is not pending or, to the knowledge of the Borrower and the Subsidiaries, threatened any proceeding or investigation
under the Medicare program involving Holdings, the Borrower, any of the Subsidiaries or any Healthcare Facility. Except as set forth on Schedule 3.08(c), as of the Closing Date, none of Holdings, the Borrower or any of the Subsidiaries nor any of
their respective shareholders, directors, officers nor, except as would not individually or in the aggregate reasonably be expected to have a Material Adverse Effect, any of their employees, are excluded from participation in the Medicare program
and, to the knowledge of the Borrower and the Subsidiaries, no such exclusion is pending or threatened. 
  
 (d) As of the Closing Date, each of the Healthcare Facilities described in Schedule 3.08(d) participates in its respective state’s Medicaid program,
is in compliance in all material respects with the conditions of participation for Medicaid and has a current and valid provider contract and provider number with the Medicaid program. Set forth on Schedule 3.08(d) are, as of the Closing Date, the
Medicaid provider numbers of each of the Healthcare Facilities, as applicable. Each such Healthcare Facility is eligible to receive payment under Title XIX of the Social Security Act and is a “provider” under provider agreements with the
Medicaid program in their state. Except as set forth on Schedule 3.08(d) or under seal and not known to Holdings, the Borrower or any Subsidiary, as of the Closing Date, there is not pending or, to the knowledge of Holdings, the Borrower or any
Subsidiary, threatened any proceeding or investigation under any Medicaid program involving Holdings, the Borrower, any of the Subsidiaries or any Healthcare Facility. Except as set forth on Schedule 3.08(d), as of the Closing Date, none of
Holdings, the Borrower or any of the Subsidiaries nor any of their respective shareholders, directors, officers nor, except as would not individually or in the aggregate reasonably be expected to have a Material Adverse Effect, any employees, are
excluded from participation in any state’s Medicaid program and, to the knowledge of the Borrower and the Subsidiaries, no such exclusion is pending or threatened. 
  
 (e) Except as set forth on Schedule 3.08(e) or as otherwise would not reasonably be expected, individually or in the
aggregate, to have a Material Adverse Effect, the Medicare and Medicaid cost reports of the Healthcare Facilities for the years since January 1, 1997 have been timely filed and are complete and correct in all material respects. Except as set
forth on Schedule 3.08(e) or as otherwise would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, there are no claims, actions or appeals pending before any commission, board or agency, including any
fiscal intermediary or carrier, or the Provider Reimbursement Review Board of the Administrator of CMS, with respect to any state or federal Medicare and Medicaid cost reports filed on behalf of the Healthcare Facilities or any disallowances by any
Governmental Authority in connection with any audit of such cost reports. Except as set forth on Schedule 3.08(e), the potential reimbursement liabilities that the Borrower and 

  

 LifeCare Credit Agreement 
 66 

 
the Subsidiaries may have under any such cost reports (i) did not as of the date of the audited consolidated balance sheet of the Borrower for the
fiscal year ended December 31, 2004, exceed the reserve therefor set forth on the face of the such audited balance sheet (rather than in any notes thereto) and (ii) do not exceed that reserve as adjusted for the passage of time through the
Closing Date in accordance with the past custom and practice of the Borrower and its Subsidiaries. 
  
 (f) Set forth on Schedule 3.08(f) is a true, correct and complete list of all Healthcare Facilities owned or leased and operated by the Holdings, the
Borrower or one of the Subsidiaries as of the Closing Date. As of the Closing Date, each Healthcare Facility listed on Schedule 3.08(f) is duly and appropriately licensed as a hospital by the applicable Governmental Authority to operate the number
of beds listed adjacent to its name on Schedule 3.08(f). Each Healthcare Facility holds all other licenses, permits, variances, exemptions, waivers and approvals that are required by applicable law to operate the business, except where the failure
to hold such licenses, permits and approvals has not had and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect. Except as set forth on Schedule 3.08(f), each Healthcare Facility is in compliance with
all licensing requirements except where the failure to so comply has not had and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect. Set forth on Schedule 3.08(f) is a list of all material licenses
and permits owned or held by Holdings, the Borrower or the Subsidiaries relating to each Healthcare Facility set forth thereon as of the Closing Date. 
  
 SECTION 3.09. Investment and Holding Company Status. None of Holdings, the Borrower or any of its Subsidiaries is (a) an
“investment company” as defined in, or subject to regulation under, the Investment Company Act of 1940, as amended, or (b) a “holding company” as defined in, or subject to regulation under, the Public Utility Holding Company
Act of 1935, as amended. 
  
 SECTION 3.10. Taxes. Each of
Holdings, the Borrower and its Subsidiaries has timely filed or caused to be filed all material Tax returns and reports required to have been filed and has paid or caused to be paid all material Taxes required to have been paid by it, except any
Taxes that are being contested in good faith by appropriate proceedings and for which Holdings, the Borrower or such Subsidiary, as applicable, has set aside on its books adequate reserves in accordance with GAAP. 
  
 SECTION 3.11. ERISA; Margin Regulations. (a) During the five year
period prior to the date on which this representation is made or deemed to be made with respect to any Plan or Multiemployer Plan, no ERISA Event has occurred or is reasonably expected to occur that, when taken together with all other such ERISA
Events for which liability has occurred during such five year period or for which liability is reasonably expected to occur, could reasonably be expected to result in a Material Adverse Effect. The present value of all accumulated benefit
obligations under each Plan (based on the assumptions used for purposes of Statement of Financial Accounting Standards No. 87) did not, as of the date of the most recent financial statements reflecting such amounts, exceed the fair market value
of the assets of such Plan by an amount that would reasonably be expected to have a Material Adverse Effect, and the present value of 

  

 LifeCare Credit Agreement 
 67 

 
all accumulated benefit obligations of all underfunded Plans (based on the assumptions used for purposes of Statement of Financial Accounting Standards
No. 87) did not, as of the date of the most recent financial statements reflecting such amounts, exceed the fair market value of the assets of all such underfunded Plans by an amount that would reasonably be expected to have a Material Adverse
Effect. 
  
 (b) None of Holdings, the Borrower or any of its
Subsidiaries is engaged principally, or as one of its important activities, in the business of extending credit for the purpose of buying or carrying Margin Stock. No part of the proceeds of any Loan or any Letter of Credit will be used, whether
directly or indirectly, and whether immediately, incidentally or ultimately, in any manner that would entail a violation of the regulations of the Board, including Regulation T, U or X. 
  
 SECTION 3.12. Disclosure. Neither the Information Memorandum nor any of the other written reports, financial
statements, certificates or other written information, taken as a whole, furnished by or on behalf of any Loan Party to the Administrative Agent or any Lender in connection with the negotiation of this Agreement or any other Loan Document or
delivered hereunder or thereunder (as of the date thereof and as modified or supplemented by other information so furnished) contains any material misstatement of fact or omits to state any material fact necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading; provided that, with respect to information of a general economic nature, estimates and projected financial information, Holdings and the Borrower represent only that
such information was prepared in good faith based upon assumptions believed to be reasonable (i) at the time such projected financial information was prepared, (ii) on the date of the Information Memorandum and (iii) as of the date
hereof (it being understood that actual results may vary materially from such projected financial information). 
  
 SECTION 3.13. Subsidiaries. Schedule 3.13 sets forth (i) the name of, and the ownership interest of Holdings in, each subsidiary of
Holdings and identifies each subsidiary that is a Subsidiary Loan Party, in each case as of the Closing Date, and (ii) the name of, and the ownership interest of the Borrower in, each Subsidiary of the Borrower and identifies each Subsidiary
that is a Subsidiary Loan Party, in each case as of the Closing Date. 
  
 SECTION 3.14. Insurance. Schedule 3.14 sets forth a description of all material insurance maintained by or on behalf of Holdings, the Borrower and its Subsidiaries as of the Closing Date. As of the Closing Date, all premiums due and
payable in respect of such insurance have been paid. The properties of Holdings, the Borrower and its Subsidiaries are insured by financially sound and reputable insurance companies not Affiliates (other than any Insurance Subsidiary) of the
Borrower, in such amounts, with such deductibles and covering such risks as are customarily carried by companies engaged in similar businesses and owning similar properties in localities where Holdings, the Borrower or the applicable Subsidiary
operates. 
  
 SECTION 3.15. Labor Matters. Except as could
not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect: (a) as of the 

  

 LifeCare Credit Agreement 
 68 

 
Closing Date, there are no strikes, lockouts or slowdowns against Holdings, the Borrower or any Subsidiary pending or, to the knowledge of Holdings or the
Borrower, threatened; (b) the hours worked by and payments made to employees of Holdings, the Borrower and the Subsidiaries have not been in violation of the Fair Labor Standards Act or any other applicable Federal, state, local or foreign law
dealing with such matters; (c) all payments due from Holdings, the Borrower or any Subsidiary, or for which any claim may be made against Holdings, the Borrower or any Subsidiary, on account of wages and employee health and welfare insurance
and other benefits, have been paid or accrued as a liability on the books of Holdings, the Borrower or such Subsidiary; and (d) the consummation of the Transactions will not give rise to any right of termination or right of renegotiation on the
part of any union under any collective bargaining agreement to which Holdings, the Borrower or any Subsidiary is bound. 
  
 SECTION 3.16. Solvency. Immediately after the consummation of the Transactions to occur on the Closing Date (a) the fair value of the assets
of Holdings, the Borrower and its subsidiaries on a consolidated basis, at a fair valuation, will exceed the debts and liabilities, subordinated, contingent or otherwise, respectively, of Holdings, the Borrower and its subsidiaries on a consolidated
basis; (b) the present fair saleable value of the property of Holdings, the Borrower and its subsidiaries on a consolidated basis will be greater than the amount that will be required to pay the probable liability of the debts and other
liabilities, subordinated, contingent or otherwise, of Holdings, the Borrower and its subsidiaries on a consolidated basis as such debts and other liabilities become absolute and matured; (c) Holdings, the Borrower and its subsidiaries on a
consolidated basis will be able to pay the debts and liabilities, subordinated, contingent or otherwise, respectively, of Holdings, the Borrower and its subsidiaries on a consolidated basis, as such debts and liabilities become absolute and matured;
and (d) Holdings, the Borrower and its subsidiaries on a consolidated basis will not have unreasonably small capital with which to conduct the businesses in which they are engaged as such businesses are now conducted and are proposed to be
conducted following the Closing Date. 
  
 SECTION 3.17. Senior
Debt. The Obligations constitute “Senior Debt” and “Designated Senior Debt” under and as defined in the Senior Subordinated Debt Documents. 
  
 SECTION 3.18. Acquisition. As of the Closing Date, the Merger Agreement has been duly authorized, executed and
delivered by each of the parties thereto and constitutes a legal, valid and binding obligation of each such party, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws
affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law, and implied covenants of good faith and fair dealing. A true and correct copy (including
any amendments and waivers) of the Merger Agreement has been furnished to the Administrative Agent. As of the Closing Date, except as consented to by the Required Lenders, the Merger Agreement has not been amended, modified or waived in any
material respect. 
  

 LifeCare Credit Agreement 
 69 

 SECTION 3.19. Security Documents. (a) The Collateral Agreement is effective to create in
favor of the Collateral Agent, for the benefit of the respective Secured Parties, a legal, valid and enforceable security interest in the Collateral described therein and proceeds thereof, except with respect to payments under Medicare and Medicaid,
which may be subject to limitations under federal and state laws and regulations. In the case of the Pledged Stock (as defined in the Collateral Agreement), when stock certificates representing such Pledged Stock are delivered to the Collateral
Agent, and in the case of the other Collateral described in the Collateral Agreement (except as otherwise provided in paragraph (b) of this Section 3.19, except with respect to payments under Medicaid and Medicare, which may be subject to
limitations under federal and state laws and regulations), when financing statements and other filings specified on Schedule 5 of the Perfection Certificate in appropriate form are filed in the offices specified on Schedule 6 of the Perfection
Certificate (as updated by the Borrower from time to time in accordance with Section 5.03), the Collateral Agreement shall constitute a fully perfected Lien on, and security interest in, all right, title and interest of the Loan Parties in the
Collateral and the proceeds thereof, as security for the Obligations, to the extent perfection can be obtained by filing Uniform Commercial Code financing statements or such other filings specified on Schedule 5 of the Perfection Certificate, in
each case prior and superior in right to any other Person (except, in the case of Collateral other than the Pledged Stock, Liens permitted by Section 6.02). 
  
 (b) When the Intellectual Property Security Agreement or summaries thereof are properly filed in the United States Patent
and Trademark Office and the United States Copyright Office, and, with respect to Collateral in which a security interest can be perfected by filing Uniform Commercial Code financing statements, upon the proper filing of the financing statements
referred to in paragraph (a) above, the Intellectual Property Security Agreement and such financing statements shall constitute a fully perfected Lien on, and security interest in, all right, title and interest of the grantors thereunder in the
Intellectual Property (as defined in the Collateral Agreement), in each case prior and superior in right to any other Person, except Liens permitted by Section 6.02 (it being understood that subsequent recordings in the United States Patent and
Trademark Office and the United States Copyright Office may be necessary to perfect a lien on registered trademarks and patents, trademark and patent applications and registered copyrights acquired by the grantors after the date hereof). 

 
 (c) The Mortgages entered into on the Closing Date are, and the Mortgages,
if any, entered into after the Closing Date pursuant to Section 5.12 shall be, effective to create in favor of the Collateral Agent, for the ratable benefit of the applicable Secured Parties, a legal, valid and enforceable Lien on all of the
Loan Parties’ right, title and interest in and to the Mortgaged Property thereunder and the proceeds thereof, and when such Mortgages are filed in the proper real estate filing offices, such Mortgages shall constitute a fully perfected Lien on,
and security interest in, all right, title and interest of Loan Parties in such Mortgages Property and the proceeds thereof, in each case prior and superior in right to any other Person, other than with respect to the rights of Person pursuant to
Liens expressly permitted by Section 6.02. 
  

 LifeCare Credit Agreement 
 70 

 SECTION 3.20. Liens. There are no Liens of any nature whatsoever on any properties of Holdings,
the Borrower or any of its Subsidiaries other than Permitted Encumbrances and Liens permitted by Section 6.02. 
  
 SECTION 3.21. No Default. (a) None of Holdings, the Borrower or any of the Subsidiaries is a party to any agreement or instrument, or subject
to any corporate restriction, that, individually or in the aggregate, has resulted or could reasonably be expected to result in a Material Adverse Effect. No Default has occurred and is continuing or would result from the consummation of the
transactions contemplated by this Agreement or any other Loan Document. 
  
 (b) None of Holdings, the Borrower or any of the Subsidiaries is in default in the performance, observance or fulfillment of any of the obligations, covenants or conditions contained in (i) any Medicaid Provider Agreement, Medicare
Provider Agreement or other agreement or instrument to which any of Holdings, the Borrower or any Subsidiary is a party, which default has resulted in, or if not remedied within any applicable grace period could result in, the revocation,
termination, cancellation or suspension of Medicaid Certification or Medicare Certification of any of Holdings, the Borrower or any of its Subsidiaries and such revocation, termination, cancellation or suspension could reasonably be expected to have
a Material Adverse Effect or (ii) any other agreement or instrument to which any of Holdings, the Borrower or any Subsidiary is a party, which default has, or if not remedied within any applicable grace period could reasonably be likely to
have, a Material Adverse Effect. 
  
 SECTION 3.22. Casualty,
Etc. Neither the business nor the properties of any Loan Party or any of its Subsidiaries are affected by any fire, explosion, accident, strike, lockout or other labor dispute, drought, storm, hail, earthquake, embargo, act of God or of the
public enemy or other casualty (whether or not covered by insurance) that could be reasonably likely to have a Material Adverse Effect. 
  
 ARTICLE IV 
  
 Conditions 
  
 SECTION 4.01. Closing Date. The obligations of the Lenders to make Loans and of the Issuing Bank to issue Letters of Credit hereunder shall not become effective until the date on which each of the following conditions is satisfied
(or waived in accordance with Section 9.02): 
  
 (a) The Administrative Agent (or its counsel) shall have received from each party hereto either (i) a counterpart of this Agreement signed on behalf of such party or (ii) written evidence satisfactory to the Administrative Agent
(which may include telecopy or electronic transmission of a signed signature page of this Agreement) that such party has signed a counterpart of this Agreement. 
  

 LifeCare Credit Agreement 
 71 

 (b) The Administrative Agent shall have received favorable written opinions (addressed to
the Administrative Agent and the Lenders and dated the Closing Date) of (i) Ropes & Gray LLP, counsel for the Borrower, substantially in the form of Exhibit B-1; and (ii) local counsel in each jurisdiction where a Subsidiary is
organized as specified on Schedule 4.01 or in which a Mortgaged Property is located, substantially in the form of Exhibit B-2. 
  
 (c) The Administrative Agent shall have received such documents and certificates as the Administrative Agent or its counsel may reasonably
request relating to the organization, existence and good standing of each Loan Party, the authorization of the Transactions and any other legal matters relating to the Loan Parties, the Loan Documents or the Transactions, all in form and substance
reasonably satisfactory to the Administrative Agent. 
  
 (d) The Administrative Agent shall have received a certificate, dated the Closing Date and signed by an executive officer or a Financial Officer of the Borrower, confirming compliance with the conditions set forth in
paragraphs (a) and (b) of Section 4.02. 
  
 (e) The Administrative Agent, the Arrangers and the Initial Lenders shall have received all fees and other amounts due and payable on or prior to the Closing Date, including, to the extent invoiced, reimbursement or payment of all
reasonable documented out-of-pocket expenses (including reasonable fees, charges and disbursements of counsel) required to be reimbursed or paid by any Loan Party hereunder or under any other Loan Document. The other costs and expenses of the
Transactions, to the extent then due and owing, shall have been paid, or shall be paid substantially simultaneously with the initial Borrowings hereunder. 
  
 (f) The Collateral and Guarantee Requirement shall have been satisfied and the Administrative Agent shall have received a completed
Perfection Certificate dated the Closing Date and signed by an executive officer or Financial Officer of the Borrower, together with all attachments contemplated thereby, including the results of a search of the Uniform Commercial Code (or
equivalent) filings made with respect to the Loan Parties in the jurisdictions contemplated by the Perfection Certificate and copies of the financing statements (or similar documents) disclosed by such search and evidence reasonably satisfactory to
the Administrative Agent that the Liens indicated by such financing statements (or similar documents) are permitted by Section 6.02 or have been released. 
  

(g) The Administrative Agent (or its counsel) shall have received a counterpart from each party thereto either (i) a counterpart
of the Assumption Agreement signed on behalf of such party or (ii) written evidence reasonably satisfactory to the Administrative Agent (which may include telecopy or electronic transmission of a signed signature page of the 

  

 LifeCare Credit Agreement 
 72 

 
Assumption Agreement) that such party has signed a counterpart of the Assumption Agreement. 
  
 (h) The Administrative Agent shall have received evidence that the insurance required by Section 5.07
and the Security Documents is in effect. 
  
 (i)
The Initial Lenders shall have received satisfactory evidence that the total equity contributed by the Permitted Holders (including the Equity Financing and rollover equity contributed by the Management Group in an amount not to exceed $1,200,000)
is not less than $170,700,000 and that the Borrower has received gross cash proceeds of not less than $170,700,000 from the Equity Financing. The Administrative Agent shall have received copies of all instruments, agreements or other documents
evidencing the Equity Financing, certified by an executive officer or a Financial Officer as true and correct. 
  
 (j) There shall be no less than $75,000,000 of availability under the Revolving Credit Facility, after giving effect to the Transactions
and all Borrowings under the Revolving Credit Facility; provided, however, that an aggregate amount of up to $10,000,000 shall be available under the Revolving Credit Facility on the Closing Date solely for Revolving Loans the proceeds
of which are used to pay estimated purchase price adjustments and the anticipated fees and expenses in connection with the Transactions and for working capital. 
  
 (k) The Borrower shall have received gross cash proceeds of not less than $150,000,000 from the issuance of
the Senior Subordinated Debt. The terms and conditions of the Senior Subordinated Debt and the provisions of the Senior Subordinated Debt Documents shall be consistent in all material respects with the Offering Memorandum of the Borrower, dated
August 5, 2005 and otherwise reasonably satisfactory to the Initial Lenders. The Administrative Agent shall have received copies of the Senior Subordinated Debt Documents, certified by an executive officer or a Financial Officer as true and
correct. 
  
 (l) The Arrangers and the Initial
Lenders shall have received evidence reasonably satisfactory to them that the Acquisition shall have been consummated or shall be consummated simultaneously with the initial funding of the Loans on the Closing Date in all material respects in
compliance with applicable laws and regulatory approvals and in accordance with the terms of the Merger Agreement and any documents related thereto, without any amendment to or waiver or other modification of any material term or condition in the
Merger Agreement or any documents related thereto not approved by the Initial Lenders. The Administrative Agent shall have received copies of the Merger Agreement and any documents related thereto and all material certificates, opinions and other
documents delivered thereunder, certified by an executive officer or a Financial Officer as true 

  

 LifeCare Credit Agreement 
 73 

 
and correct. The Arrangers and the Initial Lenders shall be satisfied in all respects with the terms of any agreements (including definitive documentation)
to be entered into in connection with the Transactions, including, without limitation, all tax aspects thereof as contemplated by the Merger Agreement, and shall be reasonably satisfied with any amendment, change or modification to (x) the
Merger Agreement since the time of its execution and (y) such documents and agreements related to the Merger Agreement, in each case, to the extent executed in a form different from that included as an exhibit to, or otherwise specifically
contemplated by, the Merger Agreement as initially executed. 
  
 (m) The Lenders shall have received a letter attesting to the solvency of the Borrower and the Guarantors (after giving effect to the Transactions and the incurrence of Indebtedness related thereto), taken as a whole,
in form and substance reasonably satisfactory to the Lenders from a nationally recognized appraisal firm or valuation consultant reasonably satisfactory to the Lenders. 
  
 (n) After giving effect to the Transactions to be consummated on the Closing Date, Holdings, the Borrower
and the Subsidiaries shall have outstanding no Indebtedness or preferred Equity Interests that would be required to be reflected on a balance sheet prepared in accordance with GAAP other than (i) the Loans, (ii) the Senior Subordinated
Debt and (iii) the Indebtedness set forth in Schedule 6.01. 
  
 (o) (i) Except as could not reasonably be expected to have a Material Adverse Effect, receipt of all authorizations, consents, certifications, orders or approvals of, or registrations, declarations or filings with, or
expiration of waiting periods imposed by, any Governmental Authority, in each case that are necessary in order to consummate the Transaction, and to operate each of the facilities immediately after the Closing Date substantially as operated as of
the date of the Merger Agreement without loss of any right or permission, and all consents and approvals of third parties necessary to prevent any conflict with, violation or breach of, or default under, any contract or agreement to which the
Borrower or any Subsidiary is a party or is otherwise bound, and (ii) receipt of the consents and other actions required under (or described in) Sections 6.1(b) and 7.1(a) of the Merger Agreement. The Administrative Agent shall have received a
certificate of an executive officer or a Financial Officer of the Borrower, certifying that there is no claim, action or proceeding pending or, to the knowledge of the Borrower, threatened, by any Governmental Authority to enjoin, restrain, prohibit
or impose materially burdensome conditions on the Transactions. 
  
 (p) The Arrangers and the Lenders shall have received: (i) audited consolidated financial statements of the Company and its subsidiaries for the three fiscal years ended most recently prior to the Acquisition,
(ii) unaudited consolidated financial statements of the Company and its subsidiaries for any 

  

 LifeCare Credit Agreement 
 74 

 
interim quarterly periods that have ended at least 45 days prior to the Closing Date since the most recent of such audited financial statements, which shall
meet the requirements of Regulation S-X under the Securities Act of 1933, as amended, and all other accounting rules and regulations of the SEC promulgated thereunder applicable to a registration statement under such Act on Form S-1,
(iii) forecasts prepared by management of Holdings and its subsidiaries, each in form satisfactory to the Arrangers and the Initial Lenders, of balance sheets, income statements and cash flow statements for each of the first two quarters
following the Closing Date and for each year commencing with the first fiscal year following the Closing Date for the term of the Facilities and (iv) evidence satisfactory to the Arrangers that the forecasts delivered pursuant to clause
(iii) above were prepared in good faith on the basis of the assumptions stated therein, which assumptions are fair in light of the then existing conditions, certified by the chief financial officer of Holdings and the Borrower. 
  
 (q) Since December 31, 2004, there shall not have
occurred any Material Adverse Effect. 
  
 The Administrative Agent shall notify
the Borrower and the Lenders of the Closing Date, and such notice shall be conclusive and binding. 
  
 SECTION 4.02. Each Credit Event. The obligation of each Lender to make a Loan on any date, and of the Issuing Bank to issue, increase, renew or
extend any Letter of Credit on any date, is subject to receipt of the request therefor in accordance herewith and to the satisfaction of the following conditions: 
  
 (a) The representations and warranties of each Loan Party set forth in the Loan Documents shall be true and
correct in all material respects on and as of the date such Loan is made or the date of issuance, increase, renewal or extension of such Letter of Credit, as applicable, except to the extent such representations and warranties expressly relate to an
earlier date (in which case such representations and warranties shall be true and correct in all material respects on and as of such earlier date). 
  
 (b) At the time of and immediately after giving effect to such Borrowing or the issuance, increase, renewal or extension of such Letter of
Credit, as applicable, no Default shall have occurred and be continuing. 
  
 Each
Borrowing and each issuance, increase, renewal or extension of a Letter of Credit shall be deemed to constitute a representation and warranty by Holdings and the Borrower on the date thereof as to the matters specified in paragraphs (a) and
(b) of this Section; provided, that a conversion or a continuation of a Borrowing shall not constitute a Borrowing for purposes of this paragraph. 
  

 LifeCare Credit Agreement 
 75 

 ARTICLE V 
  
 Affirmative Covenants 
  
 Until the Commitments have expired or been terminated and the principal of and interest on each Loan and all fees payable hereunder shall have been paid
in full and all Letters of Credit shall have expired or terminated and all LC Disbursements shall have been reimbursed, each of Holdings and the Borrower covenants and agrees with the Lenders that: 
  
 SECTION 5.01. Financial Statements and Other Information. The Borrower
will furnish to the Administrative Agent and each Lender: 
  
 (a) no later than the earlier of (i) 10 days after the date that the Borrower is or would be required to file a report on Form 10-K with the Securities and Exchange Commission in compliance with the
reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (whether or not the Borrower is subject to such reporting requirements), and (ii) 100 days after the end of each fiscal year of the
Borrower, the Borrower’s audited consolidated balance sheet and related statements of operations, stockholders’ equity and cash flows as of the end of and for such year, setting forth in each case in comparative form the figures for the
previous fiscal year, all reported on by KPMG LLP or another independent registered public accounting firm of recognized national standing (without a “going concern” or like qualification or exception and without any qualification or
exception as to the scope of such audit) to the effect that such consolidated financial statements present fairly in all material respects the financial condition and results of operations of the Borrower and its consolidated Subsidiaries on a
consolidated basis in accordance with GAAP consistently applied; 
  
 (b) no later than the earlier of (i) 10 days after the date that the Borrower is or would be required to file a report on Form 10-Q with the Securities and Exchange Commission in compliance with the
reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (whether or not the Borrower is subject to such reporting requirements), and (ii) 55 days after the end of each of the first three fiscal
quarters of each fiscal year of the Borrower, the Borrower’s unaudited consolidated balance sheet and related statements of operations, stockholders’ equity and cash flows as of the end of and for such fiscal quarter and the then elapsed
portion of the fiscal year, setting forth in each case in comparative form the figures for the corresponding period or periods of (or, in the case of the balance sheet, as of the end of) the previous fiscal year, all certified by a Financial Officer
as presenting fairly in all material respects the financial condition and results of operations of the Borrower and its Subsidiaries on a consolidated basis in accordance with GAAP 

  

 LifeCare Credit Agreement 
 76 

 
consistently applied, subject to normal year-end audit adjustments and the absence of footnotes; 
  
 (c) concurrently with any delivery of financial statements
under clause (a) or (b) above, a certificate of a Financial Officer of the Borrower (i) certifying as to whether a Default has occurred and, if a Default has occurred, specifying the details thereof and any action taken or
proposed to be taken with respect thereto, (ii) setting forth reasonably detailed calculations demonstrating compliance with the Financial Covenants, (iii) stating whether any change in GAAP or in the application thereof has occurred since
the date of the audited financial statements referred to in Section 3.04 and, if any such change has occurred, specifying the effect of such change on the financial statements accompanying such certificate, (iv) identifying any Subsidiary
formed or acquired since the end of the previous fiscal quarter, (v) identifying any parcels of owned real property or improvements thereto with a value exceeding $2,000,000 that have been acquired by any Loan Party since the end of the
previous fiscal quarter, (vi) identifying any changes of the type described in Section 5.03(a) that have not been previously reported by the Borrower, (vii) identifying any Permitted Acquisition or other acquisitions of going concerns
that have been consummated since the end of the previous fiscal quarter, including the date on which each such acquisition was consummated and the consideration therefor, (viii) identifying any material Intellectual Property (as defined in the
Collateral Agreement) with respect to which a notice is required to be delivered under the Collateral Agreement and has not been previously delivered, (ix) identifying any Prepayment Events that have occurred since the end of the previous
fiscal quarter and setting forth a reasonably detailed calculation of the Net Proceeds received from any such Prepayment Events, and (x) identifying (and certifying as to the nonrecurring nature of) any non-recurring charges or expenses (which
certification shall be conclusive absent manifest error) added back in the calculation of Consolidated EBITDA pursuant to clause (vi) of the definition thereof for the period of four consecutive quarters most recently ended and attaching a
schedule in reasonable detail of such charges and expenses; 
  
 (d) concurrently with any delivery of financial statements under clause (a) above, a certificate of the accounting firm that reported on such financial statements stating whether they obtained knowledge
during the course of their examination of such financial statements of any Default (which certificate may be limited to the extent required by accounting rules, guidelines or practice), provided that the Borrower shall not be required to
deliver such a certificate if, after using commercially reasonable efforts, the Borrower is unable to obtain such a certificate; 
  
 (e) within 30 days after the commencement of each fiscal year of the Borrower, a detailed consolidated budget for such fiscal year
(broken down by quarter and including (i) a projected consolidated balance sheet and 

  

 LifeCare Credit Agreement 
 77 

 
related statements of projected operations and cash flow as of the end of and for such fiscal year and setting forth the assumptions used for purposes of
preparing such budget and (ii) other information reasonably requested by the Administrative Agent) and, promptly when available, any significant revisions of such budget; 
  
 (f) promptly after the same become publicly available, copies of all periodic and current reports, proxy
statements and registration statements filed by Holdings, the Borrower or any Subsidiary with the Securities and Exchange Commission, or any Governmental Authority succeeding to any or all of the functions of said Commission, or with any national
securities exchange, or in the event Holdings becomes a publicly traded company, distributed by Holdings to its shareholders generally; 
  
 (g) promptly upon transmission or receipt thereof, copies of all material reports and statements (other than routine reports and other
statements prepared in the ordinary course of business that would not result in any adverse action) that any of Holdings, the Borrower or any Subsidiary may render to or file with any Governmental Authority, including without limitation, CMS and the
OIG; and 
  
 (h) promptly following any request
therefor, such other information regarding the operations, business affairs and financial condition of Holdings, the Borrower or any Subsidiary, or compliance with the terms of any Loan Document, as the Administrative Agent (including on behalf of
any Lender) may reasonably request, subject to confidentiality requirements required by law, including, without limitation, HIPAA; provided, that, (i) to the extent that Holdings, the Borrower or any Subsidiary is subject to HIPAA
(whether directly or by contract) it shall use reasonable best efforts to provide such information consistent with HIPAA including, without limitation, pursuant to regulations that may permit disclosure under its health care operations (as defined
in HIPAA) subject to the HIPAA minimum necessary requirement and (ii) to the extent that Holdings, Borrower or any Subsidiary is a “covered entity” under HIPAA, none of them shall by contract prohibit disclosure by any of the other of
them to the Administrative Agent that is not otherwise prohibited by HIPAA. 
  
 SECTION 5.02. Notices of Material Events. The Borrower will furnish to the Administrative Agent and each Lender written notice of the following promptly after any Financial Officer or executive officer of the
Borrower obtains actual knowledge thereof: 
  
 (a) the occurrence of any Default; 
  
 (b) the filing or commencement of any action, suit or proceeding by or before any arbitrator or Governmental Authority against or affecting Holdings, the Borrower or any Subsidiary thereof that involves a reasonable 

  

 LifeCare Credit Agreement 
 78 

 
possibility of an adverse determination and which, if adversely determined, could reasonably be expected to result in a Material Adverse Effect; 

 
 (c) the occurrence of any ERISA Event that, alone or
together with any other ERISA Events that have occurred, could reasonably be expected to result in a Material Adverse Effect; 
  
 (d) the institution of any investigation or proceeding against Holdings, the Borrower, or any Subsidiary thereof to suspend, revoke or
terminate or that may result in the termination of any Medicaid Provider Agreement, Medicaid Certification, Medicare Provider Agreement or Medicare Certification or that may result in their exclusion from participation in any federal or state
healthcare program, or with regard to Holdings, the Borrower, any Subsidiary thereof, or any employee of any of them if related to his or her employment position, the receipt of a subpoena, civil investigative demand or the commencement of a special
audit. 
  
 (e) any notice of loss or threatened
loss of any material accreditation, loss of participation in any material Medical Reimbursement Program or loss of any material applicable health care license; 
  

(f) the failure of any Healthcare Facility to meet the requirements in 42 C.F.R. §412.23(e) to qualify as a long-term care
hospital after its first complete cost report period, including the requirement with respect to such Healthcare Facility’s average length of stay in its most recently completed cost reporting period; and 
  
 (g) any other development that results in, or would
reasonably be expected to result in, a Material Adverse Effect. 
  
 Each notice
delivered under this Section shall be accompanied by a statement of a Financial Officer or other executive officer of the Borrower setting forth the details of the event or development requiring such notice and any action taken or proposed to be
taken with respect thereto. 
  
 SECTION 5.03. Information
Regarding Collateral. (a) The Borrower will furnish to the Administrative Agent prompt written notice of any change (i) in any Loan Party’s legal name, as reflected in its organization documents, (ii) in any Loan Party’s
jurisdiction of organization or organizational form and (iii) in any Loan Party’s identity, Federal Taxpayer Identification Number or organization number, if any, assigned by the jurisdiction of its organization. The Borrower agrees not to
effect or permit any change referred to in clauses (i) through (iii) of the preceding sentence unless all filings have been made, or will have been made within any statutory period, under the Uniform Commercial Code or otherwise that are
required in order for the Agent to continue at all times following such change to have a valid, legal and perfected security interest in all the Collateral for the benefit of the Secured Parties. The Borrower also 

  

 LifeCare Credit Agreement 
 79 

 
agrees promptly to notify the Administrative Agent if any damage to or destruction of Collateral that is uninsured and has a fair market value exceeding
$2,000,000 occurs. 
  
 (b) Upon the request of the Administrative
Agent, the Borrower shall promptly deliver to the Administrative Agent an updated Perfection Certificate certified by a Financial Officer of the Borrower reflecting all changes since the Closing Date or, if applicable, the date of the most recent
certificate delivered pursuant to this Section, or otherwise confirming that there has been no change in such information; provided, that unless an Event of Default has occurred and is continuing, the Borrower will not be required to deliver
an updated Perfection Certificate more than once in each fiscal quarter. 
  
 SECTION 5.04. Existence; Conduct of Business. Each of Holdings and the Borrower will, and the Borrower will cause each of the Subsidiaries to, do or cause to be done all things necessary to preserve, renew and
keep in full force and effect its legal existence and the rights, contracts, certifications, licenses, permits, privileges, franchises, patents, copyrights, trademarks and trade names, except to the extent that the failure to do so (other than in
the case of maintaining the Borrower’s existence) would not reasonably be expected to result in a Material Adverse Effect; provided that the foregoing shall not prohibit any merger, consolidation, liquidation or dissolution permitted
under Section 6.03 or any sale of assets permitted under Section 6.05. 
  
 SECTION 5.05. Payment of Obligations. The Borrower will, and will cause each of its Subsidiaries to, pay its material Indebtedness and other material obligations, including material Tax liabilities, before the
same shall become delinquent or in default, except where (a) the validity or amount thereof is being contested in good faith by appropriate actions and (b) the Borrower or such Subsidiary has set aside on its books adequate reserves with
respect thereto in accordance with GAAP. 
  
 SECTION 5.06.
Maintenance of Properties. Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, the Borrower will, and will cause each of its Subsidiaries to, keep and maintain all property in good
working order and condition, ordinary wear and tear excepted. 
  
 SECTION 5.07. Insurance. The Borrower will, and will cause each of its Subsidiaries to, maintain, with financially sound and reputable insurance companies (which may include self-insurance) (a) insurance in such amounts and
against such risks as are customarily maintained by companies of established repute engaged in the same or similar businesses operating in the same or similar locations (including medical malpractice insurance) and (b) all insurance required to
be maintained pursuant to the Security Documents. The Borrower will furnish to the Lenders, upon the reasonable request of the Administrative Agent, information in reasonable detail as to the insurance so maintained. 
  
 SECTION 5.08. Books and Records; Inspection and Audit Rights. Each of
Holdings and the Borrower will, and will cause each of its Subsidiaries to, keep books of record and account in accordance with GAAP. Each of Holdings and the Borrower 

  

 LifeCare Credit Agreement 
 80 

 
will, and will cause each of its Subsidiaries to, permit any representatives designated by any agent or any Lender, upon reasonable prior notice, to visit
and inspect its properties during normal business hours, to examine and make extracts from its books and records, and to discuss its affairs, finances and condition with its officers and independent accountants, all at such reasonable times during
normal business hours and as often as reasonably requested (subject to confidentiality requirements imposed by law or agreements); provided that (i) unless an Event of Default shall have occurred and be continuing, visits by Lenders will
be made jointly and not more often than twice each fiscal year and (ii) to the extent required by HIPAA or other privacy laws or regulations, each of Holdings and Borrower shall, and shall cause each of its Subsidiaries to, use reasonable best
efforts to permit such access consistent with HIPAA including, without limitation, pursuant to regulations that may permit disclosure under its health care operations (as defined in HIPAA) subject to the HIPAA minimum necessary requirement.

  
 SECTION 5.09. Compliance with Laws. Each of Holdings
and the Borrower will, and will cause each of its Subsidiaries to comply with all laws, rules, regulations, including all Environmental Laws and orders of any Governmental Authority applicable to it, its operations or its property, including,
without limitation, Titles XVIII and XIX of the Social Security Act, Medicare Regulations and Medicaid Regulations and HIPAA, and all laws, rules and regulations of Governmental Authorities as they may apply to the licensing of professional and
other health care providers employed by Holdings, the Borrower and each Subsidiary and a Healthcare Facility’s contracts with Contract Providers, except, in each case, where the failure to do so, individually or in the aggregate, would not
reasonably be expected to result in a Material Adverse Effect. 
  
 SECTION 5.10. Use of Proceeds and Letters of Credit. The proceeds of the Term Loans borrowed on the Closing Date, together with the proceeds of the Revolving Loans or Swingline Loans borrowed on the Closing Date and the Equity
Financing, will be used only for (a) the payment of the purchase price payable under the Merger Agreement as consideration for the Acquisition, (b) the payment of fees and expenses payable in connection with the Transactions, (c) the
refinancing of existing Indebtedness (including the redemption on the Closing Date of preferred Equity Interests of the Company and its subsidiaries) and (d) working capital in an amount (together with any amounts paid for estimated purchase
price adjustments and the anticipated fees and expenses in connection with the Transactions) not to exceed $10,000,000. The proceeds of the Revolving Loans (except as described above in this Section 5.10) and Swingline Loans borrowed after the
Closing Date, and the issuance of Letters of Credit, will be used only for working capital and other general corporate purposes of the Borrower and its Subsidiaries. No part of the proceeds of any Loan will be used, whether directly or indirectly,
for any purpose that entails a violation of any of the Regulations of the Board, including Regulations U and X. 
  
 SECTION 5.11. Additional Subsidiaries. If any additional Subsidiary is formed or acquired after the Closing Date (excluding any Foreign Subsidiary,
Insurance Subsidiary, Inactive Subsidiary or Subsidiary elected by the Borrower to be an Unrestricted Subsidiary), the Borrower will, within five Business Days after such 

  

 LifeCare Credit Agreement 
 81 

 
Subsidiary is formed or acquired, notify the Administrative Agent thereof and, within 20 Business Days after such Subsidiary is formed or acquired or such
longer period as the Administrative Agent shall agree, cause the Collateral and Guarantee Requirement to be satisfied with respect to such Subsidiary and with respect to any Equity Interest in or Indebtedness of such Subsidiary owned by or on behalf
of any Loan Party. 
  
 SECTION 5.12. Further Assurances.
(a) Each of Holdings and the Borrower will, and the Borrower will cause each Subsidiary Loan Party to, execute any and all further documents, financing statements, agreements and instruments, and take all such further actions (including the
filing and recording of financing statements, fixture filings, Mortgages and other documents), that may be required under any applicable law, or that the Administrative Agent or the Required Lenders may reasonably request, to cause the Collateral
and Guarantee Requirement to be and remain satisfied, all at the expense of the Loan Parties. Holdings and the Borrower also agree to provide to the Administrative Agent, from time to time upon reasonable request, evidence reasonably satisfactory to
the Administrative Agent as to the perfection and priority of the Liens created or intended to be created by the Security Documents. 
  
 (b) If any material asset (including any real property or improvements thereto or any interest therein) that has an individual fair market value of more
than $2,000,000 is acquired by the Borrower or any Subsidiary Loan Party after the Closing Date or owned by an entity at the time it becomes a Subsidiary Loan Party (in each case other than assets constituting Collateral under the Collateral
Agreement that become subject to the Lien of the Collateral Agreement upon acquisition thereof), the Borrower will (x) notify the Administrative Agent thereof, and (y) if such asset is comprised of real property, deliver to Administrative
Agent an updated Schedule 3.05 reflecting the addition of such asset. If requested by the Administrative Agent or the Required Lenders, the Borrower will cause such asset to be subjected to a Lien securing the Obligations and will take, and cause
the Subsidiary Loan Parties to take, at the expense of the Loan Parties, such actions as shall be necessary or reasonably requested by the Administrative Agent to grant and perfect such Liens, including, without limitation, the following:

  
 (i) the actions described in paragraph
(a) of this Section; 
  
 (ii) the actions
described in the definition of “Collateral and Guarantee Requirement”; and 
  
 (iii) the provision of one or more legal opinions as required by Section 4.01(b) hereof. 
  
 (c) The Collateral and Guarantee Requirement and the other provisions of this
Section 5.12 need not be satisfied with respect to (i) real properties owned by the Borrower or any Subsidiary with an individual fair market value (including fixtures and improvements) that is less than $2,000,000 in the case of
properties acquired after the Closing Date, (ii) any real property held by the Borrower or any Subsidiary as a lessee under a lease, (iii) any Equity Interests acquired after the Closing Date in accordance with this Agreement if, and to
the extent that, and for so long as (A) doing so would 

  

 LifeCare Credit Agreement 
 82 

 
violate applicable law binding on such Equity Interests and (B) such law existed at the time of the acquisition thereof and was not created or made
binding on such Equity Interests in contemplation of or in connection with the acquisition of such Subsidiary, (iv) any assets acquired after the Closing Date, to the extent that, and for so long as, taking such actions would violate a
contractual obligation (it being understood that a Uniform Commercial Code filing does not in and of itself constitute a contractual obligation) binding on such assets that existed at the time of the acquisition thereof and was not created or made
binding on such assets in contemplation or in connection with the acquisition of such assets (except in the case of assets acquired with Indebtedness permitted pursuant to Section 6.01(a)(vi) that is secured by a Lien permitted pursuant to
Section 6.02(e)); provided that, upon the reasonable request of the Administrative Agent, the Borrower shall, and shall cause any applicable Subsidiary to, use commercially reasonable efforts to have waived or eliminated any contractual
obligation of the types described in clause (iv) above and (v) other assets with respect to which the Administrative Agent determines that the cost or impracticability of including such assets as Collateral would be excessive in relation
to the benefits to the Secured Parties. 
  
 SECTION 5.13.
Designation of Unrestricted Subsidiaries. The Borrower’s board of directors may, at any time, designate any Subsidiary that is acquired or created after the Closing Date as an Unrestricted Subsidiary by prior written notice to the
Administrative Agent; provided that the Borrower shall only be permitted to so designate a new Unrestricted Subsidiary after the Closing Date and so long as (a) no Default or Event of Default exists or would result therefrom,
(b) such Subsidiary does not own any capital stock or Indebtedness of, or own or hold a Lien on any property of, the Borrower or any other Subsidiary that is not a subsidiary of the Subsidiary to be so designated and (c) such Unrestricted
Subsidiary shall be capitalized (to the extent capitalized by the Borrower or any of its Subsidiaries) through Investments permitted by, and in compliance with, Section 6.04(k), (o) or (r), with any assets owned by such Unrestricted
Subsidiary at the time of the initial designation thereof to be treated as Investments pursuant to Section 6.04(k), (o) or (r); provided that at the time of the initial Investment by the Borrower or any of its Subsidiaries in such
Subsidiary, the Borrower shall designate such entity as an Unrestricted Subsidiary in a written notice to the Administrative Agent. The Borrower may designate any Unrestricted Subsidiary to be a Subsidiary for purposes of this Agreement (each, a
“Subsidiary Redesignation”); provided that (i) such Unrestricted Subsidiary, both before and after giving effect to such designation, shall be a wholly owned Subsidiary of the Borrower, (ii) no Default or Event of
Default then exists or would occur as a consequence of any such Subsidiary Redesignation, (iii) calculations are made by the Borrower of Pro Forma Compliance with the Financial Covenants for the relevant period, as if the respective Subsidiary
Redesignation (as well as all other Subsidiary Redesignations theretofore consummated after the first day of such period) had occurred on the first day of such period, and such calculations shall show that such Financial Covenants would have been
complied with if the Subsidiary Redesignation had occurred on the first day of such period (for this purpose, if the first day of the respective period occurs prior to the Closing Date, calculated as if the Financial Covenants had been applicable
from the first day of such period), (iv) based on good faith projections prepared by the Borrower for the period from the date of the respective Subsidiary Redesignation to the date that is one year 

  

 LifeCare Credit Agreement 
 83 

 
thereafter, the level of financial performance measured by the Financial Covenants shall be better than or equal to such level as would be required to
provide that no Default or Event of Default would exist under the Financial Covenants through the date that is one year from the date of the respective Subsidiary Redesignation, (v) all representations and warranties contained herein and in the
other Loan Documents shall be true and correct in all material respects with the same effect as though such representations and warranties had been made on and as of the date of such Subsidiary Redesignation (both before and after giving effect
thereto), unless stated to relate to a specific earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such earlier date, (vi) the Borrower shall have delivered to the
Administrative Agent an officer’s certificate executed by a Financial Officer, certifying to the best of such officer’s knowledge, compliance with the requirements of preceding clauses (i) through (v), inclusive, and containing the
calculations required by the preceding clauses (iii) and (iv), and (vii) any Unrestricted Subsidiary subject to a Subsidiary Redesignation may not thereafter be designated as an Unrestricted Subsidiary. 
  
 SECTION 5.14. Material Contracts. Each of Holdings and the Borrower
will, and will cause each Subsidiary Loan Party to, perform and observe all of the terms and conditions of each material agreement to be performed or observed by it, maintain each such material agreement in full force and effect, enforce each such
material agreement in accordance with its terms, except, in any case, where the failure to do so, either individually or in the aggregate, could not be reasonably likely to have a Material Adverse Effect. 
  
 SECTION 5.15. Healthcare Licenses. (a) Each of Holdings and the
Borrower will, and will cause each of its Subsidiaries to, (i) obtain and maintain all material licenses, permits, certifications and approvals of all applicable Governmental Authorities as are required for the conduct of its business as
currently conducted on the date hereof and herein contemplated, including, without limitation, Medicaid Certifications and Medicare Certifications and (ii) ensure that billing policies, arrangements, protocols and instructions will comply in
all material respects with reimbursement requirements under Medicare, Medicaid and other Medical Reimbursement Programs and will be administered by properly trained personnel. 
  
 (b) The Borrower has in place and shall maintain a compliance program for its Subsidiaries that is reasonably designed to
provide effective internal controls that promote adherence to, prevent and detect material violations of, any Medicaid Regulations and Medicare Regulations applicable to its Subsidiaries, which compliance program includes the implementation of
internal audits and monitoring on a regular basis to monitor compliance therewith and with such regulations. 
  
 (c) Each of the Borrower, Holdings and the Subsidiaries that is a “covered entity” under HIPAA has in place and the Borrower shall cause each of
them to (i) maintain in effect policies and procedures that materially comply with HIPAA as applicable to any of Holdings, the Borrower or any of its Subsidiaries and (ii) comply in all material respects with such policies and procedures.

  

 LifeCare Credit Agreement 
 84 

 SECTION 5.16. Interest Rate Hedging. Within 90 days following the Closing Date, the Borrower will
enter into and maintain for a period of two years one or more interest rate Swap Agreements in form and substance and with Persons reasonably acceptable to the Administrative Agent and providing for protection against fluctuations in interest rate
with coverage in a notional amount of 40% of the aggregate principal amount of the Term Loan Commitments and the Senior Subordinated Debt. 
  
 ARTICLE VI 
  
 Negative Covenants 
  
 Until the Commitments have expired or terminated and the principal of and interest on each Loan and all fees payable hereunder have been paid in full and all Letters of Credit have expired or terminated and all LC
Disbursements shall have been reimbursed, each of Holdings and the Borrower covenants and agrees with the Lenders that: 
  
 SECTION 6.01. Indebtedness; Certain Equity Securities. (a) The Borrower will not, and will not permit any Subsidiary to, create, incur, assume
or permit to exist any Indebtedness, except: 
  
 (i) Indebtedness created under the Loan Documents (including any Guarantees thereof); 
  
 (ii) the Senior Subordinated Debt and Refinancing Indebtedness in respect thereof; 
  
 (iii) Indebtedness existing on the date hereof and set forth
in Schedule 6.01 and Refinancing Indebtedness in respect thereof; 
  
 (iv) Indebtedness of the Borrower owed to any Subsidiary and of any Subsidiary owed to the Borrower or any other Subsidiary; provided that (i) any such Indebtedness owed by a Loan Party is subordinated to
the Obligations pursuant to the Affiliate Subordination Agreement and (ii) Indebtedness of any Subsidiary that is not a Loan Party to the Borrower or any Subsidiary Loan Party shall be subject to Section 6.04; and provided,
further, that (A) Indebtedness owed to any Insurance Subsidiary by the Borrower or any other Subsidiary shall be limited in principal amount to the aggregate amount of Investments made in such Insurance Subsidiary pursuant to
Section 6.04(s) and (B) notwithstanding the first proviso above, such Indebtedness owed to any Insurance Subsidiary shall only be subordinated to the extent permitted by applicable laws or regulations; 
  
 (v) Guarantees by the Borrower of Indebtedness of any
Subsidiary, by any Subsidiary of Indebtedness of any other Subsidiary and by any Subsidiary Loan Party of Indebtedness of the Borrower; provided that Guarantees by the Borrower 

  

 LifeCare Credit Agreement 
 85 

 
or any Subsidiary Loan Party of Indebtedness of any Subsidiary that is not a Loan Party shall be subject to Section 6.04; 
  
 (vi) Indebtedness of the Borrower or any Subsidiary
(a) incurred to finance the acquisition, construction or improvement of any fixed or capital assets, including Capital Lease Obligations and any Indebtedness assumed in connection with the acquisition of any such assets or secured by a Lien on
any such assets prior to the acquisition thereof, and extensions, renewals, refinancings and replacements of any such Indebtedness that do not increase the outstanding principal amount thereof (other than by an amount not greater than fees and
expenses, including premium and defeasance costs, associated therewith) or result in a decreased average weighted life thereof, provided that such Indebtedness is incurred prior to or within 180 days after such acquisition or the
completion of such construction or improvement, or (b) constituting a Capital Lease Obligation as part of a sale and leaseback transaction permitted by Section 6.06; provided that the aggregate principal amount of Indebtedness
permitted by this clause (vi) shall not at any time exceed the greater of $20,000,000 and 3.25% of Consolidated Total Assets; 
  
 (vii) Indebtedness of any Person that becomes a Subsidiary after the date hereof, and extensions, renewals, refinancings and replacements
of any such Indebtedness that do not increase the outstanding principal amount thereof (other than by an amount not greater than fees and expenses, including premium and defeasance costs, associated therewith), add any new obligor or security
therefor or result in a decreased average weighted life thereof; provided that (A) such acquired Indebtedness exists at the time such Person becomes a Subsidiary and is not created in contemplation of or in connection with such Person
becoming a Subsidiary (except to the extent such acquired Indebtedness refinanced other Indebtedness to facilitate such entity becoming a Subsidiary) and (B) the aggregate principal amount of Indebtedness permitted by this clause (vii)
shall not at any time exceed the greater of $25,000,000 and 4.00% of Consolidated Total Assets; 
  
 (viii) Indebtedness owed to (including obligations in respect of letters of credit or bank guarantees or similar instruments for the
benefit of) any person providing workers’ compensation, health, disability or other employee benefits or property, casualty or liability insurance to the Borrower or any Subsidiary, pursuant to reimbursement or indemnification obligations to
such person, provided that upon the incurrence of Indebtedness with respect to reimbursement obligations regarding workers’ compensation claims, such obligations are reimbursed not later than 30 days following such incurrence;

  
 (ix) Indebtedness arising from the honoring
by a bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business or other cash management services in the ordinary course of business, provided that (i) such
Indebtedness (other than credit or purchase cards) is extinguished within ten Business Days of its incurrence and 

  

 LifeCare Credit Agreement 
 86 

 
(ii) such Indebtedness in respect of credit or purchase cards is extinguished within 60 days from its incurrence; 
  
 (x) Indebtedness arising from agreements of the Borrower or
any Subsidiary providing for indemnification, adjustment of purchase or acquisition price or similar obligations, in each case, incurred or assumed in connection with the disposition of any business, assets or a Subsidiary permitted hereunder, other
than Guarantees of Indebtedness incurred by any person acquiring all or any portion of such business, assets or a Subsidiary for the purpose of financing such acquisition; 
  
 (xi) Indebtedness in respect of performance bonds, bid bonds, appeal bonds, surety bonds, financial
assurances and completion guarantees and similar obligations, in each case provided in the ordinary course of business, including those incurred to secure health, safety and environmental obligations in the ordinary course of business; 

 
 (xii) all premium (if any), interest (including
post-petition interest), fees, expenses, charges and additional or contingent interest on obligations described in paragraphs (i) through (xiii) above and paragraph (xv) below; 
  
 (xiii) cash management obligations and other Indebtedness in
respect of netting services, overdraft protection and similar arrangements, in each case, in connection with cash management and deposit accounts; 
  
 (xiv) other Indebtedness in an aggregate principal amount not exceeding the greater of $30,000,000 and 4.75% of Consolidated Total Assets;

  
 (xv) Indebtedness of any Loan Party pursuant
to Swap Agreements permitted by Section 6.07; 
  
 (xvi) Indebtedness representing deferred compensation to employees of the Borrower incurred in the ordinary course of business; 
  
 (xvii) Indebtedness in respect of promissory notes issued to consultants, employees or directors or former employees, consultants or
directors of a Parent, Holdings, the Borrower or any Subsidiary in connection with repurchases of Equity Interests permitted by Section 6.08(a); and 
  
 (xviii) Permitted Subordinated Indebtedness, in each case without any limitation as to amount so long as the Net Proceeds of such
Permitted Subordinated Indebtedness are used, promptly after such Net Proceeds are received, (A) to consummate one or more Permitted Acquisitions so long as after giving effect to the incurrence of such Permitted Subordinated Indebtedness, the
Leverage Ratio would be less than the Leverage Ratio set forth in Section 6.13 for such date minus 0.50 or (B) applied to prepay Loans to the extent required by Section 2.11(c); provided, that no Default has occurred and
is continuing or would result therefrom. 
  

 LifeCare Credit Agreement 
 87 

 (b) The Borrower will not, nor will it permit any Subsidiary to, issue any preferred stock or other
preferred Equity Interests, other than (i) Non-Cash Pay Preferred Stock of the Borrower, issued to Holdings and pledged pursuant to the Collateral Agreement and (ii) preferred stock or other preferred Equity Interests of a Subsidiary,
issued to a Loan Party and pledged pursuant to the Collateral Agreement. 
  
 SECTION 6.02. Liens. The Borrower will not, and will not permit any Subsidiary to, create, incur, assume or permit to exist any Lien on any property or asset now owned or hereafter acquired by it, or assign or
sell any income or revenues (including accounts receivable) or rights in respect of any thereof, except: 
  
 (a) Liens created under the Loan Documents; 
  
 (b) Permitted Encumbrances; 
  
 (c) any Lien existing on the date hereof and set forth in Schedule 6.02 on any property or asset of the Borrower or any Subsidiary;

  
 (d) any Lien existing on any property or
asset prior to the acquisition thereof by the Borrower or any Subsidiary or existing on any property or asset of any Person that becomes a Subsidiary after the date hereof prior to the time such Person becomes a Subsidiary; provided that
(i) such Lien is not created in contemplation of or in connection with such acquisition or such Person becoming a Subsidiary, as the case may be, (ii) such Lien shall not apply to any other property or assets of the Borrower or any
Subsidiary (other than proceeds and after acquired property of any acquired Subsidiary to the extent required by the terms of any Indebtedness assumed in such acquisition and permitted pursuant to Section 6.01(a)) and (iii) such Lien shall
secure only those obligations which it secures on the date of such acquisition or the date such Person becomes a Subsidiary, as the case may be and extensions, renewals, refinancings and replacements thereof that do not increase the outstanding
principal amount thereof (other than by an amount not in excess of fees and expenses, including premium and defeasance costs, associated therewith) or result in a decreased average weighted life thereof; 
  
 (e) Liens on fixed or capital assets acquired, constructed
or improved by the Borrower or any Subsidiary; provided that (i) such Liens secure Indebtedness permitted by clause (vi) of Section 6.01(a), (ii) such Liens and the Indebtedness secured thereby are incurred prior to or
within 180 days after such acquisition or the completion of such construction or improvement, (iii) the Indebtedness secured thereby does not exceed the greater of (A) the cost of acquiring, constructing or improving such fixed or
capital assets, including transaction costs incurred in connection therewith and (B) the fair market value of such fixed or capital assets, and (iv) such Liens shall not apply to any other property or assets of the Borrower or any other
Subsidiary (other than proceeds); provided that individual financings of 

  

 LifeCare Credit Agreement 
 88 

 
equipment provided by a single lender may be cross-collateralized to other financings of equipment provided solely by such lender; 
  
 (f) Cash deposits securing any Swap Agreement entered into
in connection with the Loans hereunder; 
  
 (g)
Liens not otherwise permitted by this Section 6.02 securing obligations other than Indebtedness and involuntary Liens not otherwise permitted by this Section 6.02 securing Indebtedness, which obligations and Indebtedness are in an
aggregate amount not in excess of $2,500,000 at any time outstanding; 
  
 (h) (i) deposits securing liability to insurance carriers under insurance or self-insurance arrangements in respect of such obligations and (ii) pledges and deposits securing liability for reimbursement or
indemnification obligations of (including obligations in respect of letters of credit or bank guarantees for the benefit of) insurance carriers providing property, casualty or liability insurance to the Borrower or any Subsidiary; 
  
 (i) Liens disclosed by the title insurance policies
delivered on or prior to the Closing Date and any replacement, extension or renewal of any such Lien; provided that such replacement, extension or renewal Lien shall not cover any property other than the property that was subject to such Lien prior
to such replacement, extension or renewal; provided, further, that the Indebtedness and other obligations secured by such replacement, extension or renewal Lien are permitted by this Agreement; 
  
 (j) any interest or title of a lessor under any leases or
subleases entered into by the Borrower or any Subsidiary in the ordinary course of business; 
  
 (k) Liens that are contractual rights of set-off (i) relating to the establishment of depository relations with banks not given in
connection with the issuance of Indebtedness, (ii) relating to pooled deposit or sweep accounts to permit satisfaction of overdraft or similar obligations incurred in the ordinary course of business or (iii) relating to purchase orders and
other agreements entered into with customers of the Borrower or any Subsidiary in the ordinary course of business; 
  
 (l) Liens arising solely by virtue of any statutory or common law provision relating to banker’s liens, rights of set-off or similar
rights; 
  
 (m) licenses of intellectual property
granted in the ordinary course of business; 
  
 (n) licenses, sublicenses, leases or subleases granted to others that do not interfere in any material respect with the business of the Borrower or any Subsidiary; 
  

 LifeCare Credit Agreement 
 89 

 (o) Liens solely on any cash earnest money deposits made by the Borrower or any of the
Subsidiaries in connection with any letter of intent or purchase agreement permitted hereunder; 
  
 (p) Liens arising from precautionary UCC financing statements in connection with operating leases; 
  
 (q) Liens in favor of co-venturors in Equity Interests in
joint ventures securing obligations of such joint venture; 
  
 (r) Liens on securities that are the subject of repurchase agreements constituting Permitted Investments under clause (d) of the definition thereof; 
  
 (s) Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of
customs duties in connection with the importation of goods; 
  
 (t) the prior rights of consignees and their lenders under consignment arrangements entered into in the ordinary course of business; 
  
 (u) agreements to subordinate any interest of the Borrower or any Subsidiary in any accounts receivable or
other proceeds arising from inventory consigned by the Borrower or any of its Subsidiaries pursuant to an agreement entered into in the ordinary course of business; 
  
 (v) Liens granted by any Subsidiary that is not a Loan Party in favor of the Borrower or any other Loan
Party in respect of Indebtedness owed by such Subsidiary; and 
  
 (w) other Liens with respect to property or assets of the Borrower or any Subsidiary securing Indebtedness or other obligations not at any time in excess of $5,000,000. 
  
 SECTION 6.03. Fundamental Changes. (a) The Borrower will not, and
will not permit any Subsidiary to, merge into or consolidate with any other Person, or permit any other Person to merge into or consolidate with it, or liquidate or dissolve, except that, if at the time thereof and immediately after giving effect
thereto no Event of Default shall have occurred and be continuing, (i) any Subsidiary may merge into the Borrower in a transaction in which the Borrower is the surviving corporation, (ii) any Subsidiary may merge into any Subsidiary in a
transaction in which the surviving entity is a wholly owned Subsidiary and, if any party to such merger is a Subsidiary Loan Party, a Subsidiary Loan Party, (iii) any Subsidiary may merge or consolidate with any other Person in order to effect
a Permitted Acquisition, (iv) any Subsidiary may liquidate or dissolve if the Borrower determines in good faith that such liquidation or dissolution is in the best interests of the Borrower and is not materially disadvantageous to the Lenders
and (v) any asset sale permitted by Section 6.05(i) may be effected through the merger of a Subsidiary of the Borrower with a third party; provided that any such merger involving 

  

 LifeCare Credit Agreement 
 90 

 
a Person that is not a wholly owned Subsidiary immediately prior to such merger shall not be permitted unless also permitted by Section 6.04.

  
 (b) Holdings will not conduct, transact or otherwise engage at
any time in any business or business activity, acquire any assets, incur any Indebtedness, or suffer to exist any Liens on its assets (other than Liens permitted by Section 6.02), other than (i) ownership and acquisition of the Equity
Interests in the Borrower, together with activities directly related thereto, (ii) performance of its obligations under and in connection with the Loan Documents, the Merger Agreement and the other agreements contemplated by the Merger
Agreement, the Senior Subordinated Debt Documents, the indenture or other documentation governing any Permitted Holdings Debt or other documentation governing any Permitted Holdings Debt (and Refinancing Indebtedness in respect thereof) and the
other agreements contemplated hereby and thereby, (iii) actions incidental to the consummation of the Transactions, (iv) actions required by law to maintain its existence, (v) the payment of dividends and taxes, (vi) the issuance
of and the performance of obligations in respect of its Equity Interests, (vii) the acquisition of assets that are contributed to the Borrower, (viii) the formation of a single purpose corporation to act as a co-issuer of any Permitted
Holdings Debt, and (ix) activities and liabilities incidental to its maintenance and continuance and the ownership of the Borrower and its Subsidiaries and to the foregoing activities. Notwithstanding anything to the contrary contained in
herein, (A) Holdings shall at all times own directly 100% of the Equity Interests of the Borrower and (B) Holdings shall not sell, dispose of, grant a Lien on or otherwise transfer its Equity Interests in the Borrower (other than pursuant
to the Loan Documents). 
  
 (c) Notwithstanding anything herein to
the contrary, Holdings, the Borrower and its Subsidiaries may consummate the Acquisition. 
  
 SECTION 6.04. Investments, Loans, Advances, Guarantees and Acquisitions. The Borrower will not, and will not permit any of its Subsidiaries to, make, purchase, hold or acquire (including pursuant to any merger
with any Person that was not a wholly owned Subsidiary prior to such merger) any Investment, except: 
  
 (a) the Acquisition; 
  
 (b) Permitted Investments and Investments that were Permitted Investments when made; 
  
 (c) Investments existing on, or contractually committed as
of, the date hereof and set forth on Schedule 6.04 and any modification, replacement, renewal or extension thereof; provided, that the amount of the original Investment may not be increased except by the terms of such Investment or as
otherwise permitted by this Section 6.04; 
  
 (d) Investments by the Borrower and its Subsidiaries in any other Subsidiary; provided that the aggregate amount of investments by Loan Parties in, loans and advances by Loan Parties to, and Guarantees by Loan 

  

 LifeCare Credit Agreement 
 91 

 
Parties of Indebtedness of, Subsidiaries that are not Loan Parties shall not at any time exceed the sum of (i) $20,000,000 plus (ii) an
amount equal to the Borrower’s Portion of Excess Cash Flow minus the cumulative aggregate amount of Designated Excess Cash Flow Expenditures other than pursuant to this Section 6.04(d); and provided, further that loans
or advances made by any Loan Party to a Subsidiary that is not a Loan Party shall be subordinated to the Obligations pursuant to the Affiliate Subordination Agreement; 
  
 (e) Guarantees constituting Indebtedness permitted by Section 6.01; provided that (i) a
Subsidiary shall not Guarantee the Senior Subordinated Debt unless (A) such Subsidiary also has Guaranteed the Obligations pursuant to the Collateral Agreement, (B) such Guarantee of the Senior Subordinated Debt is subordinated to such
Guarantee of the Obligations on terms no less favorable to the Lenders than the subordination provisions of the Senior Subordinated Debt and (C) such Guarantee of the Senior Subordinated Debt provides for the release and termination thereof,
without action by any party, upon any release and termination of such Guarantee of the Obligations, and (ii) the aggregate principal amount of Indebtedness of Subsidiaries that are not Loan Parties that is Guaranteed by any Loan Party shall be
subject to the limitation set forth in clause (d) above of this Section 6.04; 
  
 (f) Permitted Acquisitions; 
  
 (g) Investments (including debt obligations and equity securities) received in connection with the bankruptcy or reorganization of, or
settlement of delinquent accounts and disputes with, customers and suppliers, in each case in the ordinary course of business; 
  
 (h) accounts receivable, security deposits and prepayments arising and extensions of trade credit in the ordinary course of business and
any assets and securities received in satisfaction or partial satisfaction thereof from financially troubled account debtors to the extent reasonably necessary to prevent or limit loss and any prepayments and other credits to suppliers in the
ordinary course of business; 
  
 (i) Investments
consisting of non-cash consideration received in respect of sales, transfers or other dispositions of assets to the extent permitted by Section 6.05; 
  
 (j) Swap Agreements entered into in compliance with Section 6.07; 
  
 (k) other Investments by the Borrower or any Subsidiary, including investments in Unrestricted Subsidiaries,
in an aggregate amount not to exceed at any time the sum of (i) the greater of $20,000,000 and 3.25% of Consolidated Total Assets plus (ii) the Borrower’s Portion of Excess Cash 

  

 LifeCare Credit Agreement 
 92 

 
Flow minus the cumulative aggregate amount of Designated Excess Cash Flow Expenditures made other than pursuant to this clause (k); 

 
 (l) Investments of a Subsidiary acquired after the
Closing Date or of a corporation merged into the Borrower or merged into or consolidated with a Subsidiary in accordance with Section 6.03 after the Closing Date to the extent that such Investments were not made in contemplation of or in
connection with such acquisition, merger or consolidation and were in existence on the date of such acquisition, merger or consolidation; 
  
 (m) acquisitions by the Borrower of obligations of one or more officers or other employees of a Parent, Holdings, the Borrower or its
Subsidiaries in connection with such officer’s or employee’s acquisition of Equity Interests of Holdings, so long as no cash is actually advanced by the Borrower or any of the Subsidiaries to such officers or employees in connection with
the acquisition of any such obligations; 
  
 (n)
Guarantees by the Borrower or any Subsidiary of operating leases (other than Capital Lease Obligations) or of other obligations that do not constitute Indebtedness, in each case entered into by the Borrower or any Subsidiary in the ordinary course
of business; 
  
 (o) any Investment by the
Borrower or any Subsidiary made with Eligible Equity Proceeds that have not been applied to other Eligible Equity Proceeds Uses, provided that such Investment is made not later than 270 days after the receipt of such Eligible Equity
Proceeds by the Borrower; 
  
 (p) loans and
advances by the Borrower and any of its Subsidiaries to their employees in the ordinary course of business and for bona fide business purposes in an aggregate amount at any time outstanding not in excess of $1,500,000 and advances of payroll
payments and expenses to employees in the ordinary course of business; 
  
 (q) Investments resulting from pledges and deposits referred to in Section 6.02(b) and 6.02(h); 
  
 (r) any Investment by the Borrower or any Subsidiary made with Below Threshold Asset Disposition Proceeds that have not been applied to
other Below Threshold Asset Disposition Proceeds Uses; 
  
 (s) Investments, loans and advances by the Borrower or any Subsidiary to any Insurance Subsidiary in an amount equal to (A) the capital required under the applicable laws or regulations of the jurisdiction in which such Insurance
Subsidiary is formed or determined by independent actuaries as prudent and necessary capital to operate such Insurance Subsidiary plus (B) any reasonable general corporate and overhead expenses of such Insurance Subsidiary; 

 

 LifeCare Credit Agreement 
 93 

 (t) loans and advances to Holdings in lieu of, and not in excess of the amount of (after
giving effect to any other loans, advances or Restricted Payments in respect thereof), Restricted Payments to the extent permitted to be made to Holdings in accordance with Section 6.08(a) (which loans and advances shall be treated as
Restricted Payments for purposes of determining compliance with Section 6.08(a)); and 
  
 (u) Investments in joint ventures that are not subsidiaries of Holdings or the Borrower in an aggregate amount outstanding not to exceed
$20,000,000 at any time. 
  
 Notwithstanding the foregoing, neither the Borrower
nor any of its Subsidiaries shall form, acquire or otherwise make any Investment in any Person that, as a result of such Investment, would be or become a Foreign Subsidiary. It is further understood and agreed that for purposes of determining the
value of any Investment outstanding for purposes of this Section 6.04, such amount shall deemed to be the amount of such Investment when made, purchased or acquired without regard for subsequent increases or decreases in value of such
Investments as of the date of such determination. 
  
 SECTION
6.05. Asset Sales. The Borrower will not, and will not permit any of its Subsidiaries to, sell, transfer, lease or otherwise dispose of any asset, including any Equity Interest owned by it, nor will the Borrower permit any of it Subsidiaries
to issue any additional Equity Interest in such Subsidiary, except: 
  
 (a) sales of (x) inventory, (y) used, surplus, obsolete or worn-out equipment or other worn-out property or assets and Permitted Investments in the ordinary course of business and (z) sales, leases or
other dispositions of inventory of the Borrower and its Subsidiaries determined by the management of the Borrower to be no longer useful or necessary in the operation of the business of the Borrower or any of the Subsidiaries; 
  
 (b) sales, transfers and dispositions to the Borrower or a
Subsidiary; provided that any such sales, transfers or dispositions involving a Subsidiary that is not a Loan Party shall be made in compliance with Section 6.09; 
  
 (c) sales, transfers and dispositions of accounts receivable in connection with the compromise, settlement
or collection thereof consistent with past practice; 
  
 (d) sale and leaseback transactions permitted by Section 6.06; 
  
 (e) the sale of defaulted receivables in the ordinary course of business and not as part of an accounts receivables financing transaction; 
  
 (f) dispositions resulting from any casualty or other insured damage to, or any taking under power of
eminent domain or by condemnation or similar proceedings of, any property or asset of the Borrower or any Subsidiary; 
  

 LifeCare Credit Agreement 
 94 

 (g) licensing and cross-licensing arrangements involving any technology or other
intellectual property of the Borrower or any Subsidiary in the ordinary course of business; 
  
 (h) exchanges of property (other than Equity Interests) for similar replacement property for fair value; and 
  
 (i) sales, transfers and other dispositions of assets that
are not permitted by any other clause of this Section; provided that the aggregate cumulative fair market value of all assets sold, transferred or otherwise disposed of after the Closing Date in reliance upon this clause (i) shall not
exceed the greater of $30,000,000 and 4.75% of Consolidated Total Assets; 
  
 provided that (x) all sales, transfers, leases and other dispositions permitted hereby (other than pursuant to clauses (a)(y), (a)(z), (b), (c), (f), (g) and (h) above) shall be made for at least 75% cash and
Permitted Investments consideration (provided that for purposes of this clause (x) and the immediately following clause (y), the amount of any secured Indebtedness or other Indebtedness of a Subsidiary that is not a Loan Party (as shown on
the Borrower’s or such Subsidiary’s most recent balance sheet or in the notes thereto) of the Borrower or any Subsidiary of the Borrower that is assumed by the transferee of any such assets shall be deemed to be cash or, in the case of
Permitted Investments and sale and leaseback transactions, 100% cash and Permitted Investments consideration, (y) all sales, transfers, leases and other dispositions permitted by clause (c) or (e) above and all sales of Permitted
Investments shall be made for fair value and (z) all sales, transfers, leases and other dispositions in excess of $1,000,000 permitted by clauses (a) (other than Permitted Investments), (g) and (i) above shall be made for fair
value. 
  
 SECTION 6.06. Sale and Leaseback Transactions.
The Borrower will not, and will not permit any of its Subsidiaries to, enter into any arrangement, directly or indirectly, whereby it shall sell or transfer any property, real or personal, used or useful in its business, whether now owned or
hereinafter acquired, and thereafter rent or lease such property or other property that it intends to use for substantially the same purpose or purposes as the property sold or transferred, except for the sale of any fixed or capital assets that is
made for cash and Permitted Investments consideration and for the fair market value of such fixed or capital asset; provided, however, that all Capital Lease Obligations and Liens associated with such sale and leaseback transaction are
permitted by Sections 6.01(a)(vi) and 6.02(e). In addition, the Borrower and the Subsidiaries may engage in other sale and leaseback transactions in a cumulative aggregate amount not exceeding $5,000,000, provided that the Net Proceeds of any
such sale and leaseback transaction are used simultaneously with the consummation of such sale and leaseback transaction to prepay outstanding Term Loans without giving effect to the proviso of Section 2.11(c). 
  
 SECTION 6.07. Swap Agreements. The Borrower will not, and will not
permit any of its Subsidiaries to, enter into any Swap Agreement, except (a) Swap Agreements entered into in the ordinary course of business to hedge or mitigate risks to which the Borrower or any Subsidiary has actual exposure (other than
those in respect of 

  

 LifeCare Credit Agreement 
 95 

 
Equity Interests of the Borrower or any of its Subsidiaries) in the conduct of its business or the management of its liabilities, (b) Swap Agreements
required by Section 5.16 and (c) Swap Agreements entered into in order to effectively cap, collar or exchange interest rates (from fixed to floating rates, from one floating rate to another floating rate or otherwise) with respect to any
interest-bearing liability or investment of the Borrower or any Subsidiary. 
  
 SECTION 6.08. Restricted Payments; Certain Payments of Indebtedness. (a) The Borrower will not, and will not permit any Subsidiary to, declare or make, or agree to pay or make, directly or indirectly, any
Restricted Payment, except: 
  
 (i) Subsidiaries
of the Borrower may declare and pay dividends ratably (or in a manner more favorable to the Borrower or Subsidiaries) with respect to their capital stock; 
  
 (ii) the Borrower may make Restricted Payments pursuant to and in accordance with stock option plans or other benefit plans for
management, employees, directors or consultants (including former employees, directors or consultants) of any Parent, Holdings, the Borrower and its Subsidiaries; provided that the amount thereof does not exceed the sum of (A) $2,000,000
in any calendar year (and, to the extent the aggregate amount of Restricted Payments made in any calendar year pursuant to this clause (A) is less than $2,000,000, the amount of such difference may be carried forward and used for Restricted
Payments in the following calendar years; provided, that the maximum amount of Restricted Payments that may be made in any calendar year pursuant to this clause (A) may not exceed $4,000,000), (B) the amount of Equity Proceeds
transferred to the Borrower from sales of Equity Interests of Holdings or a Parent to directors, consultants, officers or employees in connection with permitted incentive arrangements and (C) the proceeds of any key-man life insurance policies
received by the Borrower (which amounts set forth in clauses (B) and (C), if not used in any fiscal year, may be carried forward to any subsequent fiscal year)); 
  
 (iii) the Borrower may pay dividends to Holdings at any time in such amounts as may be necessary to permit
Holdings or a Parent to pay its expenses and liabilities incurred in the ordinary course (other than payments in respect of Indebtedness or Restricted Payments), including payment of franchise taxes and other fees required to maintain its corporate
existence and to pay for general corporate and overhead expenses (including salaries and other compensation of employees) which are attributable or allocable to the ownership and operations of the Borrower and the Subsidiaries; 
  
 (iv) provided no Event of Default is continuing or would
result therefrom, the Borrower may make Restricted Payments to Holdings with Eligible Equity Proceeds that have not been applied to any other Eligible Equity Proceeds Uses; provided that (x) such Restricted Payments are made not later
than 270 days after the receipt of such Eligible Equity Proceeds by the Borrower and (y) no 

  

 LifeCare Credit Agreement 
 96 

 
Restricted Payment may be made under this clause (iv) during any fiscal quarter if the Cure Right has been (or is anticipated to be) exercised in
respect of either of the two immediately preceding fiscal quarters; 
  
 (v) provided no Event of Default is continuing or would result therefrom, the Borrower may make Restricted Payments to Holdings in an aggregate amount not to exceed the sum of (A) $15,000,000, and (B) so
long as the Leverage Ratio before and after giving effect to such Restricted Payment is less than 4.25 to 1.00, an amount equal to the Borrower’s Portion of Excess Cash Flow minus the cumulative aggregate amount of Designated Excess Cash
Flow Expenditures theretofore made (including under this clause (v)); provided that no Restricted Payments may be made under this clause (v) during any fiscal quarter if the Cure Right has been (or is anticipated to be) exercised in
respect of either of the two immediately preceding fiscal quarters; 
  
 (vi) provided no Event of Default is continuing or would result therefrom, the Borrower may make Restricted Payments to Holdings with Below Threshold Asset Disposition Proceeds that have not been applied to any other
Below Threshold Asset Disposition Proceeds Uses; 
  
 (vii) noncash repurchases of Equity Interests deemed to occur upon exercise of stock options if such Equity Interests represent a portion of the exercise price of such options; and 
  
 (viii) the Borrower or any Subsidiary may make Restricted
Payments to Holdings (i) in amounts required for Holdings or a Parent to pay federal, state and local income Taxes imposed directly on Holdings or a Parent to the extent such Taxes are attributable to the income of the Borrower and its
Subsidiaries (including, without limitation, by virtue of Holdings or a Parent being the common parent of a consolidated or combined Tax group of which the Borrower and/or its Subsidiaries are members); provided, however, that the
amount of any such dividends or distributions (plus any taxes payable directly by the Borrower and its Subsidiaries) shall not exceed the amount of such taxes that would have been payable directly by the Borrower and/or its Subsidiaries had
the Borrower been the common parent of a separate tax group that included only the Borrower and its Subsidiaries, (ii) in amounts equal to the amounts required for Holdings or a Parent to pay fees required to maintain its legal existence and
(iii) to pay any reasonable fees or expenses related to unsuccessful debt or equity offerings of Holdings or a Parent. 
  

 LifeCare Credit Agreement 
 97 

 (b) The Borrower will not, and will not permit any Subsidiary to, make or agree to pay or make, directly
or indirectly, any payment or other distribution (whether in cash, securities or other property) of or in respect of principal of or interest on any Indebtedness, or any payment or other distribution (whether in cash, securities or other property),
including any sinking fund or similar deposit, on account of the purchase, redemption, retirement, acquisition, cancellation or termination of any Indebtedness, except: 
  
 (i) payment of Indebtedness created under the Loan Documents; 
  
 (ii) payment of regularly scheduled interest and principal
payments as and when due in respect of any Indebtedness, other than payments in respect of the Senior Subordinated Debt, Permitted Subordinated Indebtedness or other subordinated Indebtedness prohibited by the subordination provisions thereof;

  
 (iii) refinancings of Indebtedness to the
extent permitted by Section 6.01; 
  
 (iv)
payment of secured Indebtedness that becomes due as a result of the voluntary sale or transfer of the property or assets securing such Indebtedness; 
  
 (v) repurchases, repayments, defeasance or other retirement of other Indebtedness in an aggregate amount not to exceed the sum of
(A) $15,000,000 and (B) so long as the Leverage Ratio before and after giving effect to such repurchase or repayment is less than 4.25 to 1.00, in an amount not to exceed the Borrower’s Portion of Excess Cash Flow, minus the
aggregate amount of Designated Excess Cash Flow Expenditures other than pursuant to this clause (v); 
  
 (vi) repurchases, repayments, defeasance or other retirement of Indebtedness made with Eligible Equity Proceeds that have not been applied
to any other Eligible Equity Proceeds Uses, provided such repurchase or repayment is made within 270 days after receipt of such Eligible Equity Proceeds by the Borrower; and provided that this Section 6.08(b) shall not prohibit
cancellation of Indebtedness of the Borrower owing to Holdings in consideration for the issuance of additional common equity of the Borrower to Holdings; 
  
 (vii) repurchases, repayments, defeasance or other retirement of Indebtedness made with Below Threshold Asset Disposition Proceeds that
have not been applied to any other Below Threshold Asset Disposition Proceeds Uses; and 
  
 (viii) payments in the ordinary course of business of principal or interest on any Indebtedness between or among the Borrower and any of
its Subsidiaries, provided that such payments are not otherwise prohibited by the terms of any of the Loan Documents. 
  
 (c) The Borrower will not, and will not permit any Subsidiary to, furnish any funds to, make any Investment in, or provide other consideration to any
other Person (including any Unrestricted Subsidiary) for purposes of enabling such Person to, or 

  

 LifeCare Credit Agreement 
 98 

 
otherwise permit any such Person to, make any Restricted Payment or other payment, repurchase, repayment or distribution restricted by this Section that
could not be made directly by the Borrower in accordance with the provisions of this Section. 
  
 SECTION 6.09. Transactions with Affiliates. The Borrower will not, and will not permit any Subsidiary to, sell, lease or otherwise transfer any property or assets to, or purchase, lease or otherwise acquire any
property or assets from, or otherwise engage in any other transactions with, any of its Affiliates, except: 
  
 (a) transactions that are at prices and on terms and conditions not less favorable to the Borrower or such Subsidiary than could be
obtained on an arm’s-length basis from a Person who is not such an Affiliate; 
  
 (b) transactions that (i) have been approved by a majority of the members of the board of directors of the Borrower having no
personal stake in such transactions and certified by a Financial Officer or executive officer of the Borrower as being on terms and conditions not less favorable to the Borrower or its Subsidiaries than could be obtained on an arm’s-length
basis from a Person who is not such an Affiliate or (ii) have been determined by a nationally recognized appraisal or investment banking firm to be fair, from a financial standpoint, to the Borrower and its Subsidiaries or on terms and
conditions not less favorable to the Borrower and its Subsidiaries than could be obtained on an arm’s-length basis from a Person who is not such an Affiliate; 
  
 (c) transactions between or among the Borrower and the Subsidiary Loan Parties not involving any other
Affiliate; 
  
 (d) any Restricted Payment
permitted by Section 6.08; 
  
 (e) any
payments to the Sponsor consisting of (i) management, consulting, monitoring and advisory fees (including Sponsor Termination Fees and any accrued fees) payable pursuant to the Sponsor Management Agreement as in effect on the Closing Date,
provided that no such fees shall be paid if an Event of Default under Section 7.01(a), (b), (h) or (i) has occurred and is continuing, (ii) payments made for financial advisory, financing, underwriting or placement
services or in respect of other investment banking services made pursuant to the Sponsor Management Agreement as in effect on the Closing Date or otherwise approved by a majority of the board of directors of the Borrower and (iii) in each case,
all reasonable out-of-pocket expenses incurred by, and indemnification payments owed to, the Sponsor in connection with its performance of management, consulting, monitoring, financial advisory or other services with respect to the Borrower and its
Subsidiaries; 
  
 (f) any employment agreements
entered into by the Borrower or any of its Subsidiaries in the ordinary course of business and any issuance of 

  

 LifeCare Credit Agreement 
 99 

 
securities, or other payments, awards or grants in cash, securities or otherwise pursuant to, or the funding of, employment arrangements, stock options and
stock ownership plans or similar employee benefit plans approved in good faith by the board of directors of the Borrower or of a Subsidiary, as appropriate, provided that any Restricted Payments contemplated thereby will be subject to
Section 6.08(a); 
  
 (g) the grant of stock
options or similar rights to employees and directors of the Company pursuant to plans approved by the board of directors of the Borrower; 
  
 (h) loans or advances to employees in the ordinary course of business which are approved by a majority of the board of directors of the
Borrower in good faith, to the extent permitted by Section 6.04(p); 
  
 (i) the payment of compensation, reasonable fees and reimbursement of expenses to, and indemnity provided on behalf of, directors, officers, consultants and employees of Holdings, of the Borrower and of the
Subsidiaries; 
  
 (j) transactions pursuant to
the Merger Agreement and other agreements governing the Transactions, including payment of fees and expenses in connection with the Transactions, and transactions pursuant to agreements in existence on the Closing Date and set forth on Schedule 6.09
or, in each case, pursuant to any amendment thereto to the extent such amendment is not, when taken as a whole, adverse to the Lenders in any material respect; 
  

(k) any purchase by Holdings of Equity Interests of the Borrower or contributions by Holdings to the equity capital of the Borrower;
provided that any Equity Interests of the Borrower purchased by Holdings shall be pledged to the Agent pursuant to the Collateral Agreement; 
  
 (l) transactions with Subsidiaries for the purchase or sale of goods, products, parts and services entered into in the ordinary course of
business in a manner consistent with past practice; 
  
 (m) payments by the Borrower or any of its Subsidiaries of reasonable insurance premiums to, and any borrowings or dividends received from, any Insurance Subsidiary; and 
  
 (n) the entry into and performance of any tax sharing agreement permitted by Section 6.08(a)(viii).

  
 SECTION 6.10. Restrictive Agreements. The Borrower will
not, and will not permit any Subsidiary to, directly or indirectly, enter into, incur or permit to exist any agreement or other arrangement that prohibits, restricts or imposes any condition upon (a) the ability of the Borrower or any
Subsidiary to create, incur or permit to exist any 

  

 LifeCare Credit Agreement 
 100 

 
Lien upon any of its property or assets securing the Obligations, or (b) the ability of any Subsidiary to pay dividends or other distributions with
respect to any shares of its capital stock or to make or repay loans or advances to the Borrower or any other Subsidiary or to Guarantee Indebtedness of the Borrower or any other Subsidiary; provided that (i) the foregoing shall not
apply to restrictions and conditions imposed by law or by any Loan Document or Senior Subordinated Debt Document, (ii) the foregoing shall not apply to restrictions and conditions existing on the date hereof identified on Schedule 6.10 (and
shall not apply to any extension or renewal of, or any amendment or modification not expanding the scope of, any such restriction or condition), (iii) the foregoing shall not apply to customary restrictions and conditions contained in
agreements relating to the sale of a Subsidiary or any asset pending such sale, provided such restrictions and conditions apply only to the Subsidiary or asset that is to be sold and such sale is permitted hereunder, (iv) clause (a) of the
foregoing shall not apply to restrictions or conditions imposed by any agreement relating to secured Indebtedness permitted by this Agreement if such restrictions or conditions apply only to the property or assets securing such Indebtedness and the
proceeds thereof, (v) clause (a) of the foregoing shall not apply to customary provisions in leases or other agreements restricting the assignment thereof, (vi) clause (a) of the foregoing shall not apply to restrictions or
conditions imposed by any agreement related to any Indebtedness incurred by a Subsidiary prior to the date on which such Subsidiary was acquired by the Borrower (but shall apply to any extension or renewal of, or any amendment or modification
expanding the scope of, any such restriction or condition), (vii) clause (a) of the foregoing shall not apply to restrictions or conditions imposed by any agreement related to the refinancing of Indebtedness, provided that the terms of any
such restrictions or conditions are not materially less favorable to the Lenders than the restrictions or conditions contained in the predecessor agreements, (viii) the foregoing shall not apply to customary net worth provisions contained in
real property leases or licenses of intellectual property and other similar agreements entered into in the ordinary course of business, so long as the Borrower has determined in good faith that such net worth provisions could not reasonably be
expected to impair the ability of the Borrower and its Subsidiaries to meet their ongoing obligations, (ix) the foregoing shall not apply to customary restrictions and conditions contained in the document relating to any Lien, so long as
(A) such Lien is permitted under Section 6.02 and such restrictions or conditions relate only to the specific asset subject to such Lien, and (B) such restrictions and conditions are not created for the purpose of avoiding the
restrictions imposed by this Section 6.10, (x) the foregoing shall not apply to customary provisions in joint venture agreements and (xi) the foregoing shall not apply to customary restrictions contained in any documents relating to
Insurance Subsidiaries. 
  
 SECTION 6.11. Change in
Business. Except for any Permitted Business or any business reasonably related, incidental or ancillary thereto, engage in any material line of business substantially different from those lines of business conducted by the Borrower and its
Subsidiaries on the date hereof. 
  
 SECTION 6.12. Fiscal
Year. Neither Holdings nor the Borrower shall change its fiscal year for accounting and financial reporting purposes to end on any date other than December 31. 
  

 LifeCare Credit Agreement 
 101 

 SECTION 6.13. Amendment of Material Documents. The Borrower will not, and will not permit any
Subsidiary to, amend, modify or waive any of its rights under (i) any Senior Subordinated Debt Document, (ii) the Sponsor Management Agreement or (iii) its certificate of incorporation, by-laws or other organizational documents if, in
each case referred to above, such amendment, modification or waiver, taken as a whole, is adverse in any material respect to the interests of the Lenders. 
  
 SECTION 6.14. Interest Coverage Ratio. The Borrower will not permit the Interest Coverage Ratio as of the end of any fiscal quarter ending during
any period set forth below to be less than the ratio set forth below opposite such period: 
  

			
	 Period

	  	Ratio

	 October 1, 2005 through March 31, 2006
	  	2.00 to 1.00
	 April 1, 2006 through March 31, 2009
	  	1.75 to 1.00
	 April 1, 2009 through March 31, 2010
	  	2.25 to 1.00
	 April 1, 2010 through March 31, 2011
	  	2.50 to 1.00
	 April 1, 2011 and thereafter
	  	3.00 to 1.00

  
 SECTION 6.15.
Leverage Ratio. The Borrower will not permit the Leverage Ratio as of the last day of a fiscal quarter ending during any period set forth below to exceed the ratio set forth opposite such period: 
  

			
	 Period

	  	Ratio

	 October 1, 2005 through March 31, 2008
	  	6.75 to 1.00
	 April 1, 2008 through March 31, 2009
	  	6.25 to 1.00
	 April 1, 2009 through March 31, 2010
	  	5.50 to 1.00
	 April 1, 2010 through March 31, 2011
	  	4.00 to 1.00
	 April 1, 2011 and thereafter
	  	3.50 to 1.00

  

 LifeCare Credit Agreement 
 102 

 SECTION 6.16. Capital Expenditures. The Borrower will not, and will not permit any of its
Subsidiaries to, make or become legally obligated to make any Capital Expenditure, except for Capital Expenditures in the ordinary course of business not exceeding $85,000,000 in the aggregate for the Borrower and its Subsidiaries during each fiscal
year; provided, however, that so long as no Default has occurred and is continuing or would result from such expenditure, any portion of any amount set forth above, if not expended in the fiscal year for which it is permitted above,
may be carried over for expenditure in successive fiscal years (such amount, the “Capital Expenditure Carryover Amount”); provided, further, that (i) Capital Expenditures made in connection with the purchase of a
hospital and (ii) Capital Expenditures made solely with Eligible Equity Proceeds shall, in each case, be disregarded for purposes of determining compliance with this Section 6.16. 
  
 SECTION 6.17. Partnerships, Etc. The Borrower will not, and will not
permit any Subsidiary to, become a general partner in any general or limited partnership or joint venture, other than any Subsidiary the sole assets of which consist of its interest in such partnership or joint venture. 
  
 ARTICLE VII 
  
 Events of Default 
  
 If any of the following events (“Events of Default”) shall occur: 
  
 (a) the Borrower shall fail to pay any principal of any Loan or any reimbursement obligation in respect of
any LC Disbursement when and as the same shall become due and payable, whether at the due date thereof or at a date fixed for prepayment thereof or otherwise; 
  

(b) the Borrower shall fail to pay any interest on any Loan or any fee or any other amount (other than an amount referred to in
clause (a) of this Article) payable under this Agreement or any other Loan Document, when and as the same shall become due and payable, and such failure shall continue unremedied for a period of three Business Days; 
  
 (c) any representation or warranty made or deemed made by
Holdings, the Borrower or any Subsidiary in or in connection with any Loan Document or any amendment or modification thereof or waiver thereunder, or in any certificate furnished pursuant to or in connection with any Loan Document or any amendment
or modification thereof or waiver thereunder, shall prove to have been incorrect in any material respect when made or deemed made; 
  
 (d) Holdings or the Borrower shall fail to observe or perform any covenant, condition or agreement contained in Section 5.02(a), 5.04
(with 

  

 LifeCare Credit Agreement 
 103 

 
respect to the existence of Holdings or the Borrower), 5.10, 5.11 or in Article VI; 
  
 (e) any Loan Party shall fail to observe or perform any covenant, condition or agreement contained in any
Loan Document (other than those specified in clause (a), (b) or (d) of this Article), and such failure shall continue unremedied for a period of 30 days after notice thereof from the Administrative Agent to the Borrower (which
notice will promptly be given at the request of any Lender); 
  
 (f) Holdings, the Borrower or any Subsidiary shall fail to make any payment (whether of principal or interest and regardless of amount) in respect of any Material Indebtedness, when and as the same shall become
due and payable (after giving effect to any applicable grace period specified in the agreement or instrument governing such Indebtedness); 
  
 (g) any event or condition occurs that results in any Material Indebtedness becoming due prior to its scheduled maturity or that enables
or permits (with or without the giving of notice, but after giving effect to all applicable grace periods contained in the applicable instrument) the holder or holders of any Material Indebtedness or any trustee or agent on its or their behalf to
cause any Material Indebtedness to become due, or to require the prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity; provided that this clause (g) shall not apply to secured Indebtedness that
becomes due as a result of the voluntary sale or transfer of the property or assets securing such Indebtedness; 
  
 (h) an involuntary proceeding shall be commenced or an involuntary petition shall be filed in a court of competent jurisdiction seeking
(i) liquidation, reorganization or other relief in respect of Holdings, the Borrower or any Material Subsidiary (except, in the case of any Material Subsidiary, in a transaction permitted by Section 6.03), or of a substantial part of its
assets, under any Federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect or (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for Holdings,
the Borrower or any Material Subsidiary or for a substantial part of its assets, and, in any such case, such proceeding or petition shall continue undismissed for 60 days or an order or decree approving or ordering any of the foregoing shall be
entered; 
  
 (i) Holdings, the Borrower or any
Material Subsidiary shall (i) voluntarily commence any proceeding or file any petition seeking relief under any Federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect, (ii) consent to the
institution of any proceeding or petition described in clause (h) of this Article, (iii) apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for Holdings, the Borrower or
any Material 

  

 LifeCare Credit Agreement 
 104 

 
Subsidiary or for a substantial part of its assets, (iv) file an answer admitting the material allegations of a petition filed against it in any such
proceeding that would entitle the other party or parties to an order for relief, (v) make a general assignment for the benefit of its creditors or (vi) generally not pay its debts as such debts become due, or admit in writing its inability
to pay its debts generally; 
  
 (j) one or more
judgments for the payment of money in an aggregate amount in excess of $12,500,000 (net of amounts covered by insurance) shall be rendered against Holdings, the Borrower, any Subsidiary and the same shall remain undischarged for a period of
45 consecutive days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to attach or levy upon any assets of Holdings, the Borrower or any Subsidiary to enforce any such judgment;

  
 (k) an ERISA Event shall have occurred that,
alone or together with any other ERISA Events that have occurred, would reasonably be expected to result in a Material Adverse Effect; 
  
 (l) any Lien purported to be created under any Security Document shall cease to be, or shall be asserted by any Loan Party not to be, a
valid and perfected Lien (perfected as, or having the priority, required by this Agreement or the relevant Security Document and subject to such limitations and restrictions as set forth herein and therein) on any Collateral having, in the
aggregate, a value in excess of $12,500,000, except (i) as a result of the sale or other disposition of the applicable Collateral in a transaction permitted under the Loan Documents or (ii) as a result of the Agent’s failure to
maintain possession of any stock certificates, promissory notes or other instruments delivered to it under the Collateral Agreement or to file Uniform Commercial Code continuation statements or any other filings required to maintain such perfection
or priority and except to the extent such loss is covered by a Lender’s title insurance policy and the Administrative Agent shall be reasonably satisfied with the credit of such insurer; 
  
 (m) a Change in Control shall occur; or 
  
 (n) any Guarantee under the Collateral Agreement for any
reason shall cease to be in full force and effect (other than in accordance with its terms), or any Guarantor shall assert in writing that the Collateral Agreement or any Guarantee thereunder has ceased to be or is not enforceable; 
  
 then, and in every such event (other than an event with respect to the Borrower described in
clause (h) or (i) of this Article), and at any time thereafter during the continuance of such event, the Administrative Agent may with the consent of the Required Lenders, and at the request of the Required Lenders shall, by notice to the
Borrower, take either or both of the following actions, at the same or different times: (i) terminate the Commitments, and thereupon the Commitments shall terminate immediately, and (ii) declare the Loans 

  

 LifeCare Credit Agreement 
 105 

 
then outstanding to be due and payable in whole or in part, and thereupon the principal of the Loans so declared to be due and payable, together with accrued
interest thereon and all fees and other obligations of the Borrower accrued hereunder, shall become due and payable immediately, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Borrower; and in
case of any event with respect to the Borrower described in clause (h) or (i) of this Article, the Commitments shall automatically terminate and the principal of the Loans then outstanding, together with accrued interest thereon and all
fees and other obligations of the Borrower accrued hereunder, shall automatically become due and payable, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Borrower. 
  
 Notwithstanding anything to the contrary contained in Article VII, in the
event that the Borrower fails to comply with the requirements of any of the Financial Covenants, until the expiration of the 10th day subsequent to the date the certificate calculating compliance with such Financial Covenant is required to be
delivered pursuant to Section 5.01, Holdings shall have the right to issue Permitted Cure Securities for cash or otherwise receive cash contributions to the capital of Holdings, and, in each case, to contribute any such cash to the capital of
the Borrower (collectively, the “Cure Right”), and upon the receipt by the Borrower of such cash (the “Cure Amount”) pursuant to the exercise by Holdings of such Cure Right, such Financial Covenant shall be
recalculated giving effect to the following pro forma adjustments: 
  
 (a) Consolidated EBITDA shall be increased, solely for the purpose of measuring compliance with such Financial Covenant and not for any other purpose under this Agreement, including in connection with determining whether, after giving
effect to an event, the requirements of any of the Financial Covenants have been met or Pro Forma Compliance exists, by an amount equal to the Cure Amount; and 
  

(b) If, after giving effect to the foregoing recalculations, the Borrower shall then be in compliance with the requirements of the Financial Covenants,
the Borrower shall be deemed to have satisfied the requirements of the Financial Covenants as of the relevant date of determination with the same effect as though there had been no failure to comply therewith at such date, and the applicable breach
or default of the Financial Covenants that had occurred shall be deemed cured for this purposes of the Agreement. 
  
 (c) Notwithstanding anything herein to the contrary, (i) in each four-fiscal-quarter period there shall be at least two fiscal quarters in which the
Cure Right is not exercised and (ii) the Cure Amount shall be no greater than the amount required for purposes of complying with the Financial Covenants. 
  

 LifeCare Credit Agreement 
 106 

 ARTICLE VIII 
  
 The Agent 
  
 Each of the Lenders and the Issuing Bank hereby irrevocably appoints the Agent as its agent and authorizes the Agent to take such actions on its behalf
and to exercise such powers as are delegated to the Agent by the terms of the Loan Documents, together with such actions and powers as are reasonably incidental thereto. 
  
 The bank serving as the Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other
Lender and may exercise the same as though it were not the Agent, and such bank and its Affiliates may accept deposits from, lend money to and generally engage in any kind of business with Holdings, the Borrower or any Subsidiary or other Affiliate
thereof as if it were not the Agent hereunder. 
  
 The Agent shall
not have any duties or obligations except those expressly set forth in the Loan Documents. Without limiting the generality of the foregoing, (a) the Agent shall not be subject to any fiduciary or other implied duties, regardless of whether a
Default has occurred and is continuing, (b) the Agent shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated by the Loan Documents that the
Agent is required to exercise in writing as directed by the Required Lenders (or such other number or percentage of the Lenders as shall be necessary under the circumstances as provided in Section 9.02), and (c) except as expressly set
forth in the Loan Documents, the Agent shall not have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to Holdings, the Borrower or any of its Subsidiaries that is communicated to or obtained by the
bank serving as Agent or any of its Affiliates in any capacity (other than as Agent). The Agent shall not be liable for any action taken or not taken by it with the consent or at the request of the Required Lenders (or such other number or
percentage of the Lenders as shall be necessary under the circumstances as provided in Section 9.02) or in the absence of its own gross negligence or willful misconduct. The Agent shall be deemed not to have knowledge of any Default unless and
until written notice thereof is given to the Agent by Holdings, the Borrower or a Lender, and the Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in
connection with any Loan Document, (ii) the contents of any certificate, report or other document delivered thereunder or in connection therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or
conditions set forth in any Loan Document, (iv) the validity, enforceability, effectiveness or genuineness of any Loan Document or any other agreement, instrument or document, or (v) the satisfaction of any condition set forth in
Article IV or elsewhere in any Loan Document, other than to confirm receipt of items expressly required to be delivered to the Agent. 
  
 The Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement,
instrument, document or other writing believed by it to be genuine and to have been signed or sent by the proper Person. The Agent also may rely upon any statement made to it orally or by 

  

 LifeCare Credit Agreement 
 107 

 
telephone and believed by it to be made by the proper Person, and shall not incur any liability for relying thereon. The Agent may consult with legal counsel
(who may be counsel for the Borrower), independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts. 

 
 The Agent may perform any and all its duties and exercise its rights and
powers by or through any one or more sub-agents appointed by the Agent. The Agent and any such sub-agent may perform any and all its duties and exercise its rights and powers through their respective Related Parties. The exculpatory provisions of
the preceding paragraphs shall apply to any such sub-agent and to the Related Parties of each Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for
herein as well as activities as Agent. 
  
 Subject to the
appointment and acceptance of a successor to the Agent as provided in this paragraph, the Agent may resign at any time by notifying the Lenders, the Issuing Bank and the Borrower. Upon any such resignation, the Required Lenders shall have the right,
with the consent of the Borrower (such consent not to be unreasonably withheld or delayed and such consent not to be required if an Event of Default under clause (a), (b), (h) or (i) of Article VII has occurred and is continuing), to
appoint a successor. If no successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30 days after the retiring Agent gives notice of its resignation, then the retiring Agent may, on behalf
of the Lenders and the Issuing Bank, appoint a successor Agent which shall be a bank with an office in New York, New York, or an Affiliate of any such bank. Upon the acceptance of its appointment as Agent and Collateral Agent hereunder by a
successor, such successor shall succeed to and become vested with all the rights, powers, privileges and duties of the retiring Agent, and the retiring Agent shall be discharged from its duties and obligations hereunder. The fees payable by the
Borrower to a successor Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrower and such successor. After the Agent’s resignation hereunder, the provisions of this Article and Section 9.03
shall continue in effect for the benefit of such retiring Agent, its sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while it was acting as Agent. 
  
 Each Lender acknowledges that it has, independently and without reliance upon
the Agent or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender also acknowledges that it will, independently and without
reliance upon the Agent or any other Lender and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other
Loan Document or related agreement or any document furnished hereunder or thereunder. 
  

 LifeCare Credit Agreement 
 108 

 ARTICLE IX 
  
 Miscellaneous 
  
 SECTION 9.01. Notices. (a) Except in the case of notices and other communications expressly permitted to be given by telephone, all notices
and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by telecopy, as follows: 
  
 (i) if to Holdings or the Borrower, to it at 5560 Tennyson
Parkway, Plano, Texas 75024, Attention of Jim Shelton, Chief Financial Officer (Telecopy No. 469-241-2199), with a copy to Ropes & Gray LLP, One International Place, Boston, Massachusetts 02110, Attention of Byung Choi (Telecopy
No. 617-951-7050); 
  
 (ii) if to the Agent,
to JPMorgan Chase Bank, N.A., Loan and Agency Services Group, 1111 Fannin, 10th Floor, Houston, Texas 77002,
Attention of Katie Rose (Telecopy No. 713-750-2782), with a copy to JPMorgan Chase Bank, N.A., 270 Park Avenue, New York, New York 10017, Attention of Rhonda Elhosseiny (Telecopy No. 212-270-5135); 
  
 (iii) if to the Agent, to JPMorgan Chase Bank, N.A., Loan
and Agency Services Group, 1111 Fannin, 10th Floor, Houston, Texas 77002, Attention of Katie Rose (Telecopy
No. 713-750-2782), with a copy to JPMorgan Chase Bank, N.A., 270 Park Avenue, New York, New York 10017, Attention of Rhonda Elhosseiny (Telecopy No. 212-270-5135); and 
  
 (iv) if to any other Lender, to it at its address (or telecopy number) set forth in its Administrative
Questionnaire. 
  
 (b) Notices and other communications to the
Lenders hereunder may be delivered or furnished by electronic communications pursuant to procedures approved by the Administrative Agent; provided that the foregoing shall not apply to notices pursuant to Article II unless otherwise agreed by
the Administrative Agent and the applicable Lender. The Administrative Agent or the Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it;
provided that approval of such procedures may be limited to particular notices or communications. 
  
 (c) Any party hereto may change its address or telecopy number for notices and other communications hereunder by notice to the other parties hereto. All
notices and other communications given to any party hereto in accordance with the provisions of this Agreement shall be deemed to have been given on the date of receipt. 
  
 SECTION 9.02. Waivers; Amendments. (a) No failure or delay by the Agent, the Issuing Bank or any Lender in
exercising any right or power hereunder or under any other Loan Document shall operate as a waiver thereof, nor shall any single or 

  

 LifeCare Credit Agreement 
 109 

 
partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further
exercise thereof or the exercise of any other right or power. The rights and remedies of the Agent, the Issuing Bank and the Lenders hereunder and under the other Loan Documents are cumulative and are not exclusive of any rights or remedies that
they would otherwise have. No waiver of any provision of any Loan Document or consent to any departure by any Loan Party therefrom shall in any event be effective unless the same shall be permitted by paragraph (b) of this Section, and then
such waiver or consent shall be effective only in the specific instance and for the purpose for which given. Without limiting the generality of the foregoing, the making of a Loan or issuance of a Letter of Credit shall not be construed as a waiver
of any Default, regardless of whether the Agent, any Lender or the Issuing Bank may have had notice or knowledge of such Default at the time. 
  
 (b) Except as provided in Section 2.20 with respect to an Incremental Facility Amendment, neither this Agreement nor any other Loan Document nor any
provision hereof or thereof may be waived, amended or modified except, in the case of this Agreement, pursuant to an agreement or agreements in writing entered into by Holdings, the Borrower and the Required Lenders or, in the case of any other Loan
Document, pursuant to an agreement or agreements in writing entered into by the Agent and the Loan Party or Loan Parties that are parties thereto, in each case with the consent of the Required Lenders; provided that no such agreement shall
(i) increase the Commitment of any Lender without the written consent of such Lender, (ii) reduce or forgive the principal amount of any Loan or LC Disbursement held by any Lender or reduce the rate of interest thereon, or reduce any fees
payable hereunder, without the written consent of such Lender, (iii) postpone the final maturity of any Lender’s Loan, or any scheduled date of payment of the principal amount of any Lender’s Term Loan under Section 2.10, or the
required date of reimbursement of any LC Disbursement held by any Lender, or any date for the payment of any interest or fees payable to any Lender hereunder, or reduce or forgive the amount of, waive or excuse any such payment, or postpone the
scheduled date of expiration of any Commitment, without the written consent of such Lender, (iv) change Section 2.18(b) or (c) in a manner that would alter the pro rata sharing of payments required thereby or change the last sentence
of Section 2.08(d) in a manner which would alter the pro rata reduction of Commitments thereby, without the written consent of each Lender, (v) change any of the provisions of this Section or the definition of “Required Lenders”
or any other provision of any Loan Document specifying the number or percentage of Lenders (or Lenders of any Class) required to waive, amend or modify any rights thereunder or make any determination or grant any consent thereunder, without the
written consent of each Lender (or each Lender of such Class, as the case may be), (vi) release Holdings from its Guarantee under the Collateral Agreement or release a substantial portion of the Guarantees of the Subsidiary Loan Parties under
the Collateral Agreement (except as expressly provided therein), or limit its liability in respect of such Guarantee, without the written consent of each Lender, (vii) release all or substantially all of the Collateral from the Liens of the
Security Documents, without the written consent of each Lender, (viii) change any provisions of any Loan Document in a manner that by its terms adversely affects the rights in respect of payments due to Lenders holding Loans of any Class
differently than those holding 

  

 LifeCare Credit Agreement 
 110 

 
Loans of any other Class, without the written consent of Lenders holding a majority in interest of the outstanding Loans and unused Commitments of each
affected Class, (ix) change the order of application of any mandatory prepayment of Loans from the application thereof set forth in Section 2.11 without the written consent of Lenders holding a majority in interest of the outstanding Term
Loan and unused Commitments of each affected Class; (x) change the order of application of payments under Section 19 of the Collateral Agreement without the written consent of each affected Lender; or (xi) waive any conditions to the
making of any Revolving Advances without the written consent of Revolving Lenders holding a majority in interest of the Revolving Exposures and Revolving Commitments; provided, further that (A) no such agreement shall amend,
modify or otherwise affect the rights or duties of the Agent, the Issuing Bank or the Swingline Lender without the prior written consent of the Agent, the Issuing Bank or the Swingline Lender, as the case may be, and (B) any waiver, amendment
or modification of this Agreement that by its terms affects the rights or duties under this Agreement of the Revolving Lenders (but not the Term Lenders) or the Term Lenders (but not the Revolving Lenders) may be effected by an agreement or
agreements in writing entered into by Holdings, the Borrower and requisite percentage in interest of the affected Class of Lenders that would be required to consent thereto under this Section if such Class of Lenders were the only Class of Lenders
hereunder at the time. Notwithstanding the foregoing, any provision of this Agreement may be amended by an agreement in writing entered into by Holdings, the Borrower, the Required Lenders and the Agent (and, if their rights or obligations are
affected thereby, the Issuing Bank and the Swingline Lender) if (i) by the terms of such agreement the Commitment of each Lender not consenting to the amendment provided for therein shall terminate upon the effectiveness of such amendment and
(ii) at the time such amendment becomes effective, each Lender not consenting thereto receives payment in full of the principal of and interest accrued on each Loan made by it and all other amounts owing to it or accrued for its account under
this Agreement. 
  
 (c) If, in connection with any proposed
change, waiver, discharge or termination of or to any of the provisions of this Agreement as contemplated by clauses (i) through (xi), inclusive, of the first proviso to Section 9.02(b), the consent of Required Lenders at such time is
obtained but the consent of one or more of such other Lenders whose consent is required is not obtained, then the Borrower shall have the right, so long as all non-consenting Lenders whose individual consent is required are treated as described in
either clause (i) or (ii) below, to either (i) replace each such non-consenting Lender or Lenders (or, at the option of the Borrower if any such Lender’s consent is required with respect to less than all Classes of Loans
(or related Commitments), to replace only the Commitments and/or Loans of such non-consenting Lender that gave rise to the need to obtain such Lender’s individual consent) with one or more assignees pursuant to, and with the effect of an
assignment under, Section 2.19 so long as at the time of such replacement, each such assignee consents to the proposed change, waiver, discharge or termination or (ii) terminate such nonconsenting Lender’s Commitment (if such
Lender’s consent is required as a result of its Commitment) and/or repay each Class of outstanding Loans of such Lender that gave rise to the need to obtain such Lender’s consent and/or cash collateralize its LC Exposure, in accordance
with Section 2.05(j); provided (A) that, unless the Commitments that are terminated and Loans that are repaid 

  

 LifeCare Credit Agreement 
 111 

 
pursuant to the preceding clause (ii) are immediately replaced in full at such time through the addition of new Lenders or the increase of the
Commitments and/or outstanding Loans of existing Lenders (who in each case must specifically consent thereto), then in the case of any action pursuant to the preceding clause (ii), Required Lenders at such time (determined after giving effect
to the proposed action) shall specifically consent thereto and (B) any such replacement or termination transaction described above shall be effective on the date notice is given of the relevant transaction and shall have a settlement date no
earlier than five Business Days and no later than 90 days after the relevant transaction; provided further that the Borrower shall not have the right to replace a Lender, terminate its Commitment or repay its Loans solely as a
result of the exercise of such Lender’s rights (and the withholding of any required consent by such Lender) pursuant to the second proviso to Section 9.02(b). 
  
 (d) Without the consent of the Lenders or Issuing Banks, the Loan Parties and the Administrative Agent may (in their sole
discretion, or shall, to the extent required by any Loan Document) enter into any amendment, modification or waiver of any Loan Document, or enter into any new agreement or instrument, to effect the granting, perfection, protection, expansion or
enhancement of any security interest in any Collateral or additional property to become Collateral for the benefit of the Secured Parties, or as required by local law to give effect to, or protect, any security interest for the benefit of the
Secured Parties in any Collateral, or so that the security interests therein comply with applicable law. 
  
 (e) Notwithstanding the provisions of clause (b), this Agreement may be amended (or amended and restated) with the written consent of the Required
Lenders, the Administrative Agent, Holdings and the Borrower (i) to add one or more additional credit facilities to this Agreement and to permit the extensions of credit from time to time thereunder and the accrued interest and fees in respect
thereof to share ratably in the benefits of this Agreement and the other Loan Documents with the Term Loans and the Revolving Loans and the accrued interest and fees in respect thereof, and (ii) to include appropriately the Lenders holding such
credit facilities in any determination of the Required Lenders. In addition, this Agreement may be amended with the written consent of the Administrative Agent, Holdings, the Borrower and the Lenders providing the relevant Replacement Term Loans (as
defined below) to permit the refinancing of all outstanding Term Loans (the “Refinanced Term Loans”) with a replacement term loan tranche hereunder (the “Replacement Term Loans”); provided that (i) the
aggregate principal amount of such Replacement Term Loans shall not exceed the aggregate principal amount of such Refinanced Term Loans, (ii) the Applicable Rate for such Replacement Term Loans shall not be higher than the Applicable Rate for
such Refinanced Term Loans, (iii) the weighted average life to maturity of such Replacement Term Loans shall not be shorter than the weighted average life to maturity of such Refinanced Term Loans at the time of such refinancing (except to the
extent of nominal amortization for periods where amortization has been eliminated as a result of prepayment of the Term Loans) and (iv) all other terms applicable to such Replacement Term Loans shall be substantially identical to, or less
favorable to the Lenders providing such Replacement Term Loans than, those applicable to such Refinanced Term Loans, except to the extent necessary to provide for covenants and other terms applicable to any 

  

 LifeCare Credit Agreement 
 112 

 
period after the latest final maturity of the Term Loans in effect immediately prior to such refinancing. 
  
 SECTION 9.03. Expenses; Indemnity; Damage Waiver. (a) The
Borrower shall pay (i) all reasonable out-of-pocket expenses incurred by the Agent, the Arrangers and their Affiliates, including the reasonable fees, charges and disbursements of transaction and documentation counsel for the Agent and the
Arrangers and such other local counsel and special counsel as may be required in the reasonable judgment of the Agent and the Arrangers, in connection with the syndication of the credit facilities provided for herein, the preparation and
administration of the Loan Documents or any amendments, modifications or waivers of the provisions thereof (whether or not the transactions contemplated hereby or thereby shall be consummated), (ii) all reasonable out-of-pocket expenses
incurred by the Issuing Bank in connection with the issuance, amendment, renewal or extension of any Letter of Credit or any demand for payment thereunder and (iii) all reasonable out-of-pocket expenses incurred by the Agent, the Arrangers, the
Issuing Bank or any Lender (including the reasonable fees, charges and disbursements of transaction and documentation counsel for the Agent, the Arrangers, the Issuing Bank and any Lender and such other local counsel and special counsel as may be
required in the reasonable judgment of the Agent and the Arrangers) in connection with documentary Taxes or the enforcement or protection of its rights in connection with the Loan Documents, including its rights under this Section, or in connection
with the Loans made or Letters of Credit issued hereunder, including all such out-of-pocket expenses incurred during any workout, restructuring or negotiations in respect of such Loans or Letters of Credit. 
  
 (b) The Borrower shall indemnify the Agent, the Arrangers, the Issuing Bank
and each Lender, and each Related Party of any of the foregoing Persons (each such Person being called an “Indemnitee”) against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related
expenses, including the reasonable fees, charges and disbursements of counsel (including such other local counsel and special counsel as may be required in the reasonable judgment of the Agent and the Arrangers), incurred by or asserted against any
Indemnitee arising out of, in connection with, or as a result of (i) the execution or delivery of any Loan Document or any other agreement or instrument contemplated hereby, the performance by the parties to the Loan Documents of their
obligations thereunder or the consummation of the Transactions or any other transactions contemplated hereby, (ii) any Loan or Letter of Credit or the use of the proceeds therefrom (including any refusal by the Issuing Bank to honor a demand
for payment under a Letter of Credit if the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit), (iii) any actual or alleged presence or Release of Hazardous Materials on or from
any Mortgaged Property or any other property currently or formerly owned or operated by the Borrower or any of its Subsidiaries, or any Environmental Liability related in any way to any Mortgaged Property, the Borrower or any of its Subsidiaries, or
(iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory and regardless of whether instituted by any Loan Party or whether any Indemnitee
is a party thereto; provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or 

  

 LifeCare Credit Agreement 
 113 

 
related expenses are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from such Indemnitee’s breach
of its Obligations under the Loan Documents or from the gross negligence or willful misconduct of such Indemnitee. 
  
 (c) To the extent that the Borrower fails to pay any amount required to be paid by it to the Agent, the Issuing Bank or the Swingline Lender under
paragraph (a) or (b) of this Section and without limiting the Borrower’s obligation to do so, each Lender severally agrees to pay to the Agent, and each Revolving Lender agrees to pay to the Issuing Bank or the Swingline Lender, as
the case may be, such Lender’s pro rata share (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount; provided that the unreimbursed expense or indemnified loss, claim,
damage, liability or related expense, as the case may be, was incurred by or asserted against the Agent, the Issuing Bank or the Swingline Lender in its capacity as such. For purposes hereof, a Lender’s “pro rata share” with respect
to payments to the Agent shall be determined based upon its share of the sum of the total Revolving Exposures, outstanding Term Loans and unused Commitments at the time, and a Revolving Lender’s “pro rata share” with respect to
payments to the Issuing Bank or Swingline Lender shall be determined based upon its share of the sum of the total Revolving Exposures and unused Commitments at the time. 
  
 (d) To the extent permitted by applicable law, neither Holdings nor the Borrower shall assert, and each hereby waives, any
claim against any Indemnitee, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement or any agreement or
instrument contemplated hereby, the Transactions, any Loan or Letter of Credit or the use of the proceeds thereof. 
  
 (e) All amounts due under this Section shall be payable not later than 10 days after written demand therefor accompanied by reasonable documentation
with respect to any reimbursement, indemnification or other amount requested. 
  
 SECTION 9.04. Successors and Assigns. (a) The provisions of this Agreement shall be binding upon and inure to the benefit of each of the parties hereto and its successors and assigns permitted hereby
(including any Affiliate of the Issuing Bank that issues any Letter of Credit), except that (i) the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of each Lender (and
any attempted assignment or transfer by the Borrower without such consent shall be null and void) and (ii) no Lender may assign or otherwise transfer its rights or obligations hereunder except in accordance with this Section. Nothing in this
Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their successors and assigns permitted hereby (including any Affiliate of the Issuing Bank that issues any Letter of Credit), Participants
(to the extent provided in paragraph (c) of this Section) and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent, the Issuing Bank and the Lenders) any legal or equitable right, remedy or claim
under or by reason of this Agreement. 
  

 LifeCare Credit Agreement 
 114 

 (b) (i) Subject to the conditions set forth in paragraph (b)(ii) below, any Lender may assign to one
or more assignees all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans at the time owing to it), with the prior written consent (such consent not to be unreasonably withheld
or delayed) of: 
  
 (A) the Borrower,
provided that no consent of the Borrower shall be required (x) for an assignment by a Revolving Lender to an existing Revolving Lender, an Affiliate of an existing Revolving Lender or an Approved Fund (as defined below) of a Revolving
Lender or an assignment of Term Loans to a Lender, an Affiliate of a Lender or an Approved Fund of a Lender or, (y) if an Event of Default under clause (a), (b), (h) or (i) of Article VII has occurred and is continuing, to
any assignee; and 
  
 (B) the Administrative
Agent (and, in the case of an assignment of all or a portion of any Lender’s obligations in respect of its Revolving Commitment (or its LC Exposure or Swingline Exposure in connection therewith), the Issuing Bank and the Swingline Lender),
provided that no consent of the Administrative Agent, Issuing Bank or Swingline Lender, as the case may be, shall be required (x) for an assignment of Revolving Loans to an assignee that is a Revolving Lender immediately prior to giving
effect to such assignment or (y) for an assignment of Term Loans to an assignee that is a Lender immediately prior to giving effect to such assignment, an Affiliate of such a Lender or an Approved Fund with respect to such a Lender. 

 
 (ii) Assignments shall be subject to the following conditions: 

 
 (A) except in the case of an assignment to a Lender, an
Affiliate of a Lender or an Approved Fund or an assignment of the entire remaining amount of the assigning Lender’s Commitment, the amount of the Commitment of the assigning Lender subject to each such assignment (determined as of the date the
Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent) shall not be less than $5,000,000 in the case of assignments of Revolving Commitments or Revolving Loans, and $1,000,000 in the case of assignments
of Term Loans, unless each of the Borrower and the Administrative Agent otherwise consent, provided that no such consent of the Borrower shall be required if an Event of Default under clause (a), (b), (h) or (i) of Article VII
has occurred and is continuing; provided, further that simultaneous assignments to or by related Approved Funds shall be treated as one assignment for purposes of the minimum assignment requirement. 
  
 (B) each partial assignment shall be made as an assignment
of a proportionate part of all the assigning Lender’s rights and obligations under this Agreement, provided that this clause shall not be construed to prohibit the assignment of a proportionate part of all the assigning Lender’s
rights and obligations in respect of one Class of Commitments or Loans; 
  

 LifeCare Credit Agreement 
 115 

 (C) the parties to each assignment shall execute and deliver to the Administrative Agent
an Assignment and Assumption, together with a processing and recordation fee of $3,500 (it being understood that only a single processing and recordation fee of $3,500 will be payable with respect to any multiple assignments to a Lender, an
Affiliate of a Lender or an Approved Fund pursuant to clause (ii)(A) above that are simultaneously consummated); and 
  
 (D) the assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire. 
  
 For purposes of this Section 9.04(b), the term “Approved Fund”
has the following meaning: 
  
 “Approved Fund”
means any Person (other than an natural person) that is engaged in making, purchasing, holding or investing in bank loans and similar extensions of credit in the ordinary course and that is administered or managed by (a) a Lender, (b) an
Affiliate of a Lender or (c) any entity or an Affiliate of an entity that administers or manages a Lender. 
  
 (iii) Subject to acceptance and recording thereof pursuant to paragraph (b)(iv) of this Section, from and after the effective date specified in each
Assignment and Assumption the assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender
thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender’s rights
and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 2.15, 2.16, 2.17 and 9.03). Any assignment or transfer by a Lender of rights or obligations under
this Agreement that does not comply with this Section 9.04 shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (c) of this Section.

  
 (iv) The Administrative Agent, acting for this purpose as an
agent of the Borrower, shall maintain at one of its offices a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitment of, and principal amount of the
Loans and LC Disbursements owing to, each Lender pursuant to the terms hereof from time to time, which register shall indicate that each lender is entitled to interest paid with respect to such Loans and LC Disbursements (the
“Register”). The entries in the Register shall be conclusive absent manifest error, and the Borrower, the Administrative Agent, the Issuing Bank and the Lenders may treat each Person whose name is recorded in the Register pursuant
to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection by the Borrower, the Issuing Bank and any Lender, at any reasonable time and from
time to time upon reasonable prior notice. 
  

 LifeCare Credit Agreement 
 116 

 (v) Upon its receipt of a duly completed Assignment and Assumption executed by an assigning Lender and an
assignee, the assignee’s completed Administrative Questionnaire (unless the assignee shall already be a Lender hereunder), the processing and recordation fee referred to in paragraph (b) of this Section 9.04 and any written consent to
such assignment required by paragraph (b) of this Section 9.04, the Administrative Agent shall accept such Assignment and Assumption and record the information contained therein in the Register. No assignment shall be effective for
purposes of this Agreement unless it has been recorded in the Register as provided in this paragraph. 
  
 (vi) Anything in this Section 9.04 to the contrary notwithstanding, any Lender may at any time, without the consent of the Borrower or the
Administrative Agent, assign and pledge all or any portion of its Commitments and the Loans owing to it to any Federal Reserve Bank (and its transferees) as collateral security pursuant to Regulation A of the Board and any Operating Circular issued
by such Federal Reserve Bank. No such assignment shall release the assigning Lender from its obligations hereunder. 
  
 (c) (i) Any Lender may, without the consent of, or notice to, the Borrower, the Administrative Agent, the Issuing Bank or the Swingline Lender, sell
participations to one or more banks or other entities (a “Participant”) in all or a portion of such Lender’s rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans owing to it);
provided that (A) such Lender’s obligations under this Agreement shall remain unchanged, (B) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (C) the
Borrower, the Administrative Agent, the Issuing Bank and the other Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement. Any agreement or instrument
pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement; provided that
such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver described in the first proviso to Section 9.02(b) that affects such Participant. Subject
to paragraph (c)(ii) of this Section, the Borrower agrees that each Participant shall be entitled to the benefits of Sections 2.15, 2.16 and 2.17 to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to
paragraph (b) of this Section. To the extent permitted by law, each Participant also shall be entitled to the benefits of Section 9.08 as though it were a Lender, provided such Participant agrees to be subject to Section 2.18(c) as
though it were a Lender. 
  
 (ii) A Participant shall not be
entitled to receive any greater payment under Section 2.15 or 2.17 than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such
Participant is made with the Borrower’s prior written consent. A Participant shall not be entitled to the benefits of Section 2.17 unless the Borrower is 

  

 LifeCare Credit Agreement 
 117 

 
notified of the participation sold to such Participant and such Participant agrees, for the benefit of the Borrower, to comply with Section 2.17(e) as
though it were a Lender. 
  
 (d) Any Lender may, without the
consent of the Borrower or the Administrative Agent, at any time pledge or assign a security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, and this Section shall not apply to any such pledge
or assignment of a security interest; provided that no such pledge or assignment of a security interest shall release a Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.

  
 (e) If the Borrower wishes to replace the Loans or Commitments
under any facility with ones having different terms, it shall have the option, with the consent of the Administrative Agent and subject to at least three Business Days’ advance notice to the Lenders under such facility, instead of prepaying the
Loans or reducing or terminating the Commitments to be replaced, to (i) require the Lenders under such facility to assign such Loans or Commitments to the Administrative Agent or its designees and (ii) amend the terms thereof in accordance
with Section 9.02 (with such replacement, if applicable, being deemed to have been made pursuant to Section 9.02(e)). Pursuant to any such assignment, all Loans and Commitments to be replaced shall be purchased at par (allocated among the
Lenders under such facility in the same manner as would be required if such Loans were being optionally prepaid or such Commitments were being optionally reduced or terminated by the Borrower), accompanied by payment of any accrued interest and fees
thereon and any amounts owing pursuant to Section 9.03(b). By receiving such purchase price, the Lenders under such facility shall automatically be deemed to have assigned the Loans or Commitments under such facility pursuant to the terms of
the form of Assignment and Acceptance attached hereto as Exhibit A, and accordingly no other action by such Lenders shall be required in connection therewith. The provisions of this paragraph (e) are intended to facilitate the maintenance
of the perfection and priority of existing security interests in the Collateral during any such replacement. 
  
 SECTION 9.05. Survival. All covenants, agreements, representations and warranties made by the Loan Parties in the Loan Documents and in the
certificates or other instruments delivered in connection with or pursuant to this Agreement or any other Loan Document shall be considered to have been relied upon by the other parties hereto and shall survive the execution and delivery of the Loan
Documents and the making of any Loans and issuance of any Letters of Credit, regardless of any investigation made by any such other party or on its behalf and notwithstanding that the Administrative Agent, the Issuing Bank or any Lender may have had
notice or knowledge of any Default or incorrect representation or warranty at the time any credit is extended hereunder, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any fee or any
other amount payable under this Agreement is outstanding and unpaid or any Letter of Credit is outstanding (unless the obligations owing to the Issuing Bank in respect of such Letter of Credit are secured by cash collateral or another letter of
credit in either case on terms reasonably acceptable to such Issuing Bank and the Revolving Lenders) and so long as the Commitments have not expired or terminated. 
  

 LifeCare Credit Agreement 
 118 

 
The provisions of Sections 2.15, 2.16, 2.17 and 9.03 and Article VIII shall survive and remain in full force and effect regardless of the consummation
of the transactions contemplated hereby, the repayment of the Loans, the expiration or termination of the Letters of Credit and the Commitments or the termination of this Agreement or any provision hereof. 
  
 SECTION 9.06. Counterparts; Integration; Effectiveness. This Agreement
may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement, the other Loan
Documents and any separate letter agreements with respect to fees payable to the Administrative Agent constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and
understandings, oral or written, relating to the subject matter hereof. Except as provided in Section 4.01, this Agreement shall become effective when it shall have been executed by the Administrative Agent and when the Administrative Agent
shall have received counterparts hereof which, when taken together, bear the signatures of each of the other parties hereto, and thereafter shall be binding upon and inure to the benefit of the parties hereto and their respective successors and
assigns. Delivery of an executed counterpart of a signature page of this Agreement by telecopy or electronic transmission shall be effective as delivery of a manually executed counterpart of this Agreement. 
  
 SECTION 9.07. Severability. Any provision of this Agreement held to be
invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining
provisions hereof; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction. 
  
 SECTION 9.08. Right of Setoff. If an Event of Default shall have occurred and be continuing, each Lender is hereby authorized at any time and from
time to time, to the fullest extent permitted by law, to set off and apply any and all deposits (general or special, time or demand, provisional or final) at any time held and other obligations at any time owing by such Lender to or for the credit
or the account of the Borrower against any of and all the obligations of the Borrower now or hereafter existing under this Agreement held by such Lender, irrespective of whether or not such Lender shall have made any demand under this Agreement and
although such obligations may be unmatured. The applicable Lender shall notify the Borrower and the Administrative Agent of such setoff or application, provided, that any failure to give or any delay in giving such notice shall not affect the
validity of any such setoff or application under this Section. The rights of each Lender under this Section are in addition to other rights and remedies (including other rights of setoff) which such Lender may have. 
  
 SECTION 9.09. Governing Law; Jurisdiction; Consent to Service of
Process. (a) This Agreement shall be construed in accordance with and governed by the law of the State of New York. 
  

 LifeCare Credit Agreement 
 119 

 (b) Each of Holdings and the Borrower hereby irrevocably and unconditionally submits, for itself and its
property, to the nonexclusive jurisdiction of the Supreme Court of the State of New York sitting in New York County and of the United States District Court of the Southern District of New York, and any appellate court from any thereof, in any action
or proceeding arising out of or relating to any Loan Document, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or
proceeding may be heard and determined in such New York State or, to the extent permitted by law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be
enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this Agreement or any other Loan Document shall affect any right that the Agent, the Issuing Bank or any Lender may otherwise have to bring
any action or proceeding relating to this Agreement or any other Loan Document against Holdings, the Borrower or its properties in the courts of any jurisdiction. 
  
 (c) Each of Holdings and the Borrower hereby irrevocably and unconditionally waives, to the fullest extent it may legally
and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or any other Loan Document in any court referred to in paragraph
(b) of this Section. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court. 
  
 (d) Each party to this Agreement irrevocably consents to service of process
in the manner provided for notices in Section 9.01. Nothing in this Agreement or any other Loan Document will affect the right of any party to this Agreement to serve process in any other manner permitted by law. 
  
 SECTION 9.10. WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES,
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY
(WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. 

 
 SECTION 9.11. Headings. Article and Section headings and the Table
of Contents used herein are for convenience of reference only, are not part of this 

  

 LifeCare Credit Agreement 
 120 

 
Agreement and shall not affect the construction of, or be taken into consideration in interpreting, this Agreement. 
  
 SECTION 9.12. Confidentiality. Each of the Agent, the Issuing Bank and
the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a) to its and its Affiliates’ directors, officers, trustees, employees and agents, including accountants,
legal counsel and other advisors (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b) to the extent
requested by any regulatory authority, (c) to the extent required by applicable laws or regulations or by any subpoena or similar legal process, (d) to any other party to this Agreement, (e) in connection with the exercise of any
remedies hereunder or any suit, action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (f) subject to an agreement containing provisions substantially the same as those
of this Section, to (i) to any pledgee under Section 9.04(d) or any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or (ii) any actual or
prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower and its obligations, (g) with the consent of the Borrower or (h) to the extent such Information (i) becomes publicly available
other than as a result of a breach of this Section or (ii) becomes available to the Agent, the Issuing Bank or any Lender on a nonconfidential basis from a source other than Holdings or the Borrower. For the purposes of this Section,
“Information” means all information received from Holdings or the Borrower relating to Holdings or the Borrower or its business, other than any such information that is available to the Agent, the Issuing Bank or any Lender on a
nonconfidential basis prior to disclosure by Holdings or the Borrower; provided that, in the case of information received from Holdings or the Borrower after the date hereof, such information is clearly identified at the time of delivery as
confidential. Any Person required to maintain the confidentiality of Information as provided in this Section shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the
confidentiality of such Information as such Person would accord to its own confidential information. 
  
 SECTION 9.13. Interest Rate Limitation. Notwithstanding anything herein to the contrary, if at any time the interest rate applicable to any Loan,
together with all fees, charges and other amounts which are treated as interest on such Loan under applicable law (collectively the “Charges”), shall exceed the maximum lawful rate (the “Maximum Rate”) which may be
contracted for, charged, taken, received or reserved by the Lender holding such Loan in accordance with applicable law, the rate of interest payable in respect of such Loan hereunder, together with all Charges payable in respect thereof, shall be
limited to the Maximum Rate and, to the extent lawful, the interest and Charges that would have been payable in respect of such Loan but were not payable as a result of the operation of this Section shall be cumulated and the interest and Charges
payable to such Lender in respect of other Loans or periods shall be increased (but not above the Maximum Rate therefor) until such cumulated amount, together with interest thereon at the Federal Funds Effective Rate to the date of repayment, shall
have been received by such Lender. 
  

 LifeCare Credit Agreement 
 121 

 SECTION 9.14. Termination or Release. (a) At such time as the Loans, the Borrower’s
obligations to reimburse the Issuing Bank pursuant to Section 2.05(e) for LC Disbursements, all accrued interest and fees under this Agreement, and all other obligations under the Loan Documents (other than (i) obligations under
Sections 2.15, 2.17 and 9.03 that are not then due and payable and (ii) obligations in respect of outstanding Letters of Credit) shall have been paid in full in cash, the Commitments have been terminated and all Letters of Credit shall
have been discharged or cash collateralized to the reasonable satisfaction of the Agent and Issuing Bank (each of which shall have confirmed such satisfaction by written notice to the Borrower), the Collateral shall be released from the Liens
created by the Security Documents, and the obligations (other than those expressly stated to survive termination) of the Agent and each Loan Party under the Security Documents shall terminate, all without delivery of any instrument or performance of
any act by any Person. 
  
 (b) A Subsidiary Loan Party shall
automatically be released from its obligations under the Collateral Agreement and the security interests in the Collateral of such Subsidiary Loan Party shall be automatically released upon the consummation of any transaction permitted by this
Agreement as a result of which such Subsidiary Loan Party ceases to be a Subsidiary of the Borrower or is designated an Unrestricted Subsidiary. 
  
 (c) Upon any sale or other transfer by any Loan Party of any Collateral that is permitted under this Agreement to any Person that is not a Loan Party, or
upon the effectiveness of any written consent to the release of the security interest granted by the Collateral Agreement in any Collateral pursuant to Section 9.02 of this Agreement, the security interest in such Collateral shall be
automatically released. 
  
 (d) In connection with any termination
or release pursuant to paragraph (a), (b) or (c) of this Section 9.14, the Collateral Agent shall execute and deliver to any Loan Party at such Loan Party’s expense all documents that such Loan Party shall reasonably request
to evidence such termination or release. Any execution and delivery of documents pursuant to this Section 9.14 shall be without recourse to or warranty by the Collateral Agent or any Lender. 
  
 SECTION 9.15. USA Patriot Act. Each Lender that is subject to the
requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the “Patriot Act”) hereby notifies Borrower that pursuant to the requirements of the Patriot Act, it is required to
obtain, verify and record information that identifies the Borrower, which information includes the name and address of the Borrower and other information that will allow such Lender to identify the Borrower in accordance with the Patriot Act.

  

 LifeCare Credit Agreement 
 122 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective
authorized officers as of the day and year first above written. 
  

			
	RAINIER ACQUISITION CORP.,
		
	by	 	 
	 	 	 Name:

	 	 	 Title:

	
	LCI HOLDCO, LLC,
		
	by	 	 
	 	 	 Name:

	 	 	 Title:

  

 LifeCare Credit Agreement 
 123 

			
	JPMORGAN CHASE BANK, N.A., individually and as Administrative Agent,
		
	by	 	 
	 	 	 Name:

	 	 	 Title:

  

 LifeCare Credit Agreement 
 124 

			
	 SIGNATURE PAGE TO THE CREDIT AGREEMENT AMONG RAINIER ACQUISITION CORP., LCI HOLDCO, LLC, THE LENDERS PARTY THERETO AND JPMORGAN CHASE BANK, N.A., AS
ADMINISTRATIVE AGENT

		
	Name of Lender:	 	 

			
		
	by	 	 
	 	 	 Name:

	 	 	 Title:

  

 LifeCare Credit AgreementSecurity Agreement dated as of August 11, 2005

 Exhibit 10.17 
  
 EXHIBIT C 
  
 SECURITY AGREEMENT 
  
 Dated August 11, 2005 
  
 From 
  
 The
Grantors referred to herein  
  
 as Grantors 

  
 to 
  
 JPMORGAN CHASE BANK, N.A.  
  
 as Collateral Agent 

 Project Trinity Security Agreement 

 TABLE OF CONTENTS 
  

					
	 Section

	  	 	  	Page

			
	Section 1.	  	Grant of Security	  	2
			
	Section 2.	  	Security for Obligations	  	6
			
	Section 3.	  	Grantors Remain Liable	  	7
			
	Section 4.	  	Delivery and Control of Security Collateral	  	7
			
	Section 5.	  	Representations and Warranties	  	8
			
	Section 6.	  	Further Assurances	  	12
			
	Section 7.	  	As to Equipment	  	13
			
	Section 8.	  	Insurance	  	13
			
	Section 9.	  	Post-Closing Changes; Collections on Assigned Agreements, Receivables and Related Contracts	  	14
			
	Section 10.	  	As to Intellectual Property Collateral	  	15
			
	Section 11.	  	Voting Rights; Dividends; Etc.	  	16
			
	Section 12.	  	As to the Assigned Agreements	  	17
			
	Section 13.	  	As to Letter-of-Credit Rights	  	18
			
	Section 14.	  	Commercial Tort Claims	  	18
			
	Section 15.	  	Transfers and Other Liens; Additional Shares	  	18
			
	Section 16.	  	Collateral Agent Appointed Attorney in Fact	  	19
			
	Section 17.	  	Collateral Agent May Perform	  	19
			
	Section 18.	  	The Collateral Agent’s Duties	  	19
			
	Section 19.	  	Remedies	  	20
			
	Section 20.	  	Indemnity and Expenses	  	22
			
	Section 21.	  	Amendments; Waivers; Additional Grantors; Etc.	  	23
			
	Section 22.	  	Notices, Etc.	  	23
			
	Section 23.	  	Continuing Security Interest; Assignments under the Credit Agreement	  	24
			
	Section 24.	  	Release; Termination	  	24

  

 Project Trinity Security Agreement 
 i 

					
			
	Section 25.	  	Execution in Counterparts	  	25
			
	Section 26.	  	Governing Law	  	25

  

					
	Schedules	  	 	  	 
			
	Schedule I	  	-	  	Investment Property
	Schedule II	  	-	  	Pledged Deposit Accounts
	Schedule III	  	-	  	[Reserved]
	Schedule IV	  	-	  	Intellectual Property
	Schedule V	  	-	  	Commercial Tort Claims
	Schedule VI	  	-	  	[Reserved]
	Schedule VII	  	-	  	Location, Chief Executive Office, Type of Organization, Jurisdiction of Organization and Organizational Identification Number
	Schedule VIII	  	-	  	Changes in Name, Location, Etc.
	Schedule IX	  	-	  	Locations of Equipment and Inventory
	Schedule X	  	-	  	Letters of Credit
			
	Exhibits	  	 	  	 
			
	Exhibit A	  	-	  	[Reserved]
	Exhibit B	  	-	  	Form of Intellectual Property Security Agreement
	Exhibit C	  	-	  	Form of Intellectual Property Security Agreement Supplement
	Exhibit D	  	-	  	Form of Security Agreement Supplement

  

 Project Trinity Security Agreement 
 ii 

 SECURITY AGREEMENT 
  
 SECURITY AGREEMENT dated August 11, 2005 made by Rainier Acquisition Corp., a Delaware corporation (the
“Borrower”) and the other Persons listed on the signature pages hereof (the Borrower and the Persons so listed being, collectively, the “Grantors”), to JPMorgan Chase Bank, N.A., as collateral agent
(together with any successor collateral agent appointed pursuant to Article VIII of the Credit Agreement (as hereinafter defined), the “Collateral Agent”) for the Agents, the Lenders, the Issuing Bank, the Hedge Banks and the
Cash Management Banks (as defined in Section 2 hereof) (collectively, the “Secured Parties”). 
  
 PRELIMINARY STATEMENTS 
  
 (1) The Borrower has entered into a Credit Agreement dated as of August 11, 2005 (said Agreement, as it may hereafter be amended, amended and
restated, supplemented or otherwise modified from time to time, being the “Credit Agreement”) with LCI Holdco, LLC, a Delaware limited liability company, certain Lenders party thereto, JPMorgan Chase Bank, N.A., as Collateral
Agent and Administrative Agent for such Lenders, J. P. Morgan Securities Inc. and GECC Capital Markets Group, Inc., as Joint Lead Arrangers and Joint Bookrunning Managers, General Electric Capital Corporation, as Syndication Agent and Banc of
America Securities Inc., as Documentation Agent (each as defined therein). 
  
 (2) Each Grantor is the owner of the shares of stock or other Equity Interests (the “Initial Pledged Equity”) set forth opposite such Grantor’s name on and as otherwise described in Part I
of Schedule I hereto and issued by the Persons named therein and of the indebtedness (the “Initial Pledged Debt”) set forth opposite such Grantor’s name on and as otherwise described in Part II of Schedule I hereto and
issued by the obligors named therein. 
  
 (3) It is a condition
precedent to the making of Loans and the issuance of Letters of Credit by the Lenders under the Credit Agreement and the entry into Secured Hedge Agreements by the Hedge Banks from time to time that the Grantors shall have granted the security
interest contemplated by this Agreement. Each Grantor will derive substantial direct and indirect benefit from the transactions contemplated by the Loan Documents. 
  
 (4) Terms defined in the Credit Agreement and not otherwise defined in this Agreement are used in this Agreement as defined
in the Credit Agreement. Further, unless otherwise defined in this Agreement or in the Credit Agreement, terms defined in Article 8 or 9 of the UCC (as defined below) are used in this Agreement as such terms are defined in such Article 8 or 9.
“UCC” means the Uniform Commercial Code as in effect from time to time in the State of New York; provided that, if perfection or the effect of perfection or non perfection or the priority of the security interest in
any Collateral is governed by the Uniform Commercial Code as in effect in a jurisdiction other than the State of New York, “UCC” means the Uniform Commercial Code as in effect from time to time in such other jurisdiction for
purposes of the provisions hereof relating to such perfection, effect of perfection or non perfection or priority. 
  
 NOW, THEREFORE, in consideration of the premises and in order to induce the Lenders to make Loans and issue Letters of Credit under the Credit Agreement
and to induce the 

  

 Project Trinity Security Agreement 

 
Hedge Banks to enter into Secured Hedge Agreements from time to time, each Grantor hereby agrees with the Collateral Agent for the ratable benefit of the
Secured Parties as follows: 
  
 Section 1. Grant of
Security. Each Grantor hereby grants to the Collateral Agent, for the ratable benefit of the Secured Parties, a security interest in such Grantor’s right, title and interest in and to the following, in each case, as to each type of property
described below, whether now owned or hereafter acquired by such Grantor, wherever located, and whether now or hereafter existing or arising (collectively, the “Collateral”): 
  
 (a) all equipment in all of its forms, including, without
limitation, all machinery, tools, motor vehicles, vessels, aircraft, furniture and fixtures, and all parts thereof and all accessions thereto, including, without limitation, computer programs and supporting information that constitute equipment
within the meaning of the UCC (any and all such property being the “Equipment”); 
  
 (b) all inventory in all of its forms, including, without limitation, (i) all raw materials, work in process, finished goods and
materials used or consumed in the manufacture, production, preparation or shipping thereof, (ii) goods in which such Grantor has an interest in mass or a joint or other interest or right of any kind (including, without limitation, goods in
which such Grantor has an interest or right as consignee) and (iii) goods that are returned to or repossessed or stopped in transit by such Grantor, and all accessions thereto and products thereof and documents therefor, including, without
limitation, computer programs and supporting information that constitute inventory within the meaning of the UCC (any and all such property being the “Inventory”); 
  
 (c) all accounts (including, without limitation,
health-care-insurance receivables), chattel paper (including, without limitation, tangible chattel paper and electronic chattel paper), instruments (including, without limitation, promissory notes), deposit accounts, letter-of-credit rights, general
intangibles (including, without limitation, payment intangibles) and other obligations of any kind, whether or not arising out of or in connection with the sale or lease of goods or the rendering of services and whether or not earned by performance,
and all rights now or hereafter existing in and to all supporting obligations and in and to all security agreements, mortgages, Liens, leases, letters of credit and other contracts securing or otherwise relating to the foregoing property (any and
all of such accounts, chattel paper, instruments, deposit accounts, letter-of-credit rights, general intangibles and other obligations, to the extent not referred to in clause (d), (e) or (f) below, being the
“Receivables,” and any and all such supporting obligations, security agreements, mortgages, Liens, leases, letters of credit and other contracts being the “Related Contracts”); 
  
 (d) the following (the “Security
Collateral”): 
  
 (i) the Initial
Pledged Equity and the certificates, if any, representing the Initial Pledged Equity, and all dividends, distributions, return of capital, cash, instruments and other property from time to time received, receivable or otherwise distributed in
respect of or in exchange for any or all of the Initial Pledged Equity and all warrants, rights or options issued thereon or with respect thereto; 
  

 Project Trinity Security Agreement 
 2 

 (ii) the Initial Pledged Debt and the instruments, if any, evidencing the Initial Pledged
Debt, and all interest, cash, instruments and other property from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of the Initial Pledged Debt; 
  
 (iii) all additional shares of stock and other Equity
Interests from time to time acquired by such Grantor in any manner (such shares and other Equity Interests, together with the Initial Pledged Equity, being the “Pledged Equity”), and the certificates, if any, representing
such additional shares or other Equity Interests, and all dividends, distributions, return of capital, cash, instruments and other property from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all
of such shares or other Equity Interests and all warrants, rights or options issued thereon or with respect thereto; provided that, notwithstanding anything contained herein to the contrary, such Grantor shall not be required to pledge, and
the terms “Pledged Equity” and “Security Collateral” used in this Agreement shall not include, any Equity Interests in any Foreign Subsidiary acquired, owned, or otherwise held by such Grantor, in each
case, that, when aggregated with all of the other shares of stock in such Foreign Subsidiary pledged by such Grantor, would result in more than 66% of the shares of stock in such Foreign Subsidiary entitled to vote (within the meaning of Treasury
Regulation Section 1.956-2(c)(2) promulgated under the Code) (the “Voting Foreign Stock”) being pledged to the Collateral Agent for the benefit of the Secured Parties under this Agreement; provided, further
that all of the shares of stock or units or other Equity Interests in such Foreign Subsidiary not entitled to vote (within the meaning of Treasury Regulation Section 1.956-2(c)(2) promulgated under the Code (the “Non-Voting Foreign
Stock”) shall be pledged by such Grantor; 
  
 (iv) all additional indebtedness from time to time owed to such Grantor (such indebtedness, together with the Initial Pledged Debt, being the “Pledged Debt”) and the instruments, if any, evidencing such indebtedness,
and all interest, cash, instruments and other property from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of such indebtedness; and 
  
 (v) all other investment property (including, without
limitation, all (A) securities, whether certificated or uncertificated, (B) security entitlements, (C) securities accounts, (D) commodity contracts and (E) commodity accounts) in which such Grantor has now, or acquires from
time to time hereafter, any right, title or interest in any manner, and the certificates or instruments, if any, representing or evidencing such investment property, and all dividends, distributions, return of capital, interest, cash, instruments
and other property from time to time received, receivable or otherwise distributed in respect of or in 

  

 Project Trinity Security Agreement 
 3 

 
exchange for any or all of such investment property and all warrants, rights or options issued thereon or with respect thereto; 
  
 (e) each Hedge Agreement to which such Grantor is now or may
hereafter become a party, as such agreements may be amended, amended and restated, supplemented or otherwise modified from time to time (collectively, the “Assigned Agreements”), including, without limitation, (i) all
rights of such Grantor to receive moneys due and to become due under or pursuant to the Assigned Agreements, (ii) all rights of such Grantor to receive proceeds of any insurance, indemnity, warranty or guaranty with respect to the Assigned
Agreements, (iii) claims of such Grantor for damages arising out of or for breach of or default under the Assigned Agreements and (iv) the right of such Grantor to terminate the Assigned Agreements, to perform thereunder and to compel
performance and otherwise exercise all remedies thereunder (all such Collateral being the “Agreement Collateral”); 
  
 (f) the following (collectively, the “Account Collateral”): 
  
 (i) all deposit accounts, including the deposit accounts
listed on Schedule II hereto (collectively, the “Pledged Deposit Accounts”) and all funds and financial assets from time to time credited thereto (including, without limitation, all cash equivalents), and all certificates and
instruments, if any, from time to time representing or evidencing the Pledged Deposit Accounts; 
  
 (ii) all promissory notes, certificates of deposit, checks and other instruments from time to time delivered to or otherwise possessed by
the Collateral Agent for or on behalf of such Grantor in substitution for or in addition to any or all of the then existing Account Collateral; and 
  
 (iii) all interest, dividends, distributions, cash, instruments and other property from time to time received, receivable or otherwise
distributed in respect of or in exchange for any or all of the then existing Account Collateral; and 
  
 (g) the following (collectively, the “Intellectual Property Collateral”): 
  
 (i) all patents, patent applications, utility models and
statutory invention registrations, all inventions claimed or disclosed therein and all improvements thereto (“Patents”); 
  
 (ii) all trademarks, service marks, domain names, trade dress, logos, designs, slogans, trade names, business names, corporate names and
other source identifiers, whether registered or unregistered (provided that no security interest shall be granted in United States intent-to-use trademark applications to the extent that, and solely during the period in which, the grant of a
security interest therein would impair the validity or enforceability of such intent-to-use trademark applications under applicable federal law), together, in each case, with the goodwill symbolized thereby (“Trademarks”);

  

 Project Trinity Security Agreement 
 4 

 (iii) all copyrights, including, without limitation, copyrights in Computer Software (as
hereinafter defined), internet web sites and the content thereof, whether registered or unregistered (“Copyrights”); 
  
 (iv) all computer software, programs and databases (including, without limitation, source code, object code and all related applications
and data files), firmware and documentation and materials relating thereto, together with any and all maintenance rights, service rights, programming rights, hosting rights, test rights, improvement rights, renewal rights and indemnification rights
and any substitutions, replacements, improvements, error corrections, updates and new versions of any of the foregoing (“Computer Software”); 
  
 (v) all confidential and proprietary information, including, without limitation, know-how, trade secrets,
manufacturing and production processes and techniques, inventions, research and development information, databases and data, including, without limitation, technical data, financial, marketing and business data, pricing and cost information,
business and marketing plans and customer and supplier lists and information (collectively, “Trade Secrets”), and all other intellectual, industrial and intangible property of any type, including, without limitation,
industrial designs and mask works; 
  
 (vi) all
registrations and applications for registration for any of the foregoing, including, without limitation, those registrations and applications for registration set forth in Schedule IV hereto, together with all reissues, divisions, continuations,
continuations-in-part, extensions, renewals and reexaminations thereof; 
  
 (vii) all tangible embodiments of the foregoing, all rights in the foregoing provided by international treaties or conventions, all rights corresponding thereto throughout the world and all other rights of any kind
whatsoever of such Grantor accruing thereunder or pertaining thereto; 
  
 (viii) all agreements, permits, consents, orders and franchises relating to the license, development, use or disclosure of any of the foregoing to which such Grantor, now or hereafter, is a party or a beneficiary,
including, without limitation, the agreements set forth in Schedule IV hereto (“IP Agreements”); and 
  
 (ix) any and all claims for damages and injunctive relief for past, present and future infringement, dilution, misappropriation,
violation, misuse or breach with respect to any of the foregoing, with the right, but not the obligation, to sue for and collect, or otherwise recover, such damages; 
  
 (h) the commercial tort claims described in Schedule V hereto (together with any commercial tort claims as
to which the Grantors have complied with the requirements of Section 14, the “Commercial Tort Claims Collateral”); 
  

 Project Trinity Security Agreement 
 5 

 (i) all books and records (including, without limitation, customer lists, credit files,
printouts and other computer output materials and records) of such Grantor pertaining to any of the Collateral; and 
  
 (j) all proceeds of, collateral for, income, royalties and other payments now or hereafter due and payable with respect to, and supporting
obligations relating to, any and all of the Collateral (including, without limitation, proceeds, collateral and supporting obligations that constitute property of the types described in clauses (a) through (i) of this Section 1) and,
to the extent not otherwise included, all (A) payments under insurance (whether or not the Collateral Agent is the loss payee thereof), or any indemnity, warranty or guaranty, payable by reason of loss or damage to or otherwise with respect to
any of the foregoing Collateral, and (B) cash; 
  
 provided that
notwithstanding anything to the contrary in this Agreement, the Collateral shall not include (A) any Equipment that is subject to a purchase money lien or capital lease permitted under the Credit Agreement to the extent the documents relating
to such purchase money lien or capital lease do not permit such Equipment to be subject to the security interests created hereby, (B) any Letter-of-Credit Rights to the extent any Grantor is required by applicable law to apply the Net Proceeds
of such Letter-of-Credit Rights for a specified purpose or (C) any tangible or intangible property or assets if (but only to the extent that) the grant of a security interest therein would (x) constitute a violation of a valid and
enforceable restriction in respect of such Collateral in favor of a third party or under any law, regulation, permit, order or decree of any Governmental Authority, unless and until all required consents shall have been obtained or
(y) expressly give any other party in respect of any such contract, lease, instrument, license or other document, the right to terminate its obligations thereunder; provided however, that the limitation set forth in clauses (A) and
(C) above shall not affect, limit, restrict or impair the grant by a Grantor of a security interest pursuant to this Agreement in any such tangible or intangible property or assets to the extent that an otherwise applicable prohibition or
restriction on such grant is rendered ineffective by any applicable law, including the UCC. Each Grantor shall, if requested to do so by the Collateral Agent, use commercially reasonable efforts to obtain any such required consent that is reasonably
obtainable with respect to Collateral (other than with respect to healthcare receivables) which the Collateral Agent reasonably determines to be material. 
  
 Section 2. Security for Obligations. This Agreement secures, in the case of each Grantor, the payment of (a) all Obligations of such Grantor
now or hereafter existing under the Loan Documents, (b) all Secured Hedge Agreements and (c) all Cash Management Obligations owing to any Lender, in each case, whether direct or indirect, absolute or contingent, and whether for principal,
reimbursement obligations, interest, fees, premiums, penalties, indemnifications, contract causes of action, costs, expenses or otherwise (all such Obligations being the “Secured Obligations”). Without limiting the generality
of the foregoing, this Agreement secures, as to each Grantor, the payment of all amounts that constitute part of the Secured Obligations and would be owed by such Grantor to any Secured Party under the Loan Documents but for the fact that they are
unenforceable or not allowable due to the existence of a bankruptcy, reorganization or similar proceeding involving a Loan Party. For purposes of this Agreement and the other Loan Documents, (a) the term “Obligations” means all
present and future obligations of any of the Loan Parties under the Loan Documents, including, without 

  

 Project Trinity Security Agreement 
 6 

 
limitation, (i) the punctual payment by the Borrower of (A) the unpaid principal and interest (including interest accruing during the pendency of
any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) on the Loans, when and as due, whether at maturity, by acceleration, upon one or more dates set for prepayment or
otherwise, (B) each payment required to be made by the Borrower under the Credit Agreement in respect of any Letter of Credit, when and as due, including payments in respect of reimbursement of disbursements, interest thereon and obligations to
provide cash collateral, and (C) all other monetary obligations of the Borrower to any of the Secured Parties under the Credit Agreement and each of the other Loan Documents, including obligations to pay fees, expense reimbursement obligations
and indemnification obligations, whether primary, secondary, direct, contingent, fixed or otherwise (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of
whether allowed or allowable in such proceeding), (ii) the due and punctual performance of all other obligations of the Borrower under or pursuant to the Credit Agreement and each of the other Loan Documents, and (iii) the due and punctual
payment and performance of all of the obligations of each other Loan Party under or pursuant to this Agreement and each of the other Loan Documents, and (b) the term “Cash Management Bank” means any Lender or Affiliate
of a Lender in its capacity as a provider of cash management services to any Loan Party and the term “Cash Management Obligations” means the Obligations of any Loan Party for cash management services that are provided by a
Cash Management Bank. 
  
 Section 3. Grantors Remain
Liable. Anything herein to the contrary notwithstanding, (a) each Grantor shall remain liable under the contracts and agreements included in such Grantor’s Collateral to the extent set forth therein to perform all of its duties and
obligations thereunder to the same extent as if this Agreement had not been executed, (b) the exercise by the Collateral Agent of any of the rights hereunder shall not release any Grantor from any of its duties or obligations under the
contracts and agreements included in the Collateral and (c) no Secured Party shall have any obligation or liability under the contracts and agreements included in the Collateral by reason of this Agreement or any other Loan Document, nor shall
any Secured Party be obligated to perform any of the obligations or duties of any Grantor thereunder or to take any action to collect or enforce any claim for payment assigned hereunder. 
  
 Section 4. Delivery and Control of Security Collateral. (a) All certificates or instruments representing or
evidencing Security Collateral shall be delivered to and held by or on behalf of the Collateral Agent pursuant hereto and shall be in suitable form for transfer by delivery, or shall be accompanied by duly executed instruments of transfer or
assignment in blank, all in form and substance reasonably satisfactory to the Collateral Agent; provided, that so long as no Event of Default has occurred and is continuing, no Grantor shall be required to deliver instruments representing or
evidencing Pledged Debt if the amount of such Pledged Debt is $500,000 or less. Upon the occurrence and during the continuance of an Event of Default, the Collateral Agent shall have the right at any time to exchange certificates or instruments
representing or evidencing Security Collateral for certificates or instruments of smaller or larger denominations. 
  
 (b) With respect to any Security Collateral that constitutes an uncertificated security, promptly upon the request of the Collateral Agent, the relevant
Grantor will cause the issuer thereof either (i) to register the Collateral Agent as the registered owner of such security or 

  

 Project Trinity Security Agreement 
 7 

 
(ii) to agree with such Grantor and the Collateral Agent that such issuer will comply with instructions with respect to such security originated by the
Collateral Agent without further consent of such Grantor, such agreement to be in form and substance reasonably satisfactory to the Collateral Agent (such agreement being an “Uncertificated Security Control Agreement”).

  
 (c) The Collateral Agent shall have the right, at any time in
its discretion and without notice to any Grantor, to transfer to or to register in the name of the Collateral Agent or any of its nominees any or all of the Security Collateral, subject only to the revocable rights specified in Section 11(a).

  
 (d) Upon the request of the Collateral Agent following the
occurrence and during the continuance of an Event of Default, each Grantor will notify each issuer of Security Collateral granted by it hereunder that such Security Collateral is subject to the security interest granted hereunder. 
  
 Section 5. Representations and Warranties. Each Grantor represents and
warrants as follows: 
  
 (a) As of the date
hereof, such Grantor’s exact legal name, location, chief executive office, type of organization, jurisdiction of organization and organizational identification number is set forth in Schedule VII hereto. As of the date hereof, such Grantor has
no trade names other than as listed on Schedule IV hereto. Within the five years preceding the date hereof, such Grantor has not changed its name, location, chief executive office, type of organization, jurisdiction of organization or organizational
identification number from those set forth in Schedule VII hereto except as set forth in Schedule VIII hereto. 
  
 (b) Such Grantor is the legal and beneficial owner of the Collateral of such Grantor free and clear of any Lien, claim, option or right of
others, except for the security interest created under this Agreement and any Liens permitted under the Credit Agreement. No effective financing statement or other instrument similar in effect covering all or any part of such Collateral or listing
such Grantor or any trade name of such Grantor as debtor is on file in any recording office, except such as may have been filed in favor of the Collateral Agent relating to the Loan Documents or as otherwise permitted under the Credit Agreement; and
no control agreement or similar instrument is, or upon the occurrence of any event will be, in effect covering any deposit account of any Grantor, except as may be executed in favor of the Collateral Agent. 
  
 (c) All of the Equipment of such Grantor is located at the
places specified therefor in Schedule IX hereto or at another location as to which such Grantor has complied with the requirements of Section 7. As of the Closing Date, all of the Inventory of such Grantor is located at the places specified
therefore in Schedule IX. Within the five years preceding the date hereof, such Grantor has not changed the location of its Equipment or Inventory except as set forth in Schedule VIII hereto. 
  

 Project Trinity Security Agreement 
 8 

 (d) None of the Receivables or Agreement Collateral is evidenced by a promissory note or
other instrument that has not been delivered to the Collateral Agent in accordance with this Agreement. 
  
 (e) If such Grantor is an issuer of Security Collateral, such Grantor confirms that it has received notice of the security interest
granted hereunder. 
  
 (f) The Pledged Equity
issued by a subsidiary of Holdings and pledged by any Grantor hereunder has been duly authorized and validly issued and is fully paid and non assessable. The Pledged Debt issued by a subsidiary of Holdings and pledged by any Grantor hereunder has
been duly authorized, authenticated or issued and delivered, is the legal, valid and binding obligation of the issuers thereof, if evidenced by one or more promissory notes, such promissory notes have been delivered to the Collateral Agent in
accordance with the terms of Section 4(a), and is not in default. 
  
 (g) The Initial Pledged Equity pledged by such Grantor constitutes the percentage of the issued and outstanding Equity Interests of the issuers thereof indicated on Schedule I hereto. The Initial Pledged Debt
constitutes all of the outstanding indebtedness owed to such Grantor by the issuers thereof and is outstanding in the principal amount indicated on Schedule I hereto. 
  
 (h) Such Grantor has no investment property, other than the investment property listed on Schedule I hereto
and additional investment property as to which such Grantor has complied with the requirements of Section 4. 
  
 (i) As of the date hereof, such Grantor has no deposit accounts, other than the Pledged Deposit Accounts listed on Schedule II hereto.

  
 (j) Such Grantor is not a beneficiary or
assignee under any letter of credit, other than the letters of credit described in Schedule X hereto and additional letters of credit as to which such Grantor has complied with the requirements of Section 13. 
  
 (k) This Agreement creates in favor of the Collateral Agent
for the benefit of the Secured Parties a valid security interest in the Collateral granted by such Grantor, securing the payment of the Secured Obligations; all filings under the UCC necessary to perfect the security interest in the Collateral
granted by such Grantor, to the extent that such security interest can be perfected by filing, have been duly made and are in full force and effect or the requisite UCC financing statements have been delivered to the Collateral Agent in appropriate
form for filing, and upon filing, will be in full force and effect; and such security interest (to the extent that such security interest can be perfected by filing) is (or, upon the filing of such financing statements, will be) first priority,
subject to Liens permitted by the Credit Agreement. All actions (including, without limitation, the actions necessary to obtain control of the Pledged Equity as provided in Section 9-106 of the UCC to the extent that such Pledged Equity
constitutes investment property) necessary to perfect the security interests in the Security Collateral granted by such Grantor have been duly taken and such security interest is first priority. 
  

 Project Trinity Security Agreement 
 9 

 (l) No authorization or approval or other action by, and no notice to or filing with, any
governmental authority or regulatory body or any other third party is required for (i) the grant by such Grantor of the security interest granted hereunder or for the execution, delivery or performance of this Agreement by such Grantor,
(ii) the perfection or maintenance of the security interest created hereunder (including the first priority nature of such security interest), except for the filing of financing and continuation statements under the UCC, which financing
statements have been duly filed and are in full force and effect or which financing statements have been delivered to the Collateral Agent in appropriate form for filing, and upon filing, will be in full force and effect, the recordation of the
Intellectual Property Security Agreements referred to in Section 10(d) with the U.S. Patent and Trademark Office and the U.S. Copyright Office, which Agreements have been duly recorded and are in full force and effect or which Agreements have
been delivered to the Collateral Agent in appropriate form for filing, and upon filing, will be in full force and effect, and the actions described in Section 4 with respect to the Security Collateral, which actions have been taken and are in
full force and effect, or (iii) the exercise by the Collateral Agent of its voting or other rights provided for in this Agreement or the remedies in respect of the Collateral pursuant to this Agreement, except as may be required in connection
with the disposition of any portion of the Security Collateral by laws affecting the offering and sale of securities generally and by applicable laws regarding the enforcement of remedies with respect to Medicare and Medicaid receivables.

  
 (m) As to itself and its Intellectual
Property Collateral: 
  
 (i) To the knowledge of
such Grantor and except as would not reasonably be expected to have a Material Adverse Effect, it is the exclusive owner of all right, title and interest in and to, or has a valid right to use, the Intellectual Property Collateral used in the
operation of such Grantor’s business as currently conducted, and is entitled to use all Intellectual Property Collateral used in the operation of such Grantor’s business as currently conducted, subject only to the terms of the IP
Agreements. 
  
 (ii) The Intellectual Property
Collateral set forth on Schedule IV hereto includes all of the patents, patent applications, domain names, trademark registrations and applications, copyright registrations and applications and IP Agreements owned by such Grantor as of the date
hereof. 
  
 (iii) To the knowledge of such
Grantor and except as would not reasonably be expected to have a Material Adverse Effect, the Intellectual Property Collateral has not been adjudged invalid or unenforceable in whole or part, and to the best of such Grantor’s knowledge, is
valid and enforceable, except as would not reasonably be expected to have a Material Adverse Effect. 
  
 (iv) To the knowledge of such Grantor and except as would not reasonably be expected to have a Material Adverse Effect, such Grantor has
made or performed all filings, recordings and other acts and has paid all required fees and taxes to maintain and protect its interest in each and every item of Intellectual 

  

 Project Trinity Security Agreement 
 10 

 
Property Collateral in full force and effect, and to protect and maintain its interest therein including, without limitation, recordations of any of its
interests in the Patents and Trademarks with the U.S. Patent and Trademark Office, and recordation of any of its interests in the Copyrights with the U.S. Copyright Office. To the knowledge of such Grantor and except as would not reasonably be
expected to have a Material Adverse Effect, such Grantor has used proper statutory notice in connection with its use of each patent, trademark and copyright in the Intellectual Property Collateral. 
  
 (v) To the knowledge of such Grantor and except as would not
reasonably be expected to have a Material Adverse Effect, no claim, action, suit, investigation, litigation or proceeding is pending or threatened against such Grantor (i) based upon or challenging or seeking to deny or restrict the
Grantor’s rights in or use of any of the Intellectual Property Collateral, (ii) alleging that the Grantor’s rights in or use of the Intellectual Property Collateral or that any services provided by, processes used by, or products
manufactured or sold by, such Grantor infringe, misappropriate, dilute, misuse or otherwise violate any patent, trademark, copyright or any other proprietary right of any third party, or (iii) alleging that the Intellectual Property Collateral
is being licensed or sublicensed in violation or contravention of the terms of any license or other agreement. To the knowledge of such Grantor and except as would not reasonably be expected to have a Material Adverse Effect, no Person is engaging
in any activity material to the operation of such Grantor’s business as currently conducted that infringes, misappropriates, dilutes, misuses or otherwise violates the Intellectual Property Collateral or the Grantor’s rights in or use
thereof. As of the date hereof, to the knowledge of such Grantor and except as would not reasonably be expected to have a Material Adverse Effect, except as set forth on Schedule IV hereto, such Grantor has not granted any license, release, covenant
not to sue, non-assertion assurance, or other right to any Person with respect to any part of the Intellectual Property Collateral. To the knowledge of such Grantor and except as would not reasonably be expected to have a Material Adverse Effect,
the consummation of the transactions contemplated by the Transaction Documents will not result in the termination or impairment of any of the Intellectual Property Collateral. 
  
 (vi) With respect to each IP Agreement and except as would not reasonably be expected to have a Material
Adverse Effect: (A) such IP Agreement is valid and binding and in full force and effect and represents the entire agreement between the respective parties thereto with respect to the subject matter thereof; (B) such IP Agreement will not
cease to be valid and binding and in full force and effect on terms identical to those currently in effect as a result of the rights and interest granted herein, nor will the grant of such rights and interest constitute a breach or default under
such IP Agreement or otherwise give any party thereto a right to terminate such IP Agreement; (C) such Grantor has not received any notice of termination or cancellation under such IP Agreement; (D) such Grantor has not received any notice
of a breach or default under such IP Agreement, which breach or default has not been cured; (E) such Grantor has not 

  

 Project Trinity Security Agreement 
 11 

 
granted to any other third party any rights, adverse or otherwise, under such IP Agreement; and (F) neither such Grantor nor any other party to such IP
Agreement is in breach or default thereof in any material respect, and no event has occurred that, with notice or lapse of time or both, would constitute such a breach or default or permit termination, modification or acceleration under such IP
Agreement. 
  
 (n) Such Grantor has no commercial
tort claims other than those listed in Schedule V hereto and additional commercial tort claims as to which such Grantor has complied with the requirements of Section 14. 
  
 Section 6. Further Assurances. (a) Each Grantor agrees that from time to time, at the expense of such Grantor,
such Grantor will promptly execute and deliver, or otherwise authenticate, all further instruments and documents, and take all further action that may be necessary or desirable, or that the Collateral Agent may reasonably request, in order to
perfect or maintain the perfection of and protect any pledge or security interest granted or purported to be granted by such Grantor hereunder or, to the extent permitted by applicable law, to enable the Collateral Agent to exercise and enforce its
rights and remedies hereunder with respect to any Collateral of such Grantor. Without limiting the generality of the foregoing, each Grantor will promptly with respect to Collateral of such Grantor: (i) upon the occurrence and during the
continuance of an Event of Default, mark conspicuously each document included in Inventory, each chattel paper included in Receivables, each Related Contract, each Assigned Agreement and, at the request of the Collateral Agent, each of its records
pertaining to such Collateral with a legend, in form and substance reasonably satisfactory to the Collateral Agent, indicating that such document, chattel paper, Related Contract, Assigned Agreement or Collateral is subject to the security interest
granted hereby; (ii) if any such Collateral shall be evidenced by a promissory note or other instrument, deliver and pledge to the Collateral Agent hereunder such note or instrument duly indorsed and accompanied by duly executed instruments of
transfer or assignment, all in form and substance reasonably satisfactory to the Collateral Agent; (iii) file such financing or continuation statements, or amendments thereto, and such other instruments or notices, as may be necessary or
desirable, or as the Collateral Agent may reasonably request, in order to perfect and preserve the security interest granted or purported to be granted by such Grantor hereunder; (iv) at the reasonable request of the Collateral Agent, take all
action to ensure that the Collateral Agent’s security interest is noted on any certificate of title related to any Collateral evidenced by a certificate of title; and (v) deliver to the Collateral Agent evidence that all other actions that
the Collateral Agent may deem reasonably necessary or desirable in order to perfect or maintain the perfection of and protect the security interest granted or purported to be granted by such Grantor under this Agreement has been taken. 

 
 (b) Each Grantor hereby authorizes the Collateral Agent to file one or
more financing or continuation statements, and amendments thereto, including, without limitation, one or more financing statements indicating that such financing statements cover all assets or all personal property (or words of similar effect) of
such Grantor, regardless of whether any particular asset described in such financing statements falls within the scope of the UCC or the granting clause of this Agreement. A photocopy or other reproduction of this Agreement shall be sufficient as a
financing statement where permitted by law. Each Grantor ratifies its 

  

 Project Trinity Security Agreement 
 12 

 
authorization for the Collateral Agent to have filed such financing statements, continuation statements or amendments filed prior to the date hereof.

  
 (c) Each Grantor will furnish to the Collateral Agent from
time to time statements and schedules further identifying and describing the Collateral of such Grantor and such other reports in connection with such Collateral as the Collateral Agent may reasonably request, all in reasonable detail and subject to
confidentiality requirements imposed by applicable law; provided, that (i) each Grantor shall use reasonable best efforts to provide such information consistent with such confidentiality requirements including, without limitation, pursuant to
regulations that may permit disclosure under its health care operations (under and as defined in HIPAA) subject to the HIPAA minimum necessary requirement and (ii) to the extent that any Grantor is a “covered entity” under HIPAA, none
of them shall by contract prohibit disclosure by any of the other of them to the Collateral Agent that is not otherwise prohibited by HIPAA. 
  
 Section 7. As to Equipment. Each Grantor will keep its Equipment at the places therefor specified in Section 5(c) or, upon 30 days’ prior
written notice to the Collateral Agent, at such other places designated by such Grantor in such notice. 
  
 Section 8. Insurance. (a) Each Grantor will, at its own expense, maintain insurance with respect to its Equipment and Inventory in such
amounts, against such risks, in such form and with such insurers, as required under the Credit Agreement. Each policy of each Grantor for liability insurance shall provide for all losses to be paid on behalf of the Collateral Agent and such Grantor
as their interests may appear, and each policy for property damage insurance shall provide for all losses (except for losses of less than $2,000,000 per occurrence) to be paid directly to the Collateral Agent. Each such policy shall in addition
(i) name such Grantor and the Collateral Agent as insured parties thereunder (without any representation or warranty by or obligation upon the Collateral Agent) as their interests may appear, (ii) contain the agreement by the insurer that
any loss thereunder shall be payable to the Collateral Agent notwithstanding any action, inaction or breach of representation or warranty by such Grantor, (iii) provide that there shall be no recourse against the Collateral Agent for payment of
premiums or other amounts with respect thereto and (iv) provide that at least 10 days’ prior written notice of cancellation or of lapse shall be given to the Collateral Agent by the insurer. Each Grantor will, upon the reasonable request
of the Collateral Agent, deliver to the Collateral Agent original or duplicate policies of such insurance and, as often as the Collateral Agent may reasonably request, a report of a reputable insurance broker with respect to such insurance. Further,
each Grantor will, at the request of the Collateral Agent upon the occurrence and during the continuance of an Event of Default, duly execute and deliver instruments of assignment of such insurance policies and cause the insurers to acknowledge
notice of such assignment. 
  
 (b) Reimbursement under any
liability insurance maintained by any Grantor pursuant to this Section 8 may be paid directly to the Person who shall have incurred liability covered by such insurance. In case of any loss involving damage to Equipment or Inventory when
subsection (c) of this Section 8 is not applicable, except as otherwise permitted under the Credit Agreement, the applicable Grantor will make or cause to be made the necessary repairs to or replacements of such Equipment or Inventory, and
any proceeds of insurance properly received by or released to such Grantor shall be used by such Grantor, except as otherwise 

  

 Project Trinity Security Agreement 
 13 

 
required hereunder or by the Credit Agreement, to pay or as reimbursement for the costs of such repairs or replacements. 
  
 (c) So long as no Event of Default shall have occurred and be continuing, all
insurance payments received by the Collateral Agent in connection with any loss, damage or destruction of any Inventory or Equipment will be released by the Collateral Agent to the applicable Grantor for application in accordance with the Credit
Agreement. Upon the occurrence and during the continuance of any Event of Default, all insurance payments in respect of such Equipment or Inventory shall be paid to the Collateral Agent and shall, in the Collateral Agent’s sole discretion,
(i) be released to the applicable Grantor to be applied as set forth in the first sentence of this subsection (c) or (ii) be held as additional Collateral hereunder or applied as specified in Section 19(b). 
  
 Section 9. Post-Closing Changes; Collections on Assigned Agreements,
Receivables and Related Contracts. (a) No Grantor will change its name, type of organization, jurisdiction of organization, organizational identification number or location from those set forth in Section 5(a) of this Agreement without
first giving at least 30 days’ prior written notice to the Collateral Agent and taking all action required by the Collateral Agent for the purpose of perfecting or maintaining the perfection of or protecting the security interest granted by
this Agreement. Each Grantor will hold and preserve its records relating to the Collateral, including, without limitation, the Assigned Agreements and Related Contracts, and will permit representatives of the Collateral Agent to visit and inspect
its records on the terms set forth in the Credit Agreement. If any Grantor does not have an organizational identification number and later obtains one, it will forthwith notify the Collateral Agent of such organizational identification number. Upon
request by the Collateral Agent from time to time (but not more than once each calendar quarter unless an Event of Default has occurred and is continuing), each Grantor shall promptly notify the Collateral Agent of any deposit account that has been
opened by (or on account of) such Grantor that is not listed on Schedule II hereto. 
  
 (b) Except as otherwise provided in this subsection (b), each Grantor will continue to collect, at its own expense, all amounts due or to become due such Grantor under the Assigned Agreements, Receivables and Related
Contracts. In connection with such collections, such Grantor may take (and, upon the occurrence and during the continuance of an Event of Default, at the Collateral Agent’s direction, will take) such action as such Grantor or the Collateral
Agent may deem necessary or advisable to enforce collection of the Assigned Agreements, Receivables and Related Contracts; provided, however, that the Collateral Agent shall have the right at any time after the occurrence and during
the continuance of an Event of Default, to the extent permitted by applicable law (it being understood that the following remedies in this Section 9(b) shall not be available to the Collateral Agent with respect to Medicare and Medicaid
receivables except as specifically noted below), upon written notice to such Grantor of its intention to do so, to notify the Obligors under any Assigned Agreements, Receivables and Related Contracts of the assignment of such Assigned Agreements,
Receivables and Related Contracts to the Collateral Agent and to direct such Obligors to make payment of all amounts due or to become due to such Grantor thereunder directly to the Collateral Agent and, upon such notification and at the expense of
such Grantor, to enforce collection of any such Assigned Agreements, Receivables and Related Contracts, to adjust, settle or compromise the amount or payment thereof, in the same manner and to the same extent as such Grantor might 

  

 Project Trinity Security Agreement 
 14 

 
have done, and to otherwise exercise all rights with respect to such Assigned Agreements, Receivables and Related Contracts, including, without limitation,
those set forth set forth in Section 9-607 of the UCC. After receipt by any Grantor of the notice from the Collateral Agent referred to in the proviso to the preceding sentence, (i) all amounts and proceeds (including, without limitation,
instruments) received by such Grantor in respect of the Assigned Agreements, Receivables and Related Contracts of such Grantor shall be received in trust for the benefit of the Collateral Agent hereunder (except that the funds received from Medicare
and Medicaid shall not be received in trust for the benefit of the Collateral Agent hereunder but shall otherwise be subject to the remedies that follow in this sentence), shall be segregated from other funds of such Grantor and shall be forthwith
paid over to the Collateral Agent in the same form as so received (with any necessary indorsement; provided, that Medicare and Medicaid receivables shall be paid over only after deposit in an account under the control of the Grantor) to be deposited
in an account under the dominion and control of the Collateral Agent and either (A) released to such Grantor so long as no Event of Default shall have occurred and be continuing or (B) if any Event of Default shall have occurred and be
continuing, applied as provided in Section 19(b) and (ii) such Grantor will not adjust, settle or compromise the amount or payment of any Receivable or amount due on any Assigned Agreement or Related Contract, release wholly or partly any
Obligor thereof or allow any credit or discount thereon. No Grantor will permit or consent to the subordination of its right to payment under any of the Assigned Agreements, Receivables and Related Contracts to any other indebtedness or obligations
of the Obligor thereof. 
  
 Section 10. As to Intellectual
Property Collateral. (a) Except as would not reasonably be expected to have a Material Adverse Effect, with respect to each item of its Intellectual Property Collateral, each Grantor agrees to take, at its expense, all necessary steps,
including, without limitation, in the U.S. Patent and Trademark Office, the U.S. Copyright Office and any other governmental authority, to (i) maintain the validity and enforceability of such Intellectual Property Collateral and maintain such
Intellectual Property Collateral in full force and effect, and (ii) pursue the registration and maintenance of each patent, trademark, or copyright registration or application, now or hereafter included in such Intellectual Property Collateral
of such Grantor, including, without limitation, the payment of required fees and taxes, the filing of responses to office actions issued by the U.S. Patent and Trademark Office, the U.S. Copyright Office or other governmental authorities, the filing
of applications for renewal or extension, the filing of affidavits under Sections 8 and 15 of the U.S. Trademark Act, the filing of divisional, continuation, continuation-in-part, reissue and renewal applications or extensions, the payment of
maintenance fees and the participation in interference, reexamination, opposition, cancellation, infringement and misappropriation proceedings. No Grantor shall, without the written consent of the Collateral Agent, discontinue use of or otherwise
abandon any Intellectual Property Collateral, or abandon any right to file an application for patent, trademark, or copyright, unless such Grantor shall have previously determined that such use or the pursuit or maintenance of such Intellectual
Property Collateral is no longer desirable in the conduct of such Grantor’s business and that the loss thereof would not be reasonably likely to have a Material Adverse Effect. 
  
 (b) Each Grantor agrees promptly to notify (it being understood that notification need not be given more than once in each
fiscal quarter) the Collateral Agent if such Grantor becomes aware that any material item of the Intellectual Property Collateral may have become abandoned, placed in the public domain, invalid or unenforceable, or of the institution of any 

  

 Project Trinity Security Agreement 
 15 

 
proceeding (including, without limitation, the institution of any proceeding in the U.S. Patent and Trademark Office or any court) involving such Grantor
regarding any material item of the Intellectual Property Collateral. 
  
 (c) In the event that any Grantor becomes aware that any material item of the Intellectual Property Collateral is being infringed or misappropriated by a third party, such Grantor shall promptly notify (it being understood that notification
need not be given more than once in each fiscal quarter) the Collateral Agent and shall take commercially reasonable actions, at its expense, to protect or enforce such Intellectual Property Collateral, including, without limitation, suing for
infringement or misappropriation and for an injunction against such infringement or misappropriation, except to the extent that the failure to do so would not be reasonably likely to result in a Material Adverse Effect. 
  
 (d) With respect to its Intellectual Property Collateral, each Grantor agrees
to execute or otherwise authenticate an agreement, in substantially the form set forth in Exhibit B hereto or otherwise in form and substance reasonably satisfactory to the Collateral Agent (an “Intellectual Property Security
Agreement”), for recording the security interest granted hereunder to the Collateral Agent in such Intellectual Property Collateral with the U.S. Patent and Trademark Office, the U.S. Copyright Office and any other governmental
authorities necessary to perfect the security interest hereunder in such Intellectual Property Collateral. 
  
 (e) Each Grantor agrees that should it obtain an ownership interest in any item of the type set forth in Section 1(g) that is not on the date hereof
a part of the Intellectual Property Collateral (“After-Acquired Intellectual Property”) (i) the provisions of this Agreement shall automatically apply thereto, and (ii) any such After-Acquired Intellectual Property
and, in the case of trademarks, the goodwill symbolized thereby, shall automatically become part of the Intellectual Property Collateral subject to the terms and conditions of this Agreement with respect thereto. At the end of each fiscal year of
the Borrower, each Grantor shall give written notice to the Collateral Agent identifying the After-Acquired Intellectual Property acquired during such fiscal year, and such Grantor shall execute and deliver to the Collateral Agent with such written
notice, or otherwise authenticate, an agreement substantially in the form of Exhibit C hereto or otherwise in form and substance reasonably satisfactory to the Collateral Agent (an “IP Security Agreement Supplement”) covering
such After-Acquired Intellectual Property, which IP Security Agreement Supplement shall be recorded with the U.S. Patent and Trademark Office, the U.S. Copyright Office and any other governmental authorities necessary to perfect the security
interest hereunder in such After-Acquired Intellectual Property. 
  
 Section 11. Voting Rights; Dividends; Etc. (a) So long as no Event of Default shall have occurred and be continuing: 
  
 (i) Each Grantor shall be entitled to exercise any and all voting and other consensual rights pertaining to the Security Collateral of
such Grantor or any part thereof for any purpose; provided however, that such Grantor will not exercise or refrain from exercising any such right if such action would have a material adverse effect on the value of the Security Collateral or
any part thereof. 
  

 Project Trinity Security Agreement 
 16 

 (ii) Each Grantor shall be entitled to receive and retain any and all dividends, interest
and other distributions paid in respect of the Security Collateral of such Grantor if and to the extent that the payment thereof is not otherwise prohibited by the terms of the Loan Documents; provided, however, that any and all
dividends, interest and other distributions paid or payable other than in cash in respect of, and instruments and other property received, receivable or otherwise distributed in respect of, or in exchange for, any Security Collateral shall be, and
shall be forthwith delivered to the Collateral Agent to hold as, Security Collateral and shall, if received by such Grantor, be received in trust for the benefit of the Collateral Agent, be segregated from the other property or funds of such Grantor
and be forthwith delivered to the Collateral Agent as Security Collateral in the same form as so received (with any necessary indorsement). 
  
 (iii) The Collateral Agent will execute and deliver (or cause to be executed and delivered) to each Grantor all such proxies and other
instruments as such Grantor may reasonably request for the purpose of enabling such Grantor to exercise the voting and other rights that it is entitled to exercise pursuant to paragraph (i) above and to receive the dividends or interest
payments that it is authorized to receive and retain pursuant to paragraph (ii) above. 
  
 (b) Upon the occurrence and during the continuance of an Event of Default: 
  
 (i) All rights of each Grantor (x) to exercise or refrain from exercising the voting and other consensual rights that it would
otherwise be entitled to exercise pursuant to Section 11(a)(i) shall, upon notice to such Grantor by the Collateral Agent, cease and (y) to receive the dividends, interest and other distributions that it would otherwise be authorized to
receive and retain pursuant to Section 11(a)(ii) shall automatically cease, and all such rights shall thereupon become vested in the Collateral Agent, which shall thereupon have the sole right to exercise or refrain from exercising such voting
and other consensual rights and to receive and hold as Security Collateral such dividends, interest and other distributions. 
  
 (ii) All dividends, interest and other distributions that are received by any Grantor contrary to the provisions of paragraph (i) of
this Section 11(b) shall be received in trust for the benefit of the Collateral Agent, shall be segregated from other funds of such Grantor and shall be forthwith paid over to the Collateral Agent as Security Collateral in the same form as so
received (with any necessary indorsement). 
  
 Section 12. As
to the Assigned Agreements. (a) Each Grantor will at its expense: 
  
 (i) perform and observe all terms and provisions of the Assigned Agreements to be performed or observed by it, maintain the Assigned Agreements to which it is a party in full force and effect, enforce the Assigned
Agreements to which it is a party in accordance with the terms thereof and take all such action to such end as may be requested from time to time by the Collateral Agent; and 
  
 (ii) furnish to the Collateral Agent promptly upon receipt thereof copies of all notices, requests and other
documents received by such Grantor under or pursuant to the 

  

 Project Trinity Security Agreement 
 17 

 
Assigned Agreements to which it is a party, and from time to time (A) furnish to the Collateral Agent such information and reports regarding the
Assigned Agreements and such other Collateral of such Grantor as the Collateral Agent may reasonably request and (B) upon request of the Collateral Agent, make to each other party to any Assigned Agreement to which it is a party such demands
and requests for information and reports or for action as such Grantor is entitled to make thereunder. 
  
 (b) Each Grantor hereby consents on its behalf and on behalf of its Subsidiaries to the assignment and pledge to the Collateral Agent for benefit of the
Secured Parties of each Assigned Agreement to which it is a party by any other Grantor hereunder. 
  
 Section 13. As to Letter-of-Credit Rights. (a) Each Grantor, by granting a security interest in its Receivables consisting of letter-of-credit
rights to the Collateral Agent, intends to (and hereby does) assign to the Collateral Agent its rights (including its contingent rights) to the proceeds of all Related Contracts consisting of letters of credit in an amount individually in excess of
$500,000 of which it is or hereafter becomes a beneficiary or assignee. Each Grantor will promptly use its commercially reasonable efforts to cause the issuer of each such letter of credit and each nominated person (if any) with respect thereto to
consent to such assignment of the proceeds thereof pursuant to a consent in form and substance reasonably satisfactory to the Collateral Agent and deliver written evidence of such consent to the Collateral Agent. 
  
 (b) Upon the occurrence of an Event of Default, each Grantor will, promptly
upon request by the Collateral Agent, (i) notify (and such Grantor hereby authorizes the Collateral Agent to notify) the issuer and each nominated person with respect to each of the Related Contracts consisting of letters of credit that the
proceeds thereof have been assigned to the Collateral Agent hereunder and any payments due or to become due in respect thereof are to be made directly to the Collateral Agent or its designee and (ii) arrange for the Collateral Agent to become
the transferee beneficiary of letter of credit. 
  
 Section 14.
Commercial Tort Claims. Each Grantor will promptly give notice to the Collateral Agent of any commercial tort claim with an amount in controversy in excess of $2,000,000 that may arise after the date hereof and will immediately execute or
otherwise authenticate a supplement to this Agreement, and otherwise take all necessary action, to subject such commercial tort claim to the first priority security interest created under this Agreement. 
  
 Section 15. Transfers and Other Liens; Additional Shares.
(a) Each Grantor agrees that it will not (i) sell, assign or otherwise dispose of, or grant any option with respect to, any of the Collateral, other than sales, assignments and other dispositions of Collateral, and options relating to
Collateral, permitted under the terms of the Credit Agreement, or (ii) create or suffer to exist any Lien upon or with respect to any of the Collateral of such Grantor except for the pledge, assignment and security interest created under this
Agreement and Liens permitted under the Credit Agreement. 
  
 (b)
Each Grantor agrees that it will (i) cause each subsidiary of Holdings that is an issuer of the Pledged Equity pledged by such Grantor not to issue any Equity Interests or other securities in addition to or in substitution for the Pledged
Equity issued by such issuer, except to 

  

 Project Trinity Security Agreement 
 18 

 
such Grantor, and (ii) pledge hereunder, promptly upon its acquisition (directly or indirectly) thereof, any and all additional Equity Interests or
other securities. 
  
 Section 16. Collateral Agent Appointed
Attorney in Fact. Solely to the extent permitted by applicable law, each Grantor hereby irrevocably appoints the Collateral Agent such Grantor’s attorney in fact, with full authority in the place and stead of such Grantor and in the name of
such Grantor or otherwise, from time to time, upon the occurrence and during the continuance of an Event of Default, in the Collateral Agent’s discretion, to take any action and to execute any instrument that the Collateral Agent may deem
necessary or advisable to accomplish the purposes of this Agreement, including, without limitation: 
  
 (a) to obtain and adjust insurance required to be paid to the Collateral Agent pursuant to Section 8, 
  
 (b) to ask for, demand, collect, sue for, recover,
compromise, receive and give acquittance and receipts for moneys due and to become due under or in respect of any of the Collateral (except in respect of Medicare and Medicaid receivables to the extent prohibited by applicable law). 
  
 (c) to receive, indorse and collect any drafts or other
instruments, documents and chattel paper, in connection with clause (a) or (b) above (except in respect of Medicare and Medicaid receivables to the extent prohibited by applicable law), and 
  
 (d) to file any claims or take any action or institute any
proceedings that the Collateral Agent may deem necessary or desirable for the collection of any of the Collateral or otherwise to enforce compliance with the terms and conditions of any Assigned Agreement or the rights of the Collateral Agent with
respect to any of the Collateral (except in respect of Medicare and Medicaid receivables to the extent prohibited by applicable law). 
  
 Section 17. Collateral Agent May Perform. If any Grantor fails to perform any agreement contained herein, the Collateral Agent may, but without any
obligation to do so and without notice, itself perform, or cause performance of, such agreement, and the expenses of the Collateral Agent incurred in connection therewith shall be payable by such Grantor under Section 20. 
  
 Section 18. The Collateral Agent’s Duties. (a) The powers
conferred on the Collateral Agent hereunder are solely to protect the Secured Parties’ interest in the Collateral and shall not impose any duty upon it to exercise any such powers. Except for the safe custody of any Collateral in its possession
and the accounting for moneys actually received by it hereunder, the Collateral Agent shall have no duty as to any Collateral, as to ascertaining or taking action with respect to calls, conversions, exchanges, maturities, tenders or other matters
relative to any Collateral, whether or not any Secured Party has or is deemed to have knowledge of such matters, or as to the taking of any necessary steps to preserve rights against any parties or any other rights pertaining to any Collateral. The
Collateral Agent shall be deemed to have exercised reasonable care in the custody and preservation of any Collateral in its possession if such Collateral is accorded treatment substantially equal to that which it accords its own property.

  

 Project Trinity Security Agreement 
 19 

 (b) Anything contained herein to the contrary notwithstanding, the Collateral Agent may from time to
time, when the Collateral Agent deems it to be necessary, appoint one or more subagents (each a “Subagent”) for the Collateral Agent hereunder with respect to all or any part of the Collateral. In the event that the
Collateral Agent so appoints any Subagent with respect to any Collateral, (i) the assignment and pledge of such Collateral and the security interest granted in such Collateral by each Grantor hereunder shall be deemed for purposes of this
Security Agreement to have been made to such Subagent, in addition to the Collateral Agent, for the ratable benefit of the Secured Parties, as security for the Secured Obligations of such Grantor, (ii) such Subagent shall automatically be
vested, in addition to the Collateral Agent, with all rights, powers, privileges, interests and remedies of the Collateral Agent hereunder with respect to such Collateral, and (iii) the term “Collateral Agent,” when used herein in
relation to any rights, powers, privileges, interests and remedies of the Collateral Agent with respect to such Collateral, shall include such Subagent; provided, however, that no such Subagent shall be authorized to take any action
with respect to any such Collateral unless and except to the extent expressly authorized in writing by the Collateral Agent. 
  
 Section 19. Remedies. If any Event of Default shall have occurred and be continuing: 
  
 (a) The Collateral Agent may exercise in respect of the Collateral, in addition to other rights and remedies
provided for herein or otherwise available to it, all the rights and remedies of a secured party upon default under the UCC (whether or not the UCC applies to the affected Collateral) (except in respect of Medicare and Medicaid receivables to the
extent prohibited by applicable law) and also may (except in respect of Medicare and Medicaid receivables to the extent prohibited by applicable law): (i) require each Grantor to, and each Grantor hereby agrees that it will at its expense and
upon request of the Collateral Agent forthwith, assemble all or part of the Collateral as directed by the Collateral Agent and make it available to the Collateral Agent (subject to confidentiality agreements required by applicable law;
provided, that (i) each Grantor shall use reasonable best efforts to provide such information consistent with such confidentiality requirements including, without limitation, pursuant to regulations that may permit disclosure under its
health care operations (under and as defined in HIPAA) subject to the HIPAA minimum necessary requirement and (ii) to the extent that any Grantor is a “covered entity” under HIPAA, none of them shall by contract prohibit disclosure by
any of the other of them to the Collateral Agent that is not otherwise prohibited by HIPAA) at a place and time to be designated by the Collateral Agent that is reasonably convenient to both parties; (ii) without notice except as specified
below, sell the Collateral or any part thereof in one or more parcels at public or private sale, at any of the Collateral Agent’s offices or elsewhere, for cash, on credit or for future delivery, and upon such other terms as the Collateral
Agent may deem commercially reasonable; (iii) occupy any premises owned or leased by any of the Grantors where the Collateral or any part thereof is assembled or located for a reasonable period in order to effectuate its rights and remedies
hereunder or under law, without obligation to such Grantor in respect of such occupation; and (iv) exercise any and all rights and remedies of any of the Grantors under or in connection with the Collateral, or otherwise in respect of the
Collateral, including, without limitation, (A) any and all rights of such Grantor to demand or otherwise require payment of any amount under, or performance of any provision of, the 

  

 Project Trinity Security Agreement 
 20 

 
Assigned Agreements, the Receivables, the Related Contracts and the other Collateral and (B) exercise all other rights and remedies with respect to the
Assigned Agreements, the Receivables, the Related Contracts and the other Collateral, including, without limitation, those set forth in Section 9-607 of the UCC. Each Grantor agrees that, to the extent notice of sale shall be required by law,
at least ten days’ notice to such Grantor of the time and place of any public sale or the time after which any private sale is to be made shall constitute reasonable notification. The Collateral Agent shall not be obligated to make any sale of
Collateral regardless of notice of sale having been given. The Collateral Agent may adjourn any public or private sale from time to time by announcement at the time and place fixed therefor, and such sale may, without further notice, be made at the
time and place to which it was so adjourned. 
  
 (b) Any cash held by or on behalf of the Collateral Agent and all cash proceeds received by or on behalf of the Collateral Agent in respect of any sale of, collection from, or other realization upon all or any part of the Collateral may, in
the discretion of the Collateral Agent, be held by the Collateral Agent as collateral for, and/or then or at any time thereafter applied (after payment of any amounts payable to the Collateral Agent pursuant to Section 20) in whole or in part
by the Collateral Agent for the ratable benefit of the Secured Parties against, all or any part of the Secured Obligations, in the following manner: 
  
 (i) first, paid to the Agents for any amounts then owing to the Agents pursuant to Section 9.03 of the Credit Agreement or
otherwise under the Loan Documents, ratably in accordance with the amounts then owing to the Agents; and 
  
 (ii) second, ratably (A) paid to the Lenders and the Hedge Banks for any amounts then owing to them, in their capacities as
such, under the Loan Documents and the Secured Hedge Agreements ratably in accordance with the amounts then owing to the Lenders and the Hedge Banks, provided that, for purposes of this Section 19, the amount owing to any Hedge Bank
pursuant to any Secured Hedge Agreement to which it is a party (other than any amount theretofore accrued and unpaid) shall be deemed to be equal to the Agreement Value thereof and (B) deposited as Collateral in the letter of credit cash
collateral account up to an amount equal to the LC Exposure on such date, plus any accrued and unpaid interest thereon, to be applied in accordance with Section 2.05(j) of the Credit Agreement. As used herein, the term “Agreement
Value” means, for each Hedge Agreement, on any date of determination, an amount determined by the Administrative Agent equal to the amount, if any, that would be payable by any Loan Party or any of its subsidiaries to its counterparty
to such Hedge Agreement in accordance with its terms as if (A) such Hedge Agreement was being terminated early on such date of determination, (B) such Loan Party or subsidiary was the sole “Affected Party” and (C) the
Administrative Agent was the sole party determining such payment amount. 
  
 Any
surplus of such cash or cash proceeds held by or on the behalf of the Collateral Agent and remaining after payment in full of all the Secured Obligations shall be paid over to the applicable Grantor or to whomsoever may be lawfully entitled to
receive such surplus. 
  

 Project Trinity Security Agreement 
 21 

 (c) All payments received by any Grantor under or in connection with any Assigned
Agreement or otherwise in respect of the Collateral shall be received in trust for the benefit of the Collateral Agent, shall be segregated from other funds of such Grantor and shall be forthwith paid over to the Collateral Agent in the same form as
so received (with any necessary indorsement). 
  
 (d) The Collateral Agent may, without notice to any Grantor except as required by law and at any time or from time to time, charge, set off and otherwise apply all or any part of the Secured Obligations against any funds held with respect
to the Pledged Deposit Accounts or in any other deposit account. 
  
 (e) The Collateral Agent may send to each bank, securities intermediary or issuer party to any Uncertificated Security Control Agreement a “Notice of Exclusive Control” as defined in and under such
Agreement. 
  
 (f) In the event of any sale or
other disposition of any of the Intellectual Property Collateral of any Grantor, the goodwill symbolized by any Trademarks subject to such sale or other disposition shall be included therein, and such Grantor shall supply to the Collateral Agent or
its designee such Grantor’s know-how and expertise, and documents and things relating to any Intellectual Property Collateral subject to such sale or other disposition, and such Grantor’s customer lists and other records and documents
relating to such Intellectual Property Collateral and to the manufacture, distribution, advertising and sale of products and services of such Grantor, in each case subject to confidentiality agreements imposed by applicable law; provided,
that (i) each Grantor shall use reasonable best efforts to provide such information consistent with such confidentiality requirements including, without limitation, pursuant to regulations that may permit disclosure under its health care
operations (under and as defined in HIPAA) subject to the HIPAA minimum necessary requirement and (ii) to the extent that any Grantor is a “covered entity” under HIPAA, none of them shall by contract prohibit disclosure by any of the
other of them to the Collateral Agent that is not otherwise prohibited by HIPAA. 
  
 Section 20. As to Equipment. Each Grantor will keep its Equipment at the places therefor specified in Section 5(c) or, upon 30 days’ prior written notice to the Collateral Agent, at such other places
designated by such Grantor in such notice. 
  
 (a) Indemnity and
Expenses. (a) Each Grantor agrees to indemnify, defend and save and hold harmless each Secured Party and each of their Affiliates and their respective officers, directors, employees, agents and advisors (each, an “Indemnified
Party”) from and against, and shall pay on demand, any and all claims, damages, losses, liabilities and expenses (including, without limitation, reasonable fees and expenses of counsel) that may be incurred by or asserted or awarded
against any Indemnified Party, in each case arising out of or in connection with or resulting from this Agreement (including, without limitation, enforcement of this Agreement), except to the extent such claim, damage, loss, liability or expense is
found in a 

  

 Project Trinity Security Agreement 
 22 

 
final, non-appealable judgment by a court of competent jurisdiction to have resulted from such Indemnified Party’s gross negligence or willful
misconduct. 
  
 (b) Each Grantor will upon demand pay to the
Collateral Agent the amount of any and all reasonable expenses, including, without limitation, the reasonable fees and expenses of its counsel and of any experts and agents, that the Collateral Agent may incur in connection with (i) the
administration of this Agreement, (ii) the custody, preservation, use or operation of, or the sale of, collection from or other realization upon, any of the Collateral of such Grantor, (iii) the exercise or enforcement of any of the rights
of the Collateral Agent or the other Secured Parties hereunder or (iv) the failure by such Grantor to perform or observe any of the provisions hereof. 
  
 Section 21. Amendments; Waivers; Additional Grantors; Etc. (a) No amendment or waiver of any provision of this Agreement, and no consent to any
departure by any Grantor herefrom, shall in any event be effective unless the same shall be in writing and signed by the Collateral Agent, and then such waiver or consent shall be effective only in the specific instance and for the specific purpose
for which given. No failure on the part of the Collateral Agent or any other Secured Party to exercise, and no delay in exercising any right hereunder, shall operate as a waiver thereof; nor shall any single or partial exercise of any such right
preclude any other or further exercise thereof or the exercise of any other right. 
  
 (b) Upon the execution and delivery by any Person of a security agreement supplement in substantially the form of Exhibit D hereto (each a “Security Agreement Supplement”), such Person shall be
referred to as an “Additional Grantor” and shall be and become a Grantor hereunder, and each reference in this Agreement and the other Loan Documents to “Grantor” shall also mean and be a reference to such
Additional Grantor, each reference in this Agreement and the other Loan Documents to the “Collateral” shall also mean and be a reference to the Collateral granted by such Additional Grantor and each reference in this Agreement to a
Schedule shall also mean and be a reference to the schedules attached to such Security Agreement Supplement. 
  
 Section 22. Notices, Etc. All notices and other communications provided for hereunder shall be either (i) in writing (including telegraphic,
telecopier or telex communication) and mailed, telegraphed, telecopied, telexed or otherwise delivered or (ii) by electronic mail (if electronic mail addresses are designated as provided below) confirmed immediately in writing, in the case of
the Borrower or the Collateral Agent, addressed to it at its address specified in the Credit Agreement and, in the case of each Grantor other than the Borrower, addressed to it at its address set forth opposite such Grantor’s name on the
signature pages hereto or on the signature page to the Security Agreement Supplement pursuant to which it became a party hereto; or, as to any party, at such other address as shall be designated by such party in a written notice to the other
parties. All such notices and other communications shall, when mailed, telegraphed, telecopied, telexed, sent by electronic mail or otherwise, be effective when deposited in the mails, delivered to the telegraph company, telecopied, confirmed by
telex answerback, sent by electronic mail and confirmed in writing, or otherwise delivered (or confirmed by a signed receipt), respectively, addressed as aforesaid; except that notices and other communications to the Collateral Agent shall not be
effective until received by the Collateral Agent. Delivery by telecopier of an executed counterpart of any amendment or waiver of any provision of this 

  

 Project Trinity Security Agreement 
 23 

 
Agreement or of any Security Agreement Supplement or Schedule hereto shall be effective as delivery of an original executed counterpart thereof. 

 
 Section 23. Continuing Security Interest; Assignments under the Credit
Agreement. This Agreement shall create a continuing security interest in the Collateral and shall (a) remain in full force and effect until the latest of (i) the payment in full in cash of the Secured Obligations, (ii) the Term
Loan Maturity Date and (iii) the termination or expiration of all Letters of Credit (other than Letters of Credit that are cash collateralized or backstopped by another letter of credit, in each case on terms to the reasonable satisfaction of
the Administrative Agent and the Issuing Bank) and all Secured Hedge Agreements, (b) be binding upon each Grantor, its successors and assigns and (c) inure, together with the rights and remedies of the Collateral Agent hereunder, to the
benefit of the Secured Parties and their respective successors, transferees and assigns. Without limiting the generality of the foregoing clause (c), any Lender may assign or otherwise transfer all or any portion of its rights and obligations under
the Credit Agreement (including, without limitation, all or any portion of its Commitment(s), the Loans owing to it and any promissory note or notes, if any, held by it) to any other Person, and such other Person shall thereupon become vested with
all the benefits in respect thereof granted to such Lender herein or otherwise, in each case as provided in Section 9.04 of the Credit Agreement. 
  
 Section 24. Release; Termination. (a) Upon any sale, lease, transfer or other disposition of any item of Collateral of any Grantor in
accordance with the terms of the Loan Documents (other than sales of Inventory in the ordinary course of business), the Collateral Agent will, at such Grantor’s expense, execute and deliver to such Grantor such documents as such Grantor shall
reasonably request to evidence the release of such item of Collateral from the assignment and security interest granted hereby; provided, however, that (i) at the time of such request and such release no Default shall have
occurred and be continuing, (ii) such Grantor shall have delivered to the Collateral Agent, at least ten Business Days prior to the date of the proposed release, a written request for release describing the item of Collateral and the terms of
the sale, lease, transfer or other disposition in reasonable detail, including, without limitation, the price thereof and any expenses in connection therewith, together with a form of release for execution by the Collateral Agent and a certificate
of such Grantor to the effect that the transaction is in compliance with the Loan Documents and as to such other matters as the Collateral Agent may request and (iii) the proceeds of any such sale, lease, transfer or other disposition required
to be applied, or any payment to be made in connection therewith, in accordance with Section 2.11 of the Credit Agreement shall, to the extent so required, be paid or made to, or in accordance with the instructions of, the Collateral Agent when
and as required under Section 2.11 of the Credit Agreement. 
  
 (b) Upon the latest of (i) the payment in full in cash of the Secured Obligations, (ii) the Term Loan Maturity Date and (iii) the termination or expiration of all Letters of Credit (other than Letters of Credit that are cash
collateralized or backstopped by another letter of credit, in each case to the reasonable satisfaction of the Administrative Agent and the Issuing Bank) and all Secured Hedge Agreements, the pledge and security interest granted hereby shall
terminate and all rights to the Collateral shall revert to the applicable Grantor. Upon any such termination, the Collateral Agent will, at the applicable Grantor’s expense, execute and deliver to such Grantor such documents as such Grantor
shall reasonably request to evidence such termination. 
  

 Project Trinity Security Agreement 
 24 

 Section 25. Execution in Counterparts. This Agreement may be executed in any number of
counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by telecopier shall
be effective as delivery of an original executed counterpart of this Agreement. 
  
 Section 26. Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York. 
  

 Project Trinity Security Agreement 
 25 

 IN WITNESS WHEREOF, each Grantor has caused this Agreement to be duly executed and delivered by its
officer thereunto duly authorized as of the date first above written. 
  

									
	 	 	 	 	 RAINIER ACQUISITION CORP.

					
	 	 	 	 	 	 	 By
	 	 
	 	 	 	 	 	 	 Title:

			
	 Address for Notices:
	 	 	 	 LCI HOLDCO, LLC

	 	 	 	 	 
			
	 	 	 	 	 
	 	 	 	 	 	 	 By
	 	 
	 	 	 	 	 	 	 Title:

			
	 Address for Notices:
	 	 	 	 [NAME OF GRANTOR]

	 	 	 	 	 
			
	 	 	 	 	 
	 	 	 	 	 	 	 By
	 	 
	 	 	 	 	 	 	 Title:

			
	 Address for Notices:
	 	 	 	 [NAME OF GRANTOR]

	 	 	 	 	 
			
	 	 	 	 	 
	 	 	 	 	 	 	 By
	 	 
	 	 	 	 	 	 	 Title:

			
	 	 	 	 	 [ETC.]

  

 Project Trinity Security Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}]]